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Abstract
Background
Stem cell transplantation is routinely used in the treatment of
haematological malignancy. However, it is an intensive treatment
frequently associated with a considerable deterioration in patients'
wellbeing and prolonged recovery. Research into the amelioration of the
negative biopsychosocial factors associated with stem cell transplantation
is essential, facilitating nurses and other health professionals to provide the
best possible care to individuals who have been treated with a stem cell
transplant.
Study Design
58 patients who had been treated with a stem cell transplant were
recruited and randomly allocated to either a health profession led
rehabilitation programme or a self managed rehabilitation programme.
Follow-up measures (SF-36, QHQ, Graham and Longman QoL Scale and
SWT) were taken at three and six months. Qualitative interviews were
conducted with 15 of the 58 participants and with five members of staff.
Results
In all dimensions of the SF-36 the scores of patients recovering after stem
cell transplantation indicated poorer health status in comparison to UK
population norms supporting the need for rehabilitation services for this
patient group. No evidence of a difference between the two modes of
rehabilitation was observed for any of the trial outcomes.
The qualitative interview data indicated that from patients' and staff's
perspectives there was scope for improvement in the rehabilitation
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programmes. The interview data also highlighted that staff were concerned
that the trial conditions had negatively impacted the provision of
rehabilitation, drawing attention to the difficu Ities inherent in the
evaluation of complex interventions.
Conclusions
Existing literature, the SF-36 data collected in this study and the
experiences of both patients and health professionals expressed in the
qualitative component of this study all indicate that rehabilitation is an
important component of health care following stem cell transplantation.
However, the rehabilitation needs and desires of this patient group are
complex and therefore any rehabilitation programme must reflect this
complexity. Enabling patients to work collaboratively with health
professionals in determining the most appropriate provision of
rehabilitation may result in enhanced levels of patient satisfaction with
rehabilitation services. However, the efficacy of rehabilitation following
stem cell transplantation remains unproven and the provision and
evaluation of patient centred rehabilitation raises numerous practical and
methodological challenges.
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Chapter 1 - Introduction
1.1 Stem cell transplantation
Stem cell transplantation is a routine treatment for many patients
diagnosed with a haematological malignancy (Duncombe 2003). However
the impact that diagnosis and subsequent treatment with stem cell
transplantation has on an individual should not be underestimated.
Individuals with haematological malignancies can present with a very short
clinical history of weeks or even days. Alternatively patients may have
spent months feeling vaguely unwell without seeking medical advice since
they had no specific symptoms. Newly diagnosed patients are often
encouraged to rapidly progress to active treatment. Treatment usually
consists of chemotherapy often combined with total body irradiation. This
process causes the destruction of the patient's own bone marrow cells.
These cells are then replaced with bone marrow or peripheral blood stem
cells that have been collected, either from a donor or from the patient
during a period of disease remission. Whilst these treatments do now offer
the chance of cure from previously fatal diseases, stem cell transplantation
is still a high risk treatment which is associated with significant short and
long term side effects that have a considerable impact on every aspect of
an individual's life.
1.2 The study
A randomised controlled trial was used to evaluate a health profession led
rehabilitation programme following stem cell transplantation for the
treatment of haematological malignancies. The health profession led
rehabilitation programme consisted of a ten week programme of exercise,
relaxation and information. In order to provide a suitable comparator a self
managed rehabilitation programme was devised. The self managed
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programme consisted of a series of information leaflets. The primary aim of
this study was to evaluate the effectiveness of the health profession led
rehabilitation programme in promoting recovery six months after stem cell
transplantation.
1.3 Clarification of terms
The terms that are commonly used in relation to stem cell transplantation
are set out in figure 1.1. The terms 'haemopoietic transplant' and 'stem cell
transplant' are synonymous and refer to the transplantation of any stem
cells regardless of their source or site of collection. Throughout this study
the term stem cell transplant will be used. The term 'allogeneic transplant'
refers to a transplant using donated stem cells. The term 'autologous'
refers to transplants using stem cells that have been collected from an
individual and stored whilst they undergo treatment and then returned to
the same individual. Stem cells for use in autologous or allogeneic
transplants can be harvested either directly from the bone marrow where
they are produced or from the peripheral blood. In order to ensure
sufficient numbers of cells are present in peripheral blood prior to collection
the individual is treated with chemotherapy and/or growth stimulating
factors to increase stem cell production. This study included individuals
who had undergone any type of stem cell transplant.
12
Generic terms
Figure 1.1: Transplant terminology (adapted from Duncombe 2003)
Donor Source Site of stem cell collection
Bone
Marrow
Allogeneic
Peripheral
BloodHaemopoietic
Transplant or
Stem cell
transplant Bone
MarrowAutologous
Peripheral
Blood
1.4 Epistemological, ontological and methodological
foundations
This research is based upon a post-positivist epistemology and a critical
realist ontological position recognising that we can never verify that we
have achieved absolute knowledge, but asserting that it is possible to
establish rules of causation that allow general principles to be drawn from
specific examples. Traditionally different research methods have been
inextricably linked to different ontological positions, quantitative techniques
to realism and qualitative techniques to relativism. Post-positivism's
acknowledgement that different research methodologies lead to different
types of knowledge is crucial to this research project. Both quantitative and
qualitative approaches have been employed in order to explore different
aspects of recovery after stem cell transplantation and in so doing to
conduct research that is reflective of the experience of patients, and that
can be used to influence policy decisions relating to service provision.
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1.S Theoretical foundations
This study is situated within a biopsychosocial framework. At the core of
this framework is the conviction that not just biological but also social,
psychological and behavioural dimensions are crucial in the assessment of
health. The biopsychosocial framework recognises that the boundaries
between health and disease, between well and sick, are far from clear and
that these concepts are diffused by cultural, social and psychological
considerations (Engel, 1977). Further consideration of this theory can be
found in section 2.6 of chapter two.
1.6 Clinical relevance of the study
The code for professional conduct for nurses and midwives in the UK states
that nurses must deliver care based on the best available evidence
(Nursing & Midwifery Council, 2008). However, the guidelines do not
provide advice on the appropriate course of action to take when the best
available evidence is inconclusive, incomplete or contradictory. This was
the situation encountered by the team at a busy haematology centre. The
team had identified a need for further support, both physical and
Psychosocial, to individuals following stem cell transplantation. However,
the existing evidence failed to demonstrate how best to proceed with
meeting this need. The clinical team approached the University of
Nottingham to ask for assistance in the evaluation of a rehabilitation
service that they had designed to meet the identified need. Therefore the
research on which this thesis is based was initiated in the clinical
environment in response to an acknowledged need. It set out to answer a
question raised by those actively involved in the delivery of care to those
undergoing stem cell transplantation. As such, the study is rooted at the
heart of clinical practice.
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1.7 Overview of the thesis
Chapter two discusses the use of stem cell transplantation as a treatment
for haematological malignancies. The positive and negative sequelae
associated with haematological malignancy and stem cell transplantation
are considered in order to explore the long-term consequences of this
diagnosis and its treatment. Consideration is also given to the research
concerning the amelioration of these long-term effects and also to the
wider body of work exploring the concept of cancer rehabilitation in
general. It is shown that patients who have been diagnosed with a
haematological malignancy and undergone treatment with a stem cell
transplant have a range of physical, psychological and social rehabilitation
needs and that there is some evidence that a combination of exercise,
emotional and information may be effective in meeting this need. It is
established that further research in this area is required.
In chapter three the methods employed in this study are described.
Consideration is first given to the structure and content of the rehabilitation
programme. This programme was originally proposed by a clinical team in
response to an unmet need that they had perceived in patient care. Details
are provided of a preliminary study that was carried out by this clinical
team to assess the acceptability and feasibility of the programme. The aim
and objectives for the current study are set out, followed by an explanation
of why a randomised controlled trial was chosen as the most suitable
method for meeting these. The changes to the rehabilitation programme
that were introduced in order for a randomised controlled trial to be
possible are then outlined. Once this important groundwork has been
established the details of the research design for the randomised controlled
trial are discussed.
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Chapter four reports the results of the bone marrow and stem cell
transplant rehabilitation trial. The chapter includes a description of the
study sample and compares the demographic characteristics of those who
took part with those who did not. The reasons participants gave for not
wishing to take part are also reported. Detailed demographic and clinical
details as well as baseline scores for the outcome measures are provided
for participants randomised to both the health profession led and self
managed rehabilitation programmes. The results of analysis carried out on
the primary and secondary outcome data is then presented. Exploratory
analysis is presented and finally the SF 36 data from this trial is compared
with some normative data from the UK population.
Chapter five reports the findings of the qualitative data analysis conducted
on the semi structured interviews that were carried out with 15 trial
participants and five members of staff. The findings from each group of
interviews are presented separately. Firstly, the views of participant
interviewees on the experience of participating in a randomised controlled
trial are presented. Secondly, the acceptability of each programme to
participants is discussed. Finally, the experiences of the staff interviewees
are explored.
Chapter six presents a discussion on the findings of the stem cell transplant
trial and the associated qualitative investigation. This is followed by an
examination of the methodology employed in this study. The rationale for
using a randomised controlled trial is reconsidered and the potential merits
and limitations of alternative designs that could have been employed are
debated. Finally, consideration is given to the implications of this research
for practice.
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Chapter 2 - Literature Review
2.1 Introduction
This chapter discusses the use of stem cell transplantation as a treatment
for haematological malignancies. The positive and negative sequelae
associated with haematological malignancy and stem cell transplantation
are considered in order to explore the long-term consequences of this
diagnosis and its treatment. Consideration is also given to the research
concerning the amelioration of these long-term effects and also to the
wider literature relating to cancer rehabilitation.
2.2 Haematological Malignancies
The majority of haematological malignancies fall into one of three broad
diagnostic groups: leukaemia, myeloma or lymphoma. Leukaemia accounts
for approximately three percent of all cancers in the United Kingdom. Each
year in the UK almost 7,000 people are diagnosed with leukaemia and the
disease causes more than 4,250 deaths (Cancer Research UK, 2006).
Leukaemia is a neoplastic proliferation of cells of haematopoietic origin. It
can be treated with chemotherapy which, in some cases, is combined with
stem cell transplantation. The symptoms of leukaemia are due to the
proliferation of leukaem ic cells and their infiltration into normal tissue
(Bratt-Wyton, 2000). Infiltration of leukaemic cells into the bone marrow
leads to anaemia, neutropenia and thrombocytopenia, which can lead to
infection and haemorrhage (Dexter, 1977). The four most common types
of leukaemia are acute myeloid leukaemia, acute lymphoblastic leukaemia,
chronic myeloid leukaemia and chronic lymphoblastic leukaemia (Bratt-
Wyton, 2000).
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Myeloma is a disease arising from uncontrolled growth of plasma cells
(Dowling, 2000). It accounts for approximately one percent of all cancer
diagnoses in the United Kingdom. Each year in the UK more than 3,600
cases of multiple myeloma are diagnosed and the disease causes more
than 2,600 deaths (Cancer Research UK 2006). Symptoms of the disease
occur either directly from the excessive malignant plasma protein in the
bone or indirectly from the secreted products of abnormal
immunoglobulins. The majority of patients present with symptoms which
are secondary to bone destruction resulting from osteolytic lesions. Since
myeloma is incurable the goal of treatment is symptom control (Dowling,
2000).
Lymphomas are a diverse group of diseases arising from lymphoid tissue.
Lymphomas comprise two distinct groups: Hodgkin's lymphoma and non-
Hodgkin's lymphoma. According to data gathered from 1973-1996 by the
World Health Organisation International Agency for Research on Cancer the
world-wide incidence of non-Hodgkin's lymphoma is rising steadily and
incidence rates are observed to be higher in western Europe, North
America and Australia (Parkin et al., 1997). The incidence of Hodgkin's
lymphoma is consistently lower than that of non-Hodgkin's lymphoma. In
contrast to the steady rise seen in incidence rates for non-Hodgkin's
lymphoma, there was a 16% decrease in the incidence of Hodgkin's
lymphoma from 1973-1996 (Parkin et al., 1997). Presenting symptoms for
lymphoma can include localised lymphadenopathy, malaise, fever, night
sweats and unexplained weight loss (Grundy, 2000). Both Hodgkin's
lymphoma and non-Hodgkin's lymphoma are treatable, although non-
Hodgkin's lymphoma in particular is still associated with significant
mortality rates (Grundy, 2000).
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2.3 Development of stem cell transplantation as a
treatment for haematological cancers
The first known medical use of bone marrow was by Brown-Sequard in
1891. Marrow was given orally after meals for the treatment of leukaemia
(Benjamin, 1995). Between 1891 and the middle of the 20th century a
number of attempts were made to use marrow in a variety of ways, albeit
unsuccessfully, to cure diseases of the blood (Whedon, 1995). Animal
experiments in the 1950's demonstrated that marrow cells could be
successfully transfused, following destruction of haematopoietic cells with
toxic radiation, resulting in engraftment of the transfused cells and
restoration of haematopoiesis (Duncombe, 2003). However, attempts to
replicate this finding in humans were hindered by a lack of understanding
in the field of immunology. The first successful human bone marrow
transplant was between identical twin siblings. Successful transplantation
and engraftment of marrow between non-identical siblings and unrelated
individuals only became possible with the discovery of the human leukocyte
antigen (HLA) system. Human leukocyte antigens are a major component
of the immune system and allow the body to recognise foreign material
and attack it. If a donor and recipient are not well HLA-matched,
transplanted cells recognise the recipient's body as foreign and attack it.
This reaction is now known as graft versus host disease. The key historical
milestones in the development of allogenic stem cell transplantation are
summarised in figure 2.1.
Not all haematopoietic transplants require that donor cells be used. For
some conditions it is sufficient to remove haematopoietic cells from an
individual, treat the person with chemotherapy and/or radiotherapy and
then re-infuse the person's own cells. Whilst from an immunological
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perspective this procedure is far simpler than using donor cells, its
development as a treatment was only possible following the development
of cryopreservation - a process whereby cells are preserved by cooling
them to sub-zero temperatures (approximately -196°C) so that biological
activity is effectively stopped.
Figure 2.1: Historical milestones in the development of allogeneic
stem cell transplantation.
• 1950's - Animal experiments demonstrate that marrow cells
can be successfully transfused.
• 1956 - First successful human bone marrow transplant was
carried out between identical twins.
• 1958 - Discovery of the HLA system and first human
histocompatibility antigen described.
• 1968 - First successful transplantation between non-identical
siblings was carried out.
• 1973 - First successful unrelated bone marrow transplant
carried out.
2.4 Allogeneic Transplantation
Allogeneic transplants use stem cells that have been harvested from the
peripheral blood, bone marrow or umbilical cord blood of a healthy
matched donor. The donor may be a family member, most frequently a
sibling, or an unrelated volunteer. The major limiting factor for the number
of allogeneic transplants performed is the availability of suitable donors
(Lennard and Jackson, 2000). Donors and recipients need to be HLA
matched to reduce the likelihood of the transplanted cells attacking the
reclplents own cells causing potentially fatal graft versus host disease.
Population based studies indicate that only 20%-25% of patients eligible
for allogene!c transplantation will have a HLA matched sibling (Lennard et
al., 1998). A number of registries of volunteer stem cell donors have been
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developed in order to increase the likelihood of finding an unrelated
matched donor. There are now over six million donors registered on
national donor registers worldwide (Lennard and Jackson, 2000).
Allogeneic transplants are used in the treatment of chronic myeloid
leukaemia, acute myeloid leukaemia, myelodysplasia, acute myeloid
leukaemia, acute lymphoblastic leukaemia, thalassaemia, multiple
myeloma, Hodgkin's lymphoma and Non-Hodgkin's lymphoma (Lennard
and Jackson, 2000). The process of treatment with an allogeneic transplant
is summarised in figure 2.2. Before the transplant can take place the
recipient must undergo a course of chemotherapy which mayor may not
be combined with radiotherapy. Stem cells which have previously been
collected from the bone marrow or peripheral blood of a donor are then
transfused into the recipient. Between transplantation and engraftment of
the donated cells there is a period of severe myelosuppression which
results in profound neutropenia. As the donated stem cells become
engrafted into the recipient's marrow, blood cell production gradually
increases and recovery begins.
Figure 2.2: Procedure for treatment with an allogeneic transplant
(adapted from Duncombe 2003)
Recipient Donor
Chemotherapy or Harvesting of stem cells
chemoradiotherapy from bone marrow or
1
peripheral blood
I
Transplantation of stem cells
1
Severe myelosuppression
1
Engraftment
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2.S Autologous Transplantation
Autologous transplants use stem cells which are collected from the
patient's own bone marrow or peripheral blood. The cells are processed
and cryopreserved while the patient undergoes a conditioning regime of
chemotherapy or chemoradiotherapy. After this treatment period the stem
cells are thawed and returned to the patient. As with allograft transplants
following transplantation there is a period of severe myelosuppression
before engraftment of the transplanted cells. The process of treatment with
an autologous transplant is summarised in figure 2.3. Autologous
transplantation is the most common type of stem cell transplantation
(Lennard and Jackson, 2000). Autologous transplants are used in the
treatment of acute lymphoblastic leukaemia, Hodgkin's lymphoma, Non-
Hodgkin's lymphoma, multiple myeloma, chronic myeloid leukaemia, acute
myeloid leukaemia (Lennard and Jackson, 2000).
Figure 2.3: Procedure for treatment with an autologous transplant
(adapted from Duncombe 2003)
Stem cells harvested from bone marrow or peripheral blood of the
patient (whilst disease is in remission)
r~
Processing and Patient treated with chemotherapy
Cryopreservation of stem cells or chemoradiotherapy
L. ...JTransplantation of
thawed stem cells
1
Severe
myelosu ppression
,
Engraftment
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2.6 Biopsychosocial Framework
The effects of these illnesses and treatments are complex and affect not
only the physical but also the psychological and social functioning of
individuals. Therefore it is important that this topic is viewed within a
dynamic framework that enables consideration of the many and varied
problems associated with haematological malignancy and stem cell
transplantation.
The biopsychosocial framework highlights that not only are biological
aspects crucial in the assessment of health but that social, psychological
and behavioural dimensions are of equal importance. The biopsychosocial
framework recognises that the boundaries between health and disease,
between well and sick, are far from clear and that these concepts are
diffused by cultural, social and psychological considerations (Engel, 1977).
Engel (1977) in his seminal work on the framework discusses the complex
issue of health specifically in situations where the doctor and the patient
experience differing perspectives of health. Engel uses the examples of
diabetes and schizophrenia to highlight the issues, but haematological
malignancy can serve as an equally good illustration. Many patients feel
healthy but medical tests reveal changes in blood cell counts that are
indicative of life threatening malignant disease. Conversely, patients may
come to the end of treatment and be told that the transplant procedure has
been successful yet they may feel worse in themselves than before
treatment started. Clearly, a model of health based on organic mechanisms
alone is inappropriate for consideration of this topic. However, to dismiss
the importance of the biological aspects of treatment would be equally
remiss.
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The biopsychosocial framework is appropriate for the consideration of
diagnosis of a haematological malignancy and treatment with a stem cell
transplant because both are associated with biological, psychological and
social consequences. These sequelae need to be considered within a
structure that does not include an inherent hierarchy since biological
symptoms are not necessarily more important than psychological or social
ones. The model also recognises that these aspects of health are not
necessarily distinct categories and a symptom, treatment or sequelae may
be associated with biological, psychological and social health.
The principles of the biopsychosocial framework and the negative side-
effects associated with a diagnosis of a haematological malignancy and
treatment with stem cell transplantation have been combined to develop
figure 2.4. The model highlights that illness and treatment has an effect on
physical, psychological and social health but that the effects do not
necessarily fall into distinct categories. Fatigue, for example, has physical,
Psychological and social causes and consequences.
24
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Figure 2.4: The negative biopsychosocial sequelae associated with
stem cell transplantation
GVHD
Reduced physical functioning
Poor nutrition
Neutropenia
Fatigue
Anxiety
Depression
Stress
Alteration in roles
Financial worries
Isolation
Social
2.7 The negative consequences of haematological
malignancy and stem cell transplantation
The most common negative side-effects associated with haematological
malignancy and stem cell transplantation are summarised in figure 2.4.
These biological, psychological and social problems will now be considered
in more detail.
Graft Versus Host Disease (GVHD)
Graft versus host disease is a common consequence of allogeneic stem cell
transplantation (Wingard, 1998). Graft versus host disease occurs when
transplanted lymphocytes recognise the recipient's own cells as 'foreign'
and initiate an immune response (Mehta and Hoffbrand, 2005). Several
factors influence the likelihood of a graft versus host reaction occurring.
Since the HLA system is the principal system by which cells of the immune
system recognise foreign cells, the degree of HLA mismatch between donor
and recipient is a crucial factor influencing the development of graft versus
host disease. As the degree of HLA mismatch increases so does the risk of
graft versus host disease. The incidence of graft versus host disease is
approximately 40% with an HLA identical transplant and increases to 70%
when two HLA mismatches are present (Gillis and Donovan, 2000).
Graft versus host disease can be classified as either acute, if it occurs
within 100 days of transplantation, or chronic, if occurring after that time
(Duncombe, 2003). The initial effects of the transplanted lymphocyte
initiated immune response are skin rashes, abdominal pain, profuse
diarrhoea and jaundice (Duncombe, 2003). These symptoms are not only
distressing for transplant reclplents but acute graft versus host disease can
be so severe that it results in death. Fatality rates as high as 20% have
been found for acute graft versus host disease (Bron, 1994).
Between 30% and 70% of allograft recipients develop chronic graft versus
host disease (Atkinson et al., 1990, Ochs et al., 1994). The clinical features
associated with chronic graft versus host disease are sclerotic atrophic
skin, sicca syndrome, mucosal ulceration, malabsorption syndromes,
recurrent chest infections, jaundice, joint movement restriction,
hyposplenic infections (e.g. Pneumococcus), and myelosuppression
(Duncombe, 2003). Previous research has indicated that chronic graft
versus host disease is associated with decreased quality of life (Sutherland
et al., 1997), decreased functional status (Syrjala et al., 1993, Duell et al.,
1997, Worel et al., 2002), higher levels of depression (Syrjala et al., 2004)
and incomplete resumption of social activities (Duell et al., 1997, Worel et
al., 2002). Chronic graft versus host disease is the leading cause of late
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treatment related death amongst recipients of allogeneic transplants
(Duncombe, 2003, Duell et al., 1997, Worel et al., 2002).
There are a number of mechanisms by which the prevention and treatment
of graft versus host disease are managed. By depleting T cells from the
donor marrow prior to transplantation the incidence and severity of graft
versus host disease can be decreased. Suppression of the recipient's
immune system can also be an effective preventative measure. Ciclosporin
and methotrexate are commonly used immunosuppressive agents which
have been shown to be effective in reducing the incidence of graft versus
host disease (Bolwell et al., 2004, Ruutu et al., 2000). The primary
treatment for graft versus host disease is corticosteroids and consequently
steroid myopathy results for most patients (Gillis and Donovan, 2000).
Despite the many negative consequences of graft versus host disease, its
presence has been shown to reduce rates of disease relapse (Lee et al.,
2002). The transplanted lymphocytes recognise not only the host but also
the tumour as 'foreign' and the resulting immune response attacks the
tumour as well as the host's healthy tissue. This graft versus tumour effect
has been shown to have a significant positive impact on disease free
recovery (Horowitz et al., 1990).
Reduced Physical Functioning
Reduced physical activity is common in patients undergoing stem cell
transplantation, leading to numerous physiological consequences. A
reduction in physical activity can be caused by both the side effects of
treatment such as nausea, pain and fatigue and the boredom and physical
lack of space associated with protective isolation. Levels of activity may be
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further reduced by patients being advised not to exercise due to low
platelet counts. This is due to concern that exercise may result in injury
that causes uncontrolled bleeding.
Inactivity has dramatic effects on both the musculoskeletal and
cardiovascular systems. Musculoskeletal effects include muscle atrophy,
decreased strength of tendons and ligaments, osteoporosis, cartilage
degeneration and synovial atrophy (Topp et al., 2002). The speed with
which these problems occur varies but one study with healthy volunteers
demonstrated that one to two days of bed rest are sufficient to exacerbate
bone loss (Baecker et al., 2003) and four to six weeks of bed rest can
result in dramatic changes in muscle mass, accompanied by a decrease of
up to 40% in muscle strength (Bloomfield, 1997). Cardiovascular effects
include increased heart rate, decreased stroke volume, decreased cardiac
size/volume and decreased left ventricular end-diastolic volume (Topp et
al., 2002). One study has shown that maximal oxygen uptake (used to
evaluate cardiovascular function) decreased by 26% in healthy male
subjects after 21 days in bed. These reductions in physical functioning can
take weeks or months to recover from depending on the length of time of
decreased physical activity (McTiernan, 2004).
In their study of the long term impact of lymphoid malignancies treated
with autologous stem cell transplantation, Vase et al. (1992) found that
there was a minimal effect on pulmonary and cardiovascular functioning
one year after treatment. Molassiotis and Morris (1999b), investigated
quality of life in 28 patients diagnosed with chronic myeloid leukaemia and
treated with an unrelated bone marrow transplant. This study found that
impaired physical functioning was affecting activities of daily living in a
considerable number of survivors. Difficulty doing strenuous activities (i.e.
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carrying a heavy shopping bag or a suitcase) was reported by more than
50% of the sample. Half of the sample had trouble taking a long walk and
approximately ten percent had trouble taking even a short walk. 50% of
the sample experienced shortness of breath as a problematic symptom and
32% experienced muscle pain (Molassiotis and Morris, 1999a). The
duration of this reduction in physical functioning has not been clearly
established. A follow up study of patients after allogeneic bone marrow
transplantation identified that physical performance continued to be
affected ten years after treatment (Kiss et al., 2002).
The reduction in physical functioning caused by a reduction in physical
activity can be compounded by a number of further problems associated
with stem cell transplantation. In particular, inadequate nutritional intake
and neutropenia are two problems that most patients recovering from stem
cell transplantation experience and which have a negative impact on
physical functioning.
Nutritional Problems
Many of the side-effects experienced by stem cell transplant patients have
the potential to cause difficulty in maintaining adequate nutrition. These
side effects include nausea, vomiting, constipation, diarrhoea, taste and
smell changes, mouth sores, mouth dryness, difficulty swallowing, dental
problems and lack of appetite (Zittoun et al., 1999). A study by Larsen et
al. (2004) investigated symptom occurrence, symptom intensity and
symptom distress in 47 patients who were undergoing stem cell
transplantation. Loss of appetite, mouth dryness, nausea, diarrhoea, and
taste changes were reported by more than 50% of patients. Loss of
appetite and mouth dryness were reported as two of the three symptoms
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that patients found most intense and distressing (Larsen et al., 2004). The
same study found that over 50% of the sample were still experiencing one
or more of these distressing symptoms when they were discharged from
hospital (Larsen et al., 2004).
A study of similar size (n=50) conducted by Molassiotis et al. (1995)
reported that patients who have undergone treatment with an allograft
transplant may still experience problems related to a dry and painful mouth
more than six months after their treatment. 38% of the study sample
reported ongoing problems related to a dry mouth and 15% reported a
sore mouth and pain when swallowing. However the results also indicated
that problems with diarrhoea and vomiting tended to be resolved within six
months of treatment (Molassiotis et al., 1995). In another study,
undertaken with patients who had been treated with an autologous
transplant more than one year previously, 96% of patients thought that
their appetite was good and 86% reported that their weight was either
stable or that they had gained weight since transplant (Vose et al., 1992).
These findings are supported by the work of Molassiotis (2003) who
reanalysed data gathered in two other studies carried out with patients
with haematological malignancies. The results from this reanalysis
indicated that nutritional problems did not cause long-term concern for this
patient population.
Neutropenia
Neutropenia is a problem that is commonly associated with cancer and its
treatment. This is particularly true for patients with a haematological
malignancy for whom alteration in blood cell counts can be one of the first
indications of disease (Bratt-Wyton, 2000, Dowling, 2000, Grundy, 2000).
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Hayes et al. (2003) investigated immunological changes after autologous
stem cell transplantation. The patients were immunocompromised before
their transplants and the transplant procedure caused further adverse
changes to leukocyte and lymphocyte counts. Leukocyte counts had
returned to normal within three months of transplantation. However other
immunological parameters remained depressed at three months post
transplant (Hayes et al., 2003). Immunocompromisation is an unavoidable
consequence of stem cell transplantation and therefore post transplant
infections are common. In one study conducted with patients who had
been treated with an autologous transplant found that 39% of the sample
had no problem with infection post treatment. However, 24% became
infected with herpes zoster four to eight months post transplant. Other less
common infections included bacterial pneumonia, CMV pneumonia, Cystitis,
pyelonephritis, aseptic meningitis and Hickman line infections. In this study
16% of patients experienced four or more upper respiratory tract infections
per year (Vose et al., 1992). In order to protect patients and to minimise
the risk of infection during the initial post transplant period, patients are
nursed in protective isolation. Laminar air flow systems are used to try and
prevent airborne infections and special precautions are often taken with
food and drink to reduce the risk of enteric infections.
Fatigue
Fatigue is one of the most common problems experienced by cancer
patients (Dimeo, 2001). Patients being treated for haematological
malignancy are no exception to this (Wang et al., 2002, Lee et al., 2001).
In one study 50% of patients being treated for haematological malignancy
reported severe fatigue (Wang et al., 2002).
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Fatigue, which is relieved by rest, can be a normal response to physical
and/or mental exertion. However, in a variety of circumstances this normal
response mechanism can become particularly prolonged, severe and
difficult to resolve. Cancer, its diagnosis and its treatment are associated
with particularly disabling fatigue.
Cancer-related fatigue has been characterised as a multidimensional
subjective phenomenon (Winningham et al., 1994) that develops over
time, diminishes energy, mental capacity and the psychological condition of
cancer patients (Cella et al., 1998). Fatigue has been described by patients
as tiredness, weakness, lack of energy, exhaustion, lethargy, depression,
inability to concentrate, malaise, boredom, sleepiness, lack of motivation
and decreased mental status (Winningham et al., 1994).
Fatigue is known to affect patients undergoing treatment with both
autologous and allograft transplants (Knobel et al., 2000). Research has
also shown that these patients may continue to experience fatigue for
many years after their treatment. Fatigue has been shown to be highly
prevalent in lymphoma patients four to ten years after treatment (Loge et
al., 1999). Similarly fatigue was one of the three most commonly reported
problems in a study of 125 adult survivors, six to eighteen years after
treatment (Andrykowski et al., 1990).
Distinguishing between the causes, indicators and effects of cancer-related
fatigue is challenging (Winningham et al., 1994). The mechanisms which
cause fatigue are complex and poorly understood (Gutstein, 2001). A
patient's underlying disease, its treatments and the psychological stresses
associated with cancer all contribute to the development of cancer-related
fatigue (Winningham et al., 1994).
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Cancer fatigue has been shown to affect many aspects of people's lives
including general activity, work, enjoyment of life, mood, mobility and
walking, as well as their relationships with others (Pederson and Parran,
1999). Transplant survivors who continue to suffer from fatigue report poor
vitality and poor role functioning (Sadler et al., 2002). Fatigue is also
associated with depressive symptoms (Wang et al., 2002).
Some biological causes of fatigue can be identified and treated. For
example anaemic individuals can be given a blood transfusion. However,
for the majority of cancer patients a single treatable explanation for their
fatigue does not exist. Recent research has explored the impact of a
number of different therapies on cancer-related fatigue including exercise,
relaxation, complementary therapies and massage (Adamsen et al., 2004,
Oldervoll et al., 2003, Kim and Kim, 2005, Ahles et al., 1999). These are
discussed in more detail in section 2.9.
Psychological Impact of Stem Cell Transplantation
It has been suggested that anxiety regarding painful procedures and strict
isolation, along with depression, are universal reactions during autologous
stem cell transplantation (Wolcott et al., 1987). A degree of anxiety and
depression can be a normal psychological reaction to adverse situations. It
could be argued that a patient has not comprehended the nature of their
treatment if they were to have no anxieties about it, and given the
distressing symptoms experienced during hospitalisation such as pain,
nausea, fatigue, hair loss and appetite loss (Carlson and MacRae, 2002)
feelings of anxiety and depression are hardly surprising. However, for some
individuals anxiety and depression are not simply natural responses to a
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stressful situation but on-going and persistent problems that can have a
considerable impact on daily functioning and well-being.
As part of an investigation into quality of life, Zittoun et al. (1999)
measured anxiety and depression during intensive chemotherapy and/or
bone marrow transplantation using the Hospital Anxiety and Depression
Scale (HADS) (Zigmond and Snaith, 1983). They did not identify any
significant changes in anxiety and depression over time. However, between
23% and 35% of participants did have scores that were indicative of
clinical anxiety or depression. It could be argued that this finding is to be
expected in a population of patients undergoing such intensive and
distressing treatment. But for some patients these symptoms do not
necessarily resolve on completion of treatment. Molassiotis and Morris
(1999b) also measured anxiety and depression using the HADS. Their
sample consisted of 28 participants who had undergone unrelated bone
marrow transplantation an average of 41.2 months previously. Of the
sample, 7% were identified with symptoms of clinical anxiety and a further
25% were classified as borderline cases of anxiety, with sub-clinical
symptoms. No cases of clinical depression were identified but four people
(14%) were within the borderline range (Molassiotis and Morris, 1999a).
This was a small exploratory study and general conclusions cannot be
drawn, however it does indicate that for some patients anxiety and/or
depression may be ongoing problem following stem cell transplantation.
One of the earliest studies investigating the psychosocial effects of bone
marrow transplantation was conducted by Wolcott et al. (1986). The study
assessed 26 adult patients who had survived for one year or more following
transplantation. About one quarter of the participants said that they were
experiencing significant emotional distress, chronic physical symptoms, low
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self-esteem and below optimal life satisfaction. Brown and Kelly (1976)
used a qualitative approach to explore psychological reactions to stress
over eight stages of the stem cell transplant process. They identified that
after discharge from hospital people experience a range of psychological
reactions and that in particular people may struggle with attempting to
balance feelings of entitlement at being the survivor of such a challenging
process with feelings of persistent indebtedness, having needed so much
help from their donor and others. Another issue raised by the study was
concern about whether the individual who had been treated with a stem
cell transplant had been permanently altered by the illness and its
treatment. Fear of recurrent disease/death, and coping with memories
from the transplant were causes of psychological distress identified in a
qualitative study investigating the effects of unrelated donor bone marrow
transplants (Molassiotis and Morris, 1998a). Lesko et al. (1992) have
suggested that whilst many acute leukaemia survivors experience overall
psychological well-being and social adjustment, they carry a psychological
burden of distress that does not reach a psychiatric threshold.
Social Impact of Stem Cell Transplantation
Prolonged periods of time spent in hospital, anxiety over the future and the
inevitable change in social roles that accompanies treatment with a stem
cell transplant can all have an impact on the social functioning of survivors.
A qualitative study investigating the effects of unrelated donor bone
marrow transplants asked 28 participants about difficult areas to deal with
after returning home. Responses included difficulty in coping with family
life, problems with social life, increased dependency on others, difficulty in
returning to work and dealing with financial restrictions (Molassiotis and
Morris, 1998a). These findings are supported by a small scale quantitative
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study (n=29) conducted by Whedon et al. (1995). They found that as
many as 93% of autologous bone marrow transplant survivors reported
experiencing moderate to severe distress over the effect of illness on their
family more than one year after treatment (Whedon et al., 1995).
Similarly, marital difficulties post autologous bone marrow transplantation
were noted as a problem in a study by Vose et al. (1992).
However stem cell transplantation does not necessarily have only negative
effects on social relationships. A study investigating the impact of
autologous and allograft transplants on the family relationships of survivors
several years after treatment found that family relationships tended to be
more integrated and lower in conflict compared with non transplant-
affected families (Molassiotis et al., 1995). Similarly, a follow up study of
patients at least ten years after allogeneic bone marrow transplantation
noted a high degree of satisfaction with interpersonal relationships (Kiss et
al., 2002).
A larger study (n=131) was conducted by Langer et al., the primary focus
of which was to explore prospectively patient and caregiver marital
satisfaction following stem cell transplantation. Interestingly couples were
matched in their perceptions of their relationship prior to transplantation
but grew mismatched over time. However, change in marital satisfaction
was not associated with change in physical or psychosocial characteristics.
The study also indentified that female caregivers were more depressed and
anxious, and less satisfied with their marriages compared to male
caregivers (Langer et al., 2003). This study raises some interesting issues
and highlights that the physical, cognitive and emotional challenges of
stem cell transplantation are rarely, if ever, handled in isolation. Patients,
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family members, care givers and significant others all need to adapt to the
challenges presented to them.
Several studies have investigated the impact that treatment with stem cell
transplantation has on sexual relationships. One recent study has
investigated reproduction and sexuality after total body irradiation and
stem cell transplantation. The sample included 34 men and 36 women. Out
of these 70 patients 41 reported experiencing a negative change in sexual
relations. None of the patients were fertile following treatment and 24 of
the women experienced menopausal symptoms (Claessens et al., 2006).
One systematic review of studies investigating quality of life following
autologous stem cell transplantation suggests that over half of autologous
transplant patients report a decrease in sexual pleasure and/or activity
long after their treatment is completed (Carlson and MacRae, 2002).
Clearly changes in sexual functioning following stem cell transplantation
are an important issue that has been shown to have a negative effect on
quality of life (Claessens et al., 2006).
A further aspect of social functioning is employment. Several studies have
investigated employment status five years after autologous and allograft
transplantation. Employment status consistently appears high at this time
point with one study finding that 89% of patients had returned to work
(Duell et al., 1997) and another suggesting that 84% had returned to work
(Syrjala et al., 2004). However a small scale study by Molassiotis and
Morris (Molassiotis and Morris, 1999b) conducted with survivors of
unrelated bone marrow transplantation an average of 41.2 months post
treatment, found that 46% of the participants had needed to either
considerably modify or completely change their goals concerning their
job/education and that 11% of the sample reported experiencing either a
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moderate or great increase in problems with co-workers since their illness.
These results suggest that survivors may experience problems with
employment that a simple measure of employment status, i.e. employed or
unemployed, is unable to detect.
Quality of Life
Traditionally, health has been measured by assessing reductions in
functioning. The focus on quality of life represents an important attempt to
view health as a positive construct. Unfortunately the term 'quality of life'
is frequently ill-defined. Therefore before considering studies that have
investigated the quality of life of stem cell transplant patients it is worth
exploring the concept in order to provide a definition for use in the present
study.
No common definition or definitive theoretical framework for the concept of
quality of life has emerged from the research community (Bowling, 2005).
The terms 'quality of life', 'health-related quality of life', 'health status' and
'functional assessment' are often used interchangeably to describe the
same concepts and even the same instruments (Beckie and Hayduk,
1997). This inconsistency undermines the value of quality of life research
and causes confusion when making comparisons between studies.
Bowling (2005) comments that quality of life is an amorphous concept.
However, if any meaningful research is to be undertaken in relation to
quality of life it is crucial that some structure is applied to the term. Quality
of life has been described as a multidimensional concept (Mandzuk and
McMillan, 2005). Edman et al. (2001) argue that an operational consensus
is emerging among health researchers that the domains of quality of life
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assessment are physical function, psychological function, social-role
function and disease/treatment symptoms.
A reduction in physical functioning may cause deterioration in quality of
life. Yet good physical functioning is not intrinsically necessary in order for
an individual to experience a good quality of life. The impact that physical
functioning has on quality of life will depend on the value or importance
placed on physical functioning by each individual at a given point in time.
Studies on health related quality of life often present significant differences
between global life satisfaction and physical functioning (Fegg et al., 2005).
In one study more than half of the sample reported impaired physical
functioning and a high incidence of negative symptoms two to four years
after stem cell transplantation. Despite this 80% of the participants rated
their general health as quite good or excellent (Edman et al., 2001). Whilst
this was a small exploratory study (n=25) it serves as an excellent
example of the difference between specific issues of physical functioning
and patients' perceptions of their general well being. Physical functioning
has been used here as an example - the same arguments apply to any
other domains that are attributed to quality of life. Each will only be as
important as the individual in question perceives it to be. Furthermore the
considerations used by people in assessing their own quality of life may be
different at varying time points (Graham and Longman, 1987).
Any conceptualisation of quality of life must acknowledge the potential for
the disease and its treatment to have a positive influence on some aspects
of quality of life. Several studies have shown that some patients perceive
that their quality of life has been increased by the experience of life
threatening disease and its treatment (Cella and Tross, 1986, Ferrell et al.,
1992a, Molassiotis and Morris, 1998b) . Specifically, these studies have
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identified that some patients experience a greater appreciation of life (Cella
and Tross, 1986, Ferrell et al., 1992a, Molassiotis and Morris, 1998b)
and/or an improved or more optimistic outlook on life (Ferrell et al.,
1992a), following diagnosis and treatment with a life threatening illness.
Reflecting the work of Graham and Longman (1987), in this study quality
of life is defined as 'the degree of satisfaction with current life
circumstances, as perceived by the patient'. A number of studies have used
global quality of life measures in the assessment of stem cell transplant
survivors. Results consistently suggest that survivors of stem cell
transplantation rate their own quality of life as good to excellent. Broers et
al. (2000) found that quality of life was rated by participants as good to
excellent using a two item scale three years after bone marrow
transplantation. Similarly a comparatively large study conducted with 106
patients who had received an allograft transplant more than five years
previously found that 78% of the sample reported good to very good
quality of life (Worel et al., 2002). In a study by Molassiotis et al. (1995)
the majority of participants rated their quality of life as good to excellent
following both allograft and autologous stem cell transplantation. Bush et
al. (1995) conducted a large descriptive survey of adults surviving between
six and eighteen years after bone marrow transplantation. When asked
about their current quality of life 74% of participants reported that their
current quality life was the same or better than before transplantation and
80% rated their current quality of life as good to excellent.
This evidence from quantitative studies is supported by a qualitative study
conducted by Haberman et al. (1993) that analysed the responses to a
postal questionnaire of 125 survivors, six to eighteen years after bone
marrow transplantation. The study concluded that \\... most long-term
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survivors, despite the persistence of lingering side effects, perceive
themselves as cured and well, leading full and meaningful lives"
(Haberman et al., 1993)
Summary
Haematological malignancy and stem cell transplantation are associated
with numerous biological, psychological and social side-effects. These can
be profound immediately following transplantation and reduce with time.
When considering the consequences of stem cell transplantation it is easy
to lose sight of the benefits that have come from the ability to treat
haematological cancers with stem cell transplantation. Therefore this
section is concluded with some quotes taken from a qualitative study that
explored quality of life in stem cell transplantation survivors (Ferrell et al.,
1992b).
"well, I'm still alive and the transplant taught me a whole new look on life
and priorities. "
"I try to enjoy each day with a good deal of enthusiasm knowing I have
been given a second chance at living".
"the consequence of BMT is that I'm alive and that's really important".
2.8 Current post discharge care
Duncombe (1997) states that regular haematological follow-up is
mandatory following stem cell transplantation. Furthermore, psychological
support from not only family and friends but also the transplant team is
vital for readjustment to normal life (Duncombe, 1997). A previous study
conducted at the unit where this research was carried out indicated that
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patients feel very well supported by the transplant team during the
hospitalised period of their treatment (Stone 1999). However, a study of
patients' perceptions of daily life after discharge indicated that they felt
that service provision after discharge from in-patient care was inadequate
to meet their needs (Stone 1999).
Regular contact with hospital staff is maintained through appointments at
clinic. The constraints of the clinic schedule and environment mean that a
visit to clinic does not necessarily provide the emotional support and
information desired by patients. Suggestions for improvement to the
service were provided by patients. They felt that guidance on exercise,
sharing experiences with other patients and gaining information on what to
expect after transplant would have aided their recovery after stem cell
transplantation (Stone, 1999).
2.9 Rehabilitation after Stem Cell Transplantation
Research has clearly demonstrated that diagnosis with a haematological
malignancy and treatment with a stem cell transplant has a significant
impact on physical, psychological and social functioning i.e. on almost
every aspect of an individual's life. Therefore attention has begun to focus
on how health professionals can help to reduce the extent of the impact of
these diseases and their treatment of patients' lives. Gunn (1984), one of
the first people to define the concept of cancer rehabilitation, wrote that
cancer rehabilitation is "the restoration of a patient with individual defects
as a result of treatment or disease to as normal and functional a state as
possible" (Gunn, 1984). There have been numerous studies that have
evaluated methods for promoting a return to usual functional activity
following cancer and its treatment. There is also a significant body of
research that has been built up specifically in the field of haematological
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malignancies and stem cell transplantation. There are a number of
potential components to rehabilitation following stem cell transplantation.
These include exercise, social support, informational support and relaxation
or other stress reduction techniques.
Exercise
A number of studies have investigated the effectiveness of exercise at
ameliorating the negative effects of haematological malignancy and stem
cell transplantation. It has been suggested that exercise may be effective
in reducing not only the physical effects of diagnosis and treatment but
that it may also have an affect on psychological and social functioning.
Theoretical explanations for the efficacy of exercise
Several theories have been proposed to explain the beneficial effects of
exercise on psychosocial functioning. These can broadly be divided into two
groups - physiological theories and psychological theories. Psychological
theories include the distraction hypothesis, the self-efficacy hypothesis and
the social interaction hypothesis. The distraction hypothesis suggests that
during exercise people are distracted from unfavourable stimuli leading to
an improvement in mood (Morgan, 1985).The self-efficacy hypothesis is
based on the assertion that gaining confidence in mastering a new set of
skills or behavioural changes leads to higher levels of self esteem (North et
al., 1990). The social interaction hypothesis suggests that the social
interaction that is often associated with exercise results in a beneficial
change in mood (Peluso and Guerra de Andrade, 2005). The two most
commonly suggested physiological explanations for the association
between exercise and mood are the endorphin hypothesis and the
monoamine hypothesis. The endorphin hypothesis proposes that the
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release of endorphins during exercise has an inhibitory effect on the central
nervous system and is responsible for the sensation of calm and improved
mood experienced after exercise (Dunn and Dishman, 1991). The
monoamine hypothesis proposes that the increase in synaptic transmission
of monoamines during exercise causes an anti-depressive effect (Peluso
and Guerra de Andrade, 2005).
Courneya (2001) has summarised the various mechanisms associated with
exercise and developed the model shown in figure 2.5, which explains how
exercise may influence quality of life during cancer treatment. The model
proposes that exercise has an effect on the biopsychosocial mechanisms
that are thought to underlie coping and adjustment to cancer. In turn,
changes in these mechanisms may alleviate or prevent the occurrence of
the symptoms associated with cancer and its treatment. Amelioration of
these symptoms may then reduce their level of interference with the daily
activities of living and working. The ability to participate in physical and
social activities may promote psychological and emotional well-being,
thereby improving overall quality of life (Courneya, 2001).
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Figure 2.5: Model showing potential mechanisms for the effect of
exercise on quality of life (Courneya (2001)
Quality of life General Happiness and Satisfaction with Life
1
Symptom
Distress
Psychological/Emotional Well-Being (e.g. anxiety,
depression, anger, hope, pride)
1
Symptom
Interference
Functional Well-Being (e.g. activities of daily living,
leisure activities, work), Social Well-Being (i.e.
interaction with others), Spiritual Well-Being (e.g.
meaning, purpose)
1
Symptom
Occurrence
Physical Well-Being (e.g. nausea, pain, fatigue,
dyspnoea, insomnia, poor appetite, constipation,
diarrhoea, weight change, asthenia, cachexia),
Cognitive Well-Being (e.g. attention, confusion)
1
Mechanisms Biological (e.g. haemoglobin, physical fitness),
Psychological (e.g. self-efficacy, distraction) and
social (e.g. interaction, support)
1
Exercise Type, Amount (frequency, intensity, duration),
Progression, Context (physical and social environment)
Safety of Exercise
Dimeo et al. (1997b) used a randomised study design to assess the effects
of exercise during autologous stem cell transplantation. This small scale
study indicated that aerobic exercise is safe immediately after high dose
chemotherapy. Furthermore the study suggested that exercise can partially
prevent the loss of physical performance associated with chemotherapy
and stem cell transplantation (Dimeo et al., 1997b). Further evidence that
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exercise does not harm patients who have undergone stem cell
transplantation is provided by Hayes et al. (2003). A small scale
randomised controlled trial was used to assess the impact of exercise on
immune cell recovery following autologous stem cell transplantation.
Participation in the exercise programme did not hinder or delay immune
cell recovery (Hayes et al. 2003).
Benefits of exercise
Courneya et al. (2000) used a prospective design to explore the possible
benefits of exercise for autologous stem cell transplant patients. The study
demonstrated that there were statistically significant correlations between
exercise and physical well-being, psychological well-being, depression,
anxiety and days hospitalised. However, due to the design of the study it
was unable to indicate whether exercise was a cause (or an effect) of the
better physical and psychological well-being. Oldervoll et al. (2003)
conducted a pilot study to explore the effect of exercise for Hodgkin's
lymphoma survivors who had been identified as suffering from chronic
fatigue. Results indicated that a home based aerobic exercise programme
had a positive effect on fatigue, physical functioning and maximal aerobic
capacity. However, this finding must be viewed with caution as this was not
a randomised controlled study and it is possible that other factors
accounted for the changes in fatigue, physical functioning and aerobic
capacity.
These studies indicate that exercise is associated with an improvement in
physical and psychological well-being but are unable to demonstrate
causation. Dimeo et al. (1997c) used a controlled trial to investigate the
effects of exercise for stem cell transplant patients. The exercise
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intervention consisted of daily training on a treadmill on weekdays for six
weeks. After seven weeks four people in the control group reported fatigue
and low physical performance compared to none in the intervention group.
However, this study involved only a small number of participants (n=16)
and allocation to intervention or control was according to distance lived
from hospital rather than random. Mello et al. (2003) conducted a study
with a population of patients undergoing allogeneic bone marrow
transfusion. In this study muscle strength was assessed at three time
points - before bone marrow transplantation, after marrow engraftment
and six weeks after engraftment. During the six weeks between
engraftment and the third data collection point patients completed either a
daily exercise programme consisting of an active range of motion
exercises, stretching exercises and treadmill walking or usual care. The
results indicated that the exercise programme was effective in promoting
an increase in muscle strength after allogeneic bone marrow
transplantation (Mello et al., 2003). These results suggest that exercise
may have a beneficial effect on reducing fatigue and increasing muscle
strength in stem cell transplant patients.
The research that has been carried out with patients who have a
haematological malignancy tends to be restricted to studies of small
sample sizes. In part this may be due to the relatively low incidence of
these cancers in the general population. To find trials with larger sample
sizes, consideration must be given to research into cancers with higher
incidence rates. Mock et al. (2001) conducted a large (n=119) multi-
institutional randomised controlled trial to determine the effects of a home
based exercise programme on levels of fatigue during treatment for breast
cancer. Intention-to-treat analysis revealed no significant differences
between the intervention and control groups. The authors suggest that this
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was due in part to a dilution of the treatment effect as 39% of the usual
care group exercised and 28% of the exercise group did not.
Courneya et al. (2003) conducted a randomised controlled trial to
determine if group psychotherapy combined with exercise improved quality
of life in cancer survivors compared to group psychotherapy without
exercise. This was a comparatively large study (n=108) and included
participants who had been treated for a variety of malignant diseases. The
study found significant improvements in functional well being and fatigue,
and borderline significant results for physical well being, satisfaction with
life and flexibility in the exercise group in comparison to the non-exercise
group (Courneya et al., 2003).
Segal et al. (2001) randomly allocated 123 women with breast cancer to
one of three programmes - a home based walking programme, a hospital
and home based programme, and usual care. Participants allocated to the
solely home based programme showed a Significant improvement in
physical functioning compared to the usual care group. Interestingly, the
participants allocated to the hospital and home based programme showed
only a borderline significant improvement in physical functioning compared
to the usual care group (Segal et al., 2001). In 2003 Segal et al. conducted
another exercise study, this time with 155 men being treated for prostate
cancer. The men were randomly allocated to either supervised strength
training exercises three times a week for 12 weeks, or to a waiting list.
Fatigue and health-related quality of life improved in the exercise group
and deteriorated in the control group (Segal et al., 2003).
A small scale randomised controlled trial (n= 18) carried out by Burnham
and Wilcox (2002) allocated patients recovering from treatment for either
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breast, colon or lung cancer to one of three treatment groups - a moderate
intensity exercise group, a low intensity exercise group and a control
group. After the intervention period was complete there were no
differences found between the two exercise groups on any of the
physiological variables. For the final analysis, data from both exercise
groups was combined and compared to data from the control group. The
results indicated statistically significant increases in aerobic capacity,
lower-body flexibility, energy levels and quality of life, measured with the
Quality of Life Index for Cancer in the exercise group compared with the
control group. There were no significant differences between the two
groups for measures of anxiety or depression (Burnham and Wilcox, 2002).
Following consideration of the research relating to exercise following stem
cell transplantation it is possible to conclude that exercise appears to be
safe for this group of patients and that a number of studies indicate that
completing exercise after a stem cell transplant is associated with improved
physical and psychosocial functioning. There have been relatively few
randomised controlled trials carried out. The evidence available from the
studies that have been conducted is supportive of the use of exercise as a
rehabilitation intervention but insufficient to be certain of its efficacy.
Social Support
Social support has been defined as the provision of information, practical
assistance and emotional empathy and comfort (Campbell et al., 2004). It
can be helpful to consider three separate aspects of support -
informational, emotional and instrumental support (Campbell et al., 2004).
Informational support, meaning the provision of information, can increase
knowledge, understanding and coping skills. Effective informational support
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may be useful in enhancing a patient's sense of control over adverse
situations (Helgeson and Cohen, 1996). Emotional support is based on
empathetic communications between patients and their support networks.
It is intended to enhance self-confidence and self-esteem, reduce negative
feelings and improve relationships. Instrumental support is the provision of
practical assistance with activities of daily living, finances, transport and
other illness related activities (Campbell et al., 2004). Social support
interventions may aim to provide one or more of these types of support.
Theoretical explanations for the efficacy of social support
Several mechanisms by which social support may influence physical,
psychological and social health have been suggested. Social comparison
theory suggests that patients benefit from being able to compare their own
experience with that of others in a similar position. This contact with people
who have been through the same experience may provide an opportunity
for positive role-modelling, encourage health-promoting behaviours and
enhance self esteem (Campbell et al., 2004). A further mechanism which
has been proposed to explain the benefit received by patients from social
support is the helper therapy principle. This principle proposes that patients
who are given the opportunity to help others benefit from improved self
esteem (Campbell et al., 2004). Coping has been defined by Lazarus and
Folkman as constantly changing cognitive and behavioural efforts to
manage specific external and/or internal demands that are appraised as
taxing or exceeding the resources of the person (Folkman and Lazarus,
1988). Modes of coping include both behaviours aimed at changing the
stressor and psychological responses aimed at preserving emotional
integrity (Backer et al., 2000). The stress and coping theory suggests that
social support including informational support improves health directly by
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enhancing coping skills and indirectly by mediating the stress response
(Bloom, 1990).
Informational Support
Informational support interventions with cancer patients involve providing
information about disease, treatment and managing the side-effects of
these. Assisting patients to gain information about their condition has been
associated with enhanced patient involvement in decision making,
improved adherence to treatment regimens, increased patient satisfaction,
increased ability to cope with distressing symptoms and side effects and
enhanced post-treatment recovery (Fernsler and Cannon, 1991, Johnson,
1996).
Roberts et al. (2002) conducted an evaluation of an educational support
programme for cancer patients and their families and friends. The
evaluation indicated that participation in the programme resulted in a
significant improvement in coping abilities, knowledge, communication and
relationships. This was a large study involving 1460 participants, however
it was not a randomised controlled trial and therefore consideration must
be given to the possibility that these changes were due to factors other
than those under evaluation.
Several studies have investigated minimal contact interventions with
cancer patients. Minimal contact interventions can include any method of
providing informational support with minimal contact between the patient
and health care professionals. These include information leaflets,
workbooks and telephone contact. Several studies have shown that
individuals who receive educational material exhibit increased compliance,
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improved knowledge and increased satisfaction with treatment compared
to individuals who do not receive educational information (Brandenberg et
al., 1994, Eardley, 1988). However, a more recent study found that
distress did not vary over the course of the study between participants
allocated to a workbook and those allocated to usual care (Trask et al.,
2003). The authors suggest that this finding was at least in part due to the
fact that many participants allocated to the workbook did not look at the
material. This study highlights that psychosocial interventions are arguably
only beneficial for patients who perceive that they need the intervention
that is being provided and who are able and willing to engage with the
intervention in the format in which it is being provided.
Evaluation of a stress and activity management programme for cancer
patients that involved education, relaxation, problem solving and exercise
found that at the end of a six week programme individuals randomly
assigned to the intervention group had increased cancer knowledge
compared with that of individuals in the control group but there were no
group differences in psychological adjustment (Neinrich and Schag, 1985).
Similarly a large scale randomised controlled trial was conducted with men
who had recently been treated for prostate cancer. The participants were
randomly assigned to a control group, a group education intervention or a
group education plus discussion group. Men who had participated in either
the education group or the education plus discussion group showed
increased prostate cancer knowledge in comparison to the control group
(Lepore et al., 2003). However this increased knowledge did not translate
into meaningful changes in other outcome measures. Whilst increasing the
knowledge that patients have about their disease and its treatment can be
argued to be an innately worthwhile activity, these studies highlight that
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demonstrating that increased knowledge leads to a beneficial change in
psychological adjustment is extremely difficult.
Emotional support
Emotional support can be provided by a patient's existing interpersonal
relationships, nursing and medical relationships and through friendship and
camaraderie between fellow patients. A number of different methods have
been used within health care to try and provide increased emotional
support for patients.
A qualitative study carried out by Feigin et al. (2000) investigated the
experiences of women who had been treated for breast cancer and who
were attending support groups. The study was relatively large for a
qualitative piece of work and considered 45 women attending five different
support groups. The results indicate that all of the women found the
support groups had value and significance for them. More specifically
participants expressed the view that it was helpful to meet with other
people who had been through a similar experience (Feigin et al., 2000).
This qualitative evaluation provides helpful information about the elements
of the support programme found to be helpful by attendees. However, it
must be remembered that the study was with people who had chosen to
attend a support group and had chosen to take part in an evaluation of the
group. Therefore the participants' views are unlikely to be representative of
those people who chose not to attend a support group.
Ussher et al. (2006) conducted an in-depth qualitative evaluation of
support groups for people with cancer. The participants indicated that they
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felt that support groups provided a unique sense of community,
unconditional acceptance and information about cancer and its treatment.
This study included participants who had been diagnosed with a variety of
malignant diseases. The sample was made up of 75 women and only 18
men. The authors do not provide further comment on this uneven
distribution of men and women. However, it can be argued that some men
may be put off the idea of a support group because of pre-conceptions that
they hold about what it is to be masculine and what it is like to attend a
support group. One of the benefits of combining support with an
intervention such as exercise or other action-orientated activity is that
many men may find it more acceptable and appealing to attend (Adamsen
et al., 2001, Harrison et al., 1995, Gray et al., 1997).
Bordeleau et al. (2003) conducted a large randomised controlled trial with
women with metastatic breast cancer. In this multi-centre study 235
women were randomly allocated to either a weekly 90-minute therapist led
support group or to a control arm. Quality of life measured by the EORTC
QLQ-C30 was the primary outcome measure and analysis at baseline, four,
eight and twelve months revealed no significant differences between the
two arms of the study. There are two possible explanations for this finding.
Either that there were no changes as a result of the support group or that
the EORTCQLQ-C30 was not able to detect any changes.
After consideration of the research relating to social support it is possible to
suggest that information and emotional support may be of assistance to
some patients recovering after stem cell transplantation. There is a sound
theoretical base for informational or emotional support interventions;
however the available evidence is inconclusive as to the efficacy of many of
the interventions that have been trialled.
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Complementary therapies
The potential benefit of complementary therapies is a growing area of
research in both cancer care and health care more generally. Unfortunately
studies of complementary therapies with patients who have undergone
stem cell transplants are infrequent. Furthermore much of the research
into the effectiveness of complementary therapies has been criticised for a
lack of methodological rigour. However, there may be benefits of
complementary therapies for patients being treated with a stem cell
transplant including reductions in fatigue (Kim and Kim, 2005),
psychological distress (Ahles et al. 1999), pain, nausea and vomiting
(Syrjala et al. 1992) and improvement in physiological indicators such as
time taken for engraftment of transplanted cells (Smith et al. 2003).
Kim and Kim (2005) investigated the potential benefit of completing
relaxation exercises for patients undergoing allogeneic stem cell
transplantation using a randomised controlled trial. In the study 35
patients were randomly allocated to either a relaxation group or to routine
care. The intervention period lasted six weeks and the participants
allocated to the intervention showed a greater reduction in fatigue scores
after completing the six weeks than those individuals assigned to the
control group (Kim and Kim, 2005).
Ahles et al. 1999 conducted a study to examine the impact of massage
therapy on psychological and physical measures in patients undergoing
autologous transplantation. Patients were randomly assigned to receive
either massage therapy or standard treatment. The effects of massage
therapy on anxiety, depression, and mood were assessed before, during,
and after treatment. Patients in the massage therapy group demonstrated
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significantly larger reductions in distress, fatigue, nausea, and anxiety than
the standard treatment at some but not all of the three time points.
Nausea and vomiting are common side-effects of stem cell transplantation
and a number of studies have investigated the use of complementary
therapies in alleviating these symptoms. There is evidence to suggest that
relaxation techniques and hypnosis are not effective in reducing nausea in
patients being treated with a stem cell transplant (Syrjala et al., 1992).
However, a study by Ezzone et al. (1998) reported that patients
undergoing stem cell transplantation who were assigned antiemetics plus
music distraction reported Significantly less nausea and vomiting than
those assigned antiemetic drugs alone.
The effectiveness of relaxation techniques in the management of pain is a
comparatively well researched concept and systematic reviews of the use
of relaxation for the relief of both chronic (Carroll and Seers, 1998) and
acute (Seers and Carroll, 1998) pain have been carried out. These reviews
conclude that there is some weak evidence to support the use of relaxation
in acute pain (Seers and Carroll, 1998) but that there is insufficient
evidence to confirm that relaxation can reduce chronic pain (Carroll and
Seers 1998).
Smith et al. (2003) investigated the effects of therapeutic touch and
massage therapy on engraftment time, occurrence of complications and
benefit of the therapy as perceived by the patient. The study recruited 88
adults receiving stem cell transplants, who were randomly assigned to
receive therapeutic touch, massage therapy or a 'friendly visit'. A
significantly better score for central nervous system or neurological
complications was noted for subjects who received massage therapy
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compared with the 'friendly visit' group; however, no differences were
found among the three groups with respect to other complications. The
massage therapy component was most popular with patients with the
perception of the benefits of massage therapy being significantly higher
than in the 'friendly visit' group.
The present study includes the use of relaxation techniques and massage
in a rehabilitation programme. Current evidence suggests that relaxation
techniques in the form of either massage or relaxation exercises may be
associated with a reduction in fatigue (Kim and Kim, 2005), anxiety,
depression and stress (Ahles et al. 1999) but that there is insufficient
evidence to suggest that such interventions have an impact on pain
(Carroll and Seers, 1998), nausea and vomiting (Syrjala et al. 1992) or on
engraftment of transplanted cells (Smith et al. 2003). Complementary
therapies, especially massage, as an adjunct to usual care have a high
level of acceptability and popularity with patients (Vickers and Cassileth,
2001, Smith et al., 2003) however evidence as to their efficacy remains
scant.
2.10 Summary
Stem cell transplantation is increasingly used in the treatment of
haematological malignancies. However, it has been shown that
haematological malignancy and stem cell transplantation have a
considerable impact on the physical, psychological and social well-being of
patients. In particular, these illnesses and their treatment can cause
reduced physical functioning, fatigue, graft versus host disease,
psychological distress and changes in social circumstances and
relationships. Reducing the negative impact of haematological malignancy
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and stem cell transplantation is clearly desirable and therefore research is
expanding into rehabilitation for this group of patients. Several studies
have investigated the potential benefit of exercise for stem cell transplant
patients and report favourable results in reducing fatigue, maintaining
physical function and assisting recovery. Research has also investigated
the provision of informational and emotional support to patients. These
interventions have been associated with high levels of patient satisfaction
and there is encouraging evidence that they may improve post treatment
recovery. However no studies have investigated the effectiveness of a
multidimensional rehabilitation programme which provides structured
exercise, relaxation, emotional support and information related to the side-
effects of haematological malignancy and its treatment in reducing the
biopsychosocial impact of haematological malignancy and stem cell
transplantation.
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Chapter 3 - Research Design
3.1 Introduction
In the previous chapter it was shown that patients who have been
diagnosed with a haematological malignancy and undergone treatment
with a stem cell transplant have a range of physical, psychological and
social rehabilitation needs. There is some evidence that a combination of
exercise, emotional and instructional support may be effective in meeting
this need. However, further research in this area is required since a
comprehensive understanding of rehabilitation for this patient group does
not currently exist. In particular the optimum method for the delivery of
rehabilitation is unknown.
In this chapter the methods employed in this study are described.
Consideration is first given to the structure and content of the rehabilitation
programme. This programme was originally proposed by a clinical team in
response to an unmet need that they had perceived in patient care. Details
are provided of a preliminary study that was carried out by this clinical
team to assess the acceptability and feasibility of the programme. The aim
and objectives for the current study are set out, followed by an explanation
of why a randomised controlled trial was chosen as the most suitable
research design. The changes to the rehabilitation programme required in
order for a randomised controlled trial to be possible are outlined. After
establishing this important groundwork the details of the research design
are discussed.
3.2 Preliminary Work
Nursing staff working at a large regional centre which carries out numerous
stem cell transplantations each year identified that a rehabilitation
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programme might be an appropriate method for providing additional
support and information to individuals recovering after stem cell
transplantation. In particular, staff identified that due to the constraints of
the clinic environment individuals were having the chance to discuss
biological health concerns but that little attention was being given to their
psychosocial health. Furthermore, during clinics patients were restricted to
meeting the doctor and the transplant co-ordinator or the nurse consultant.
However, there was no provision to meet with physiotherapists, dieticians,
social workers or to have in depth discussions with the nursing staff. In
order to provide a more comprehensive service to patients a rehabilitation
programme was devised. It was proposed that the programme should be
ten weeks in duration and consist of weekly sessions lasting between two
and three hours each. The different elements of the programme are
summarised by figure 3.1.
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Figure 3.1: Components of the rehabilitation programme
Exercise
Approximately 60 minutes of cardiovascular exercise
Led by a physiotherapist and consisting of warm up, circuit of specific
exercises based on the ability of the individual, walking and cool down
Relaxation
Approximately 30 minutes of relaxation and group support
Opportunity for a cup of tea, a snack and a period of informal chat
Followed by a relaxation exercise
Discussion
Approximately 40 minutes of discussion and support
Different topic each week led by a relevant health professional
Proposed topics
Nutrition
Benefits of exercise
Stress management and relaxation
Understanding drugs
Financial support
Relationships and roles
Meaning of life and spirituality
Fatigue
Expectations of life after transplant
Open forum for questions
A small scale preliminary study was conducted prior to my involvement
with the project to assess the feasibility and acceptability of the
rehabilitation programme that had been developed. Alongside informally
assessing the feasibility and acceptability of the rehabilitation, data was
collected prior to and on completion of the programme. The demographic
and clinical details of the 15 participants who completed the programme
are shown in table 3.1.
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Table 3.1: Demographic and clinical details of participants
Demographic variable
Age
Mean
(SD)
53
(13.2)
Gender(n)
Female
Male
5
10
Type of transplant (n)
Autologous BMT
Autologous PBSCT
Allogeneic BMT
Allogeneic PBSCT
1
4
2
8
Diagnosis (n)
Myeloma
Leukaemia
Lymphoma
Other
4
5
4
2
Feedback from participants who took part in the preliminary study
suggested that the format and content of the programme was acceptable.
The outcome data from the study is summarised in table 3.2. With one
exception the mean scores for participants indicated better health after
completion of the programme than before it. No control group was included
in this initial study.
The data gathered in this preliminary study was sufficient to suggest that
further evaluation of the programme was warranted. The improvement
shown between baseline and completion of the programme was particularly
encouraging for the shuttle walk test scores and for several elements of the
SF-36. However, there was no formal statistical analysis of this data.
A progressive improvement in functioning is to be expected after stem cell
transplantation and from this pilot data it cannot be established if the
improvements shown can be attributed to attendance at the rehabilitation
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programme. Furthermore, the mean SF-36 score for role limitations due to
emotional problems reduced over the intervention period indicating poorer
functioning after the programme than before it. This may simply have been
an erroneous finding that would not be borne out in a larger sample.
Alternatively, this reduction could be due to a feeling of excitement at
resuming social activities after discharge from hospitalisation and a more
pessimistic outlook at the end of the intervention period when the reality of
recovery was more keenly felt. However, without a comparison group it
was not possible to be certain that the reduced score was not associated
with attendance at the rehabilitation intervention, highlighting the need for
rigorous evaluation of the programme.
Table 3.2: Summary of Outcome Data from Preliminary Study (n=lS)
Measure Mean score at Mean score after
baseline (SO) completion of the
intervention (SO)
SF-36a - Physical 49 (22.7) 60 (24.0)
Functioning
SF-36 - Role 13 (24.8) 22 (31.1)
Limitation - physical
SF-36 - Role 60 (44.0) 51 (43.4)
Limitation - emotional
SF-36 - Social 38 (30.4) 52 (26.9)
Functioning
SF-36 - 32 (23.2) 52 (22.1)
Energy/Vitality
SF-36 - Mental Health 66 (13.0) 79 (13.3)
SF-36 - Pain 67 (26.0) 79 (22.4)
SF-36 General Health 41 (16.8) 50 (16.3)
Shuttle Walk Test" 296m (153.5) 491m (186.9)
HADSc - Anxiety 6 (3.3) 5 (2.5)
HADS - Depression 5 (2.4) 5 (2.8)
• Possible scores range from 0-100. Higher score indicates better functioning.
b Possible scores range from 0-1020 metres. Higher score indicates better physical
functioning.
C Possible scores range from 1-14 «7 indicates non-cases 8-10 indicates doubtful cases 11+
indicates definite cases)
SO = Standard Deviation
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3.3 The Main Study
Since the preliminary study indicated that the rehabilitation programme
was acceptable to patients and that it potentially had a beneficial effect on
recovery it was considered appropriate to progress with a more rigorous
evaluation of the rehabilitation programme. The primary aim of further
research was to evaluate the effectiveness of the health profession led
rehabilitation programme in promoting recovery six months after stem cell
transplantation. In order to clearly conceptualise this broad aim a number
of specific objectives were developed:
• To test the hypothesis that:
'Participants who attend the rehabilitation programme will show a
greater improvement in physical and psychosocial recovery at
twelve weeks and six months than the participants who do not
attend the rehabilitation programme.'
• To assess the effectiveness of the rehabilitation programme on
patients' physical recovery
• To assess the effectiveness of the rehabilitation programme on
patients' psychosocial recovery
• To explore patients' experiences of the rehabilitation programme
that they received.
• To explore the experiences of staff members involved in the
provision of rehabilitation following stem cell transplantation.
3.4 Rationale for the study design
Considerable debate exists as to the most appropriate way to assess the
effectiveness of health service interventions. This debate intensifies when
the focus of discussion is the evaluation of complex interventions such as
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the one in this study. Traditionally randomised controlled trials have been
seen as the 'gold standard' of evidence based medicine (Barton, 2000). The
Cochrane Glossary defines a randomised controlled trial as "an experiment
in which two or more interventions, possibly including a control
intervention or no intervention, are compared by being randomly allocated
to participants". The importance of the randomised controlled trial in
developing new drugs and technologies is well established and this
approach has produced much of our current medical knowledge. However,
the appropriateness of using randomised controlled trials to evaluate
complex interventions is more contentious.
The MRCdocument 'A Framework for the Development and Evaluation of
Randomised Control Trials for Complex Interventions' attempts to clarify
the term complex intervention and suggests that "the greater the difficulty
in defining precisely what are the active ingredients of an intervention and
how they relate to each other, the greater the likelihood that you are
dealing with a complex intervention" (Medical Research Council, 2000). It
is precisely this difficulty in understanding the interaction of complicated
factors in a complex intervention that results in debate over the use of
randomised controlled trials in their evaluation.
Hawe et al. (2004) suggest that too often a complex intervention is
reduced to its constituent parts in order for it to fulfil the strict
requirements of a randomised controlled trial. In effect this results in a
complex Interventlon being reduced to a series of simple interventions and
in doing so fails to acknowledge that a complex intervention has the
potential to be more than the sum of its parts (Hawe et al., 2004). The
authors suggest that expensive and inconclusive trials could be avoided if
standardisation of the function of an intervention rather than of its form
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was more widely utilised. This would allow for context level adaption and
enable tailoring of the intervention to the local environment, which would
potentially improve efficacy (Hawe et al., 2004).
Given the problems that can be associated with using a randomised
controlled trial design to evaluate a complex intervention many authors
argue for more use of well designed observational studies in health
evaluation research (for example Black (1996». However, there are
advantages in the randomised controlled trial approach that are not readily
available from observational designs. The primary advantage of using a
randomised controlled trial design is that it is conceptually easier to
attribute any observed effect to the treatment being tested (Barton, 2000).
Observational studies can highlight associations between variables but it is
very difficult to use data from an observational study to indicate causation.
Randomisation is important because it reduces bias in the distribution of
known and unknown confounding factors across groups (Watson et al.,
2004) and therefore makes it more likely that an observed effect is due to
the manipulation of the independent variable.
After consideration of both the advantages and disadvantages, a
randomised controlled trial design was chosen as the method for this
study. This decision reflected the fact that the primary aim of the study
was to investigate the effectiveness of the rehabilitation programme. Steps
were taken to recognise and reduce the impact of the potential
complications associated with using a randomised controlled trial to
evaluate a complex intervention. These included using qualitative
interviews to provide additional depth to the quantitative data, having a
broad range of outcome measures, drawing on preliminary data to guide
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the methodology and seeking a way of providing standardisation without
restricting the dynamic nature of the programme.
3.5 Changes to the rehabilitation programme required
by the randomised controlled trial design
The most significant change to the rehabilitation programme was the
inclusion of a series of information leaflets. These leaflets were intended to
complement the discussion part of this intervention and to provide some
degree of standardisation in order to ensure that approximately the same
information was given each time the session was run. The leaflets were
designed to be used by the health professions who led each session to
guide the discussion and they also enabled participants to revisit each topic
at home between sessions. I wrote and produced the leaflets in
collaboration with the health professional responsible for each component
of the programme. The leaflets reflected current advice available in the
literature and the clinical experiences of the various health professionals.
In total eight leaflets were produced and these are shown in Appendix A
(page 201).
A randomised controlled trial by definition requires a comparator. In
planning this study considerable attention was given to finding an
appropriate comparator for the rehabilitation programme. I was concerned
to ensure that the trial met the conditions of equipoise. There is no
evidence on the efficacy of multidimensional rehabilitation programmes for
patients who have undergone treatment with a stem cell transplant.
However, sufficient evidence does exist to suggest that some aspects of
the rehabilitation programme are beneficial to patients. For example it is
widely acknowledged that exercise is beneficial for health in general (NHS
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Choices, 2008) and therefore it would be inappropriate to not encourage all
patients including those recovering after stem cell transplantation to
complete some form of exercise regularly. In order to ensure that all
participants were receiving advice of known benefit I decided to provide
the control group with the same information leaflets as were used in the
rehabilitation programme. However, the control group were not provided
with any contact time with health professionals beyond that provided by
usual care.
Since one of the differences between the two programmes was the contact
with health professionals, the intervention was referred to as the health
profession led programme and the control was referred to as the self-
managed rehabilitation programme.
The Health Profession Led Rehabilitation Programme
The health profession led programme consisted of three elements,
exercise, relaxation and information. The programme was design to last
ten weeks and consisted of weekly sessions lasting between two and three
hours.
The exercise component
The exercise element consisted of approximately one hour of group
cardiovascular exercise directed and supervised by a team of
physiotherapists. Three different exercise programmes were designed to
suit individuals with a variety of exercise capacities. The participants were
assigned to an appropriate level of exercise programme in accordance with
their shuttle walk test results. The shuttle walk test is an incremental
walking test conducted on a 10 m course where walking pace is dictated by
bleeps on an audio CD . The three programmes are shown in Appendix B
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(page 250). Physiotherapy staff adjusted the programmes and moved
participants on to a harder programme as appropriate. Each exercise
session consisted of a warm up period, the circuit of specific exercises,
walking and a cool down period.
The relaxation component
This exercise component was followed by a period of relaxation. The first
part of this time was spent informally as participants and staff had drinks
and biscuits together. This provided an informal environment for
conversation to flow between fellow participants and between staff and
participants. This was followed by a more formal relaxation component.
When volunteers from the hospitals massage service were available
participants were given a hand, foot or shoulder massage. When this
service could not be provided the group were led by the physiotherapist in
a relaxation exercise.
The information component
Each week a discussion was led by a relevant health professional on one of
ten topics.
Benefits of exercise
In this information session the physiotherapist provided information on the
benefits of exercise, guidance on how much and what type of exercise
might be appropriate and how to exercise safely. This session was
complemented by the booklet 'Exercising after your bone marrow
transplant' which summarised the information presented by the
physiotherapist and also included a programme of home exercises which
participants were encouraged to complete two to three times a week
between rehabilitation sessions.
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Nutrition
During this information session the dietician would provide information on
common problems that frequently present after haemopoietic transplants
including the need for a neutropenic diet, taste changes, poor appetite, dry
mouth, weight loss, nausea, diarrhoea and healthy eating. The session was
supported by the booklet 'Eating after your bone marrow transplant'.
Stress management and relaxation
This session was led by a nurse and provided advice on managing stress
and relaxation techniques. It was accompanied by the booklet 'Coping with
stress after your bone marrow transplant' which provided explanations of
common relaxation techniques and gave the contact details of a variety of
organisations where participants could go for more information.
Fatigue
This session was led by an occupational therapist and gave information
about techniques for minimising and coping with fatigue. It was
accompanied by the leaflet 'Managing fatigue after your bone marrow
transplant'.
Financial support
A social worker led the session on financial support and provided
information on the benefits that are available to support people during
illness and in returning to work. This session was complemented by the
leaflet 'Financial support after your bone marrow transplant'.
Expectations of life after transplant
This session was led by a nurse and a patient who is now several years
post transplant. The session provided the opportunity for patients to
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discuss life after a transplant with someone who has been through it. The
session was complemented by the leaflet 'My life after a bone marrow
transplant, by someone who has been through it'.
Relationships and roles
This session was also led by a nurse and an ex-patient. The session was
fairly flexible and provided a time for patients to discuss the effect that
their treatment has had on their relationships with family members and
friends. Participants were invited to bring significant others along to this
session if they wished. The session was supported by the leaflet
'Relationships after your bone marrow transplant' in which previous
patients and their family members shared how the treatment process had
affected them. The leaflet also contained the contact details for a wide
variety of services which offer support to people affected by cancer.
Understanding drugs
The pharmacist led this session in which information on the medicines most
commonly used after bone marrow transplants were discussed. Information
that was presented included the usual dose of medications, the therapeutic
benefits of different medications, how long participants might expect to
continue on each medication, special instructions for taking medications
and any possible side effect that patients should look out for. This session
was supported be the leaflet 'Medication after your bone marrow
transplant'.
Meaning of life and spirituality
This session provided an opportunity for participants to talk with the
hospital chaplain. Since the session was primarily directed by the
participants it was not feasible to produce an accompanying booklet that
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summarised the content of the session. However participants were given
information on how to contact the chaplain or one of the other faith
workers associated with the hospital if they wanted to seek further advice
or support as part of the relationships leaflet.
Open forum for questions and answer session
This session provided an opportunity for participants to ask questions. The
session was attended by some of the individuals involved in giving
information on the other topics and when available a doctor from the
haematology team also attended. Given the informal nature of this session
it was not feasible to produce an accompanying booklet.
The self managed rehabilitation programme
The self managed rehabilitation programme consisted of an information
pack that contained the eight leaflets that were used as part of the health
profession led programme. Participants were encouraged to read these
booklets at home and to regularly complete the exercise programme
contained within the leaflet 'Exercising after your bone marrow transplant'.
Participants were informed that they were welcome to ask for clarification
or seek further information about any of the content of the leaflets when
they attended clinic appointments.
3.6 Study Design
A randomised controlled trial was used to compare a health profession led
rehabilitation programme with a self managed rehabilitation programme.
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3.7 Setting
This research was carried out at a large teaching hospital in the East
Midlands which provides health services to a local and regional population.
The clinical haematology unit at the hospital is a specialist centre for bone
marrow transplantation and carries out upwards of 140 stem cell
transplants each year on patients from across the Midlands. All subject
recruitment took place in the Clinical Haematology department where data
collection also took place.
3.8 Participants
The inclusion and exclusion criteria for pa rticipation in this trial were that
the patient was required to
1. Have undergone any type of stem cell transplant between six to
eight weeks prior to recruitment,
2. Be deemed physically able as identified by their medical consultant,
3. Be 18 years of age or older.
The inclusion criteria were broad in order to ensure that the study would be
representative of the wider stem cell transplant population. However, the
trial was not open to all patients recovering after stem cell transplantation
regardless of their time since transplant since it was perceived that if the
inclusion criteria were too broad the study would be unable to detect
important differences in intervention effects.
Those patients for whom participation would increase the risk of an adverse
event occurring were excluded. Therefore before patients were admitted to
the study their medical consultant was asked to confirm that they were
well enough to take part. Throughout the intervention period patients blood
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counts were checked to ensure that they were safe to participate in
exercise.
This study only recruited people who were over the age of 18 at the time of
their transplant. This decision was made because it was anticipated that
the rehabilitation needs of children and young teenagers who undergo stem
cell transplantation differ to those of adults.
3.9 Sample size
The Short Form 36 Health Survey (SF-36) physical function score was
chosen as the primary outcome measure and was used to calculate the
sample size required for the study. After looking at the data obtained from
the preliminary study, consideration of previous studies (Adamsen et al.,
2001, Shephard and Franklin, 2001, Walters and Brazier, 2003) and
reading the information provided by the tool's authors (Ware et al., 1993)
the decision was taken that it was appropriate to look for a ten point
difference between the two groups in the mean physical function score of
the SF-36. A ten point difference in scores represents a moderately large
clinically and socially relevant difference (Ware et aI., 1993).
Whilst a study power of 90% is ideal, in this study a concession to the
small study population had to be made and on the grounds of feasibility the
power calculations were made assuming a power of 80%. This study
followed statistical convention (Pocock, 1983) and set the significance level
at 0.05. Data from the pilot study was used to provide an estimation of the
standard deviation. The standard deviation used in the calculation was
18.9.
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It was calculated that 57 patients would be required in each arm of the
study (114 in total) to have an 80% chance of detecting as significant (at
the two sided 5% level) a ten paint difference between the two groups in
the mean physical function score of the SF-36. We aimed to recruit a total
of 132 patients to allow for a 15% attrition rate. This attrition rate was
estimated using data from the preliminary study. The power calculation is
shown in Appendix G.
3.10 Recruitment, consent, baseline data collection and
ra ndom isation
The process of recruitment, gaining consent, baseline data collection and
randomisation can be best summarised by figure 3.2.
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Figure 3.2: Recruitment through to randomisation
Procedure Personnel Location Timing
involved
Staff involved in The ward Prior to
Initial the patient's discharge
approach routine care from inpatient
care
A senior nurse or I Routine clinic A minimum of
Consent asked patients to appointments several days
consent after patients
were first
ap~roached
A senior nurse or I Routine clinic Between six
Baseline data collected baseline appointments and eight
collection data weeks after
the patients
SCT
A senior nurse or I Patients were Immediately
Randomisation liaised with a informed after baseline
secretary at before leaving data
Nottingham clinic as to collection
University who held the
a list of the randomisation
randomised result
allocation
Initial approach
Patients were approached by a member of the clinical team and given
information about the study when they were in hospital recovering after
their stem cell transplant. In order to ensure that all patients received the
salient information at this point a letter and information sheet (shown in
Appendix C - page 257) were given to patients alongside verbal
information. It was decided that no patient should be approached prior to
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their stem cell transplant, since this is a period of time when patients may
experience increased anxiety and depression (Gaston-Johansson and
Foxall, 1996). It was decided that the optimum time to approach people
was likely to be as they were preparing for discharge from hospital.
Patients were approached by members of staff, normally a nurse or
physiotherapist, involved in the patient's routine care. During this initial
approach patients were given the option of not being contacted again if
they felt confident that they did not want to take part in the study.
Occasionally patients were discharged from hospital prior to being
approached about the study, these patients were seen and given
information about the study at their first post discharge clinic appointment.
In exceptional circumstances the first approach was made by phone and
the information sheet was posted to participants.
Consent
At routine clinic appointments the researcher or a member of staff met
with patients, providing an opportunity to discuss the study and to answer
questions. If patients were willing to take part written consent was
obtained (consent forms are shown in appendix D - page 266). No one was
asked to consent on the same day as they were initially approached about
the study. This was to ensure that everyone had time to think about
participation and discuss it with significant others if they wished.
Base-line data collection
After patients had given their consent and prior to randomisation, baseline
data were collected. The data collected is summarised in table 3.3 and
copies of both the data collection sheets and questionnaires used are
shown in appendix E (page 275).
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Figure 3.3: Summary of baseline measures
Demographic Clinical Psychometric and Symptom
Information Information Specific Questionnaires
Age Diagnosis The SF-36
Gender Type of The Graham and Longman Q
Social transplant of L Scale
circumstances Blood counts The GHQ - 12
Presence and
degree of
GVHD
Demographic information
The demographic information that was gathered on all participants is
summarised in table 3.3. It was important to record the age of all
participants since side effects such as fatigue and pain as well as a
reduction in functional ability have been shown to correlate with age
(Hensel et al., 2002). The relationship between gender and recovery after
haemopoietic transplantation is not clearly understood. A study by Hensel
et al., investigating quality of life after transplantation, found that male and
female survivors did not differ for any QLQ-C30 items. However a study by
Syrjala et al. (1993) found that women were more depressed after
transplantation. Other authors have suggested that the acceptability of
some forms of rehabilitation and post treatment support is gender related
(Adamsen et al., 2001). It recorded whether or not patients lived with their
next of kin in order to provide a crude measure of their social
circumstances.
78
Clinical Information
A number of clinical details were gathered directly from the medical notes
of all participants. The clinical information of primary importance was
transplant type. This is due to the variation that has been shown in the
frequency and severity of the side-effects associated with the different
transplant procedures (Duncombe, 1997). The origin of the transplanted
cells i.e. whether cells have been collected from the patient themselves
(autologous) or a donor (allogeneic) has an impact on recovery since the
transplantation of donor cells is an immunologically more complicated
procedure. These patients must take immunosuppressants and are at high
risk of developing graft versus host disease.
For patients who had been treated with an allogenic transplant it was also
important to record whether the donor was either a sibling or a matched,
unrelated donor since research has shown that transplant related mortality
is 20-30% for individuals who receive sibling HLA matched allografts and
up to 45% for recipients of allografts from matched, unrelated donors
(Duncombe, 1997).
It was also important to know whether the patient received stem cells
which had been collected from the bone marrow or from the peripheral
blood system. The use of stem cells that have been harvested from the
peripheral blood is a relatively recent medical development and it is
gradually replacing bone marrow transplantation as the procedure of
choice. This is because engraftment is more rapid and patients can
normally be discharged from hospital earlier. A study by Vellenga et al.
(2001) indicates that treatment with stem cells rather than bone marrow
cells correlates significantly and positively with several important outcomes
including quality of life (Vellenga et al., 2001).
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The purpose of performing a stem cell transplant and the side-effects
induced by treatment differ for different cancers (Outhwaite, 2004).
Therefore the type of haematological malignancy with which each
participant had been diagnosed was recorded. The approximate date of the
patient's diagnosis was noted in order to give an indication of the length of
time between diagnosis and treatment in which the participant had been
able to psychologically adjust to the concept of needing a stem cell
transplant.
As previously discussed the process of preparation for a stem cell
transplant causes the destruction of blood cells that are crucial for oxygen
carriage, clotting and immune defence. During the recovery phase levels of
these cells gradually increase. Individuals with inadequate levels of these
cells are at risk of bleeding and severe breathlessness particularly during
exercise. Therefore participants' haemoglobin, platelet, white cell and
neutrophil counts were checked prior to their commencement of the trial
and regularly throughout the intervention period in order to ensure that
they were safe to complete the exercise component of the intervention.
Psychometric and Symptom Specific Questionnaires
A number of general health status questionnaires exist. The SF-36 (Ware,
Snow et al. 1993) was chosen in preference to alternatives because the SF-
36 is particularly appropriate for use with patients who are recovering from
major illness. It was also important that the tool chosen was suitable for
self administration and not too burdensome to complete. This was
particularly important as bone marrow and stem cell transplant patients
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are susceptible to fatigue. The SF-36 contains 36 questions which can be
used to calculate eight sub-scales
1. physical functioning
2. role limitation due to physical health
3. bodily pain
4. social functioning
5. general mental health
6. role limitations due to emotional problems
7. vitality, energy or fatigue
8. general health perceptions
The SF-36 has been shown to have good psychometric properties and high
levels of reliability and validity (Ware et al., 1993). Ware et al. (1993)
report the results of a factor analysis of the SF-36 and suggest that there is
strong evidence for the conceptualisation of health on which the scale is
built. This factor analysis indicated that some components of the scale
effectively measure physical health, some mental health and some
measure both (Ware et al., 1993). Brazier et al. (1992) investigated the
acceptability, validity and reliability of the SF-36 and reported that the SF-
36 had good construct validity and that it was able to detect low levels of ill
health. This study identified evidence that the SF-36 was more sensitive to
gradations in health than either the Euroqol or the Nottingham Health
Profile (Brazier, Harper et al., 1992). Considerable evidence was found for
the reliability of the SF-36 (Cronbach's alpha >0.85, reliability co-efficient
>0.75) for all dimensions except social functioning (Brazier et al., 1992). A
number of other studies have also demonstrated that the SF-36 has
acceptable internal consistency measured using Cronbach's alpha
(Jenkinson et al., 1997, Garratt et al., 1993).
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The SF-36 is one of the most widely used measures of health status
(Bowling, 2001). It has been used in a number of previous studies with
cancer patients (Ingram, 2002, Berger and Walker, 2001, Helgeson et al.,
2000) and in several studies conducted with stem cell transplant patients
(Gruber et al., 2003, So et al., 2003). Furthermore SF-36 population norms
have been established for the UK population (Jenkinson et al., 1993)
allowing comparisons to be made between the sample in this study and the
wider UK population.
In recognition of the fact that health as defined by the health professionals
may not accurately reflect the factors that are important to patients, a
quality of life scale was included as a further outcome measure. Quality of
life was measured using the Graham and Longman's two item Quality of
Life Scale (QL Scale), which asks patients to rate their current quality of
life on a scale from 1 (poor) to 10 (excellent), and their degree of
satisfaction with their current quality of life from 1 (not satisfied at all) to
10 (very satisfied). Participants completed the questionnaire themselves,
which took less than five minutes. The scale does not define quality of life
and therefore it allows patients to rate their own quality of life according to
the factors that are important for them. This scale has been shown to be a
valid and reliable tool (Graham and Longman, 1987) and when tested with
cancer patients it has been shown to have an inter-item correlation of less
than 0.05 (Porock et al., 2005) suggesting that the two items measure
different aspects of quality of life.
Since anxiety and depression are potential side effects of treatment with a
bone marrow and stem cell transplant it was also important that a specific
measure of psychological health was included as an outcome measure.
Therefore the General Health Questionnaire, GHQ-12 (Goldberg, 1978) was
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also used. The GHQ-12 is a state measure of psychiatric disturbance,
assessing current state in relation to usual state. The GHQ-12 is a short
item version of the long (60 item version), both versions having been
shown to be reliable and valid. It has been suggested that the GHQ-12 is
the scale that has been most extensively tested for reliability, validity and
sensitivity (Bowling, 2001). The GHQ-12 has been shown to correlate well
with psychiatric diagnoses of morbidity and depression. Internal
conslstency has been reported to range from 0.77 to 0.93 (Cronbach's
alpha) and test-retest correlations range from r=0.51 to 0.90 (Goldberg
and Williams, 1988). The GHQ-12 was chosen in preference to the GHQ-60
in recognition of the fact that instrument burden was a potential problem
given the number of questionnaires participants were asked to complete.
Other baseline measures
A standardised measure of exercise capacity was also included as an
outcome measure. Exercise capacity was measured using the shuttle walk
test. This measure was included to provide an objective measure of
improvement in physical functioning. The reliability and validity of the
shuttle walk test have been shown in studies with different patient
populations including patients with cancer (MacSween et al., 2001, Ngaage
et al., 2004, Win et al., 1996). It took participants approximately 20
minutes to complete the test.
During the collection of baseline data participants were also asked if they
had a preference which programme they were allocated to. This was done
to assist with data analysis. It was probable that some patients taking part
in the trial would have a strong preference for one or other of the
programmes. Their pleasure at being allocated their preferred programme
or their disappointment at not getting their preferred programme might
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have influenced the extent to which they engaged with their allocated
programme which in turn might have influenced its effectiveness.
Therefore it was important to establish if participants had a preference for
one or other of the programmes. It was reiterated to patients that their
stated preference did not influence the randomisation process.
Randomisation
Patients that met the inclusion criteria and who gave written consent were
randomly assigned to one of two groups (group SM "self managed
rehabilitation programme", and group HPL"health profession led
rehabilitation programme"). Facilitated by the website
www.randomization.com an independent person used computer
randomisation to generate randomisation lists. After the baseline measures
had been completed a telephone call was made by the researcher to a
member of administrative staff who held the randomisation lists. This
individual was not otherwise involved in the study. The researcher was told
which group the patient has been allocated to and the researcher then
informed the participant. The participant's study number and
randomisation result were logged in the trial records to enable verification
after the completion of the trial that the randomisation process had not
been manipulated.
In order to ensure that there was not too great an imbalance in the
number of participants completing each arm of the trial at anyone time,
block randomisation was used. However a system of randomised block
sizes was used to ensure that as the trial progressed it was not possible to
work out the block sizes. If block size is known the final allocation in each
block would be apparent and this would have made it easier for staff to
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manipulate allocation if they so desired. The block sizes that were
randomly assigned were six, eight and ten. The health care team and I
were blind to block sizes until after the completion of the data collection.
Stratification
Randomisation is designed to ensure that an imbalance in prognostic
factors does not occur across arms of a trial. However, in practice,
particularly in small trials such imbalances can occur. Stratification is used
to control the imbalance between groups (Matthews, 2000).
Receiving donated cells is immunologically more complicated than being re-
infused with your own cells. Therefore allogenic transplants are associated
with greater risk than autologous transplants (Outhwaite, 2004).
Transplant type is therefore a crucial prognostic factor in recovery after
stem cell transplantation. Therefore there was stratification into two groups
according to transplant type (autograft and allograft) prior to
randomisation.
3.11 Follow Up Measures
Data was gathered from participants on two further occasions, at the end
of the intervention period and six months after randomisation. The
rehabilitation programmes were ten weeks in duration. Therefore the first
of these time points was chosen in order to assess the immediate impact of
the health profession led and self managed programmes on the physical
and psychosocial recovery of participants. The final data collection point
was set at six months post randomisation in order to provide an indication
as to the sustained effect of the programmes. At both time points the
participants were asked to complete the measures shown in figure 3.4
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Figure 3.4: Follow up measures
The SF-36 Questionnaire
The Graham and Longman Quality of Life Scale
The GHQ-12 Questionnaire
The Shuttle Walk Test
Follow up measures at 3 and 6 months
3.12 Qualitative Interviews
Randomised controlled trials can provide information on how effective an
intervention is, but are unable to provide insights into the overall
experience of the patient who receives the intervention (Seers and
Crichton, 2001). The addition of a qualitative component can compensate
for this limitation and provide information about the intervention from the
perspective of patients (Seers, 1994).
Semi structured interviews allow the researcher to set the agenda in terms
of the topics covered but the interviewees responses' determine the kind of
information produced and the relative importance of each topic (Green &
Thorogood, 2005). A strength of using a guided approach is that it enables
a systematic approach to data collection (Patton, 1990) which may
increase the breadth, although not the depth, of the data generated.
Interview schedules (shown in Appendix F - page 285) were developed in
order to assist the interviewer in conducting the interviews. These topic
guides were developed through a process considering the different
elements of the rehabilitation programmes and of exploring these in
relation to the existing literature on the topic. The guides were reviewed by
clinical and research colleagues, who provided suggestions for any further
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topics for inclusion. The guides were then re-examined after the first
couple of interviews had been conducted. The guides were used purely as a
guide and did not stipulate exact phrasing of or a predetermined sequence
to the questions.
The semi-structured interviews were used to explore the patients'
experiences of recovering after a stem cell transplant, their experience of
either the health profession led programme or the self managed
programme and their experience of participation in a randomised controlled
trial. It was anticipated that the interviews would provide additional depth
to the quantitative data collected and allow participants the opportunity to
express their thoughts and opinions about their recovery after stem cell
transplantation and how the programmes provided, did or did not aid that
recovery.
Semi structured interviews were also conducted with members of staff
involved in either the health profession led programme or the provision of
medical care to patients recovering after stem cell transplantation. It was
expected that these interviews would provide an insight into the staff
members experiences of being involved in a randomised controlled trial.
The semi structured interviews were conducted at the end of the study
period, six months after randomisation and focused on the patients'
perceptions of their quality of life and their recovery from stem cell
transplantation. These interviews were conducted in a location convenient
for the participant. This tended to be in a quiet side room during a clinic
visit or at a visit by the researcher to the participant's home.
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Participants were selected to ensure that the sample included individuals
not only from each arm of the study but also from both transplant types,
both genders and a range of ages. Furthermore it was important to ensure
that within the group of interviewees there were participants with differing
reactions to the two programmes. For example it was necessary that
interviews were conducted with individuals whose attendance at the health
profession led programme had been high and with individuals whose
attendance had been sporadic or even non-existent. Staff members were
selected for interview according to their involvement in the trial or there
acknowledged expertise in the field of stem cell transplantation.
3.13 Trial Outcomes
Primary Outcome
Change in the mean SF-36 physical functioning summary score at six
months was chosen as the primary outcome measure. The time point of six
months was chosen for the primary outcome measure since establishing if
the rehabilitation programmes had any ongoing effectiveness was
considered to be more important than assessing the effects of the
programmes immediately after their completion. Since the programme has
a considerable focus on the physical components of health it was
appropriate to choose a measure of physical functioning as the primary
outcome measure.
Secondary Outcomes
A wide range of secondary outcome measures were chosen in recognition
of the complex nature of the health profession led programme. Given the
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biopsychosocial nature of the intervention under evaluation it was
important to choose measures that reflected each element of the study.
The secondary outcome measures were; Change in role limitation due to
physical health; bodily pain; social functioning; general mental health, role
limitations due to emotional problems; vitality, energy or fatigue and
general health perceptions as measured by the SF-36 between baseline
and six months; Change in physical functioning; role limitation due to
physical health; bodily pain; social functioning; general mental health, role
limitations due to emotional problems; vitality, energy or fatigue and
general health perceptions as measured by the SF-36 between baseline
and three months; Change in quality of life, as measured by the Graham
and Longman two item quality of life scale, between baseline and six
months; Change in quality of life, as measured by the Graham and
Longman two item quality of life scale, between baseline and three
months; Change in psychological health, as measured by the General
Health Questionnaire, between baseline and six months; Change in
psychological health, as measured by the General Health Questionnaire,
between baseline and three months; Change in exercise capacity, as
measured by the shuttle walk test, between baseline and six months;
Change in exercise capacity, as measured by the shuttle walk test,
between baseline and three months.
3.14 Data management and analysis
Quantitative data management
The statistical software package SPSS (v14) for windows was used to
manage and analyse the quantitative data. Prior to data analysis an
analysis plan was devised. This approach was used to avoid data dredging,
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a process whereby multiple analyses are conducted increasing the risk of
making a type I error. Descriptive statistics were used to summarise the
questionnaire and shuttle walk test data. The outcome data was analysed
using linear regression models. Data was checked to ensure it met the
assumptions required for linear regression analysis. In particular the
distribution of residuals was checked for all data. The analysis plan
included the proviso that if results that were indicative of a difference
between the two arms of the trial occurred for data where there was any
evidence to suggest the assumptions of linear regression had been
violated, then non-parametric tests would be used to see how robust the
results were.
Exploratory analysis using linear regression models was conducted to
explore if a patient's programme preference had a modifying effect on the
relationship between physical functioning and programme allocation.
Further exploratory analyses were considered but the study was considered
to be insufficiently powered to allow this. Since one of the advantages of
using the SF-36 health survey was that population norms exist for the UK
population, the SF-36 data from six months post recruitment was
compared to the UK population norms. This enabled a comparison to be
made between the health of individuals recovering after stem cell
transplantation and that of the general public. The SF-36 data was
adjusted for both age and gender.
Qualitative data management
The interviews were transcribed into word documents and then analysed.
The decision was taken not to use any additional computer packages (other
than Microsoft word) in the analysis of data but to adapt the 'scissor and
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paste' approach described by Krueger and Casey (2000). The volume of
data was comparatively small and a non-computerised method was both
feasible and appropriate.
A thematic content approach to data analysis was used. This is a commonly
used approach in health research and is appropriate for interview data
(Green and Thorogood, 2004). Following transcription which was carried
out by a combination of the researcher and an employed transcription
service, the interview transcripts were checked for accuracy, read for
context and then coded. Respondents' accounts were categorised and
compared enabling identification of the themes that were common in the
data set. Individual themes were then considered in more detail, with
attention being paid to contradictory accounts or unusual cases. The
findings were then interpreted within the context of the existing literature.
Green and Thorogood (2004) suggest a number of features of rigorous
qualitative analysis. These include transparency, providing a clear account
of the procedures used, the analysis of deviant cases and disconfirming
data, analysis of the whole data set, using more than one analyst,
providing simple frequency counts of key themes, comparing findings to
other studies and accounting for the role of the researcher in the research.
Unfortunately the study did not have the resources to use more than one
analyst to analysis the data. Therefore, several full transcripts were
reviewed by an experienced researcher and checks were made on the
interpretation of data. All the rest of the principles outlined above were
applied to the analysis of the qualitative data generated in this study.
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3.1S Ethical considerations
There were a number of ethical concerns that required consideration during
the planning of this study. A concern of all studies is to ensure that consent
is both informed and voluntary. It is clearly unethical to mislead people or
dupe them into participation. However, ensuring that consent is informed
consent, requires more than just a commitment to not deliberately mislead
people. For example, the initial draft of the information letter to be used in
the study informed participants that the allocation of rehabilitation
programmes would be on a random basis. This was clearly a truthful
statement but research has shown that participants often have very little
understanding of what random allocation actually means (Stead et al.,
2005). Therefore the final draft of the information letter (shown in
Appendix C - page 257) stated that "participants are randomly assigned to
one or other of the groups by a computer that does not have any
information about the individual - i.e. by chance". Throughout this study
we attempted to fully explain concepts in order to ensure that as far as
possible patients had not only been given accurate information but that
they had understood it. In order to ensure that participation was voluntary
we informed all potential participants that their routine care would be
unaffected by their decision either to or not to participate and that they
were free to withdraw at any point without giving a reason.
In order for a randomised controlled trial design to be ethically viable it is
crucial that genuine uncertainty exists as to which arm of the trial will
provide the most benefit to patients. It is of fundamental importance that
this equipoise exists in order to justify having a control group. It is clearly
unethical to deprive participants of an intervention that is of proven
benefit. Therefore the existing evidence was explored at length to ensure
that this research was justified and to be certain that those participants
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randomised to the control group would not have any aspect of care
withheld from them that was of known benefit. Since there is sufficient
evidence that exercise has proven health benefits this research did not
attempt to reassess this concept. This research aimed to establish whether
the structure of a health profession led rehabilitation session was more
effective at promoting recovery than a programme which provided patients
with information and support through a self managed programme. The
information pack was used in order to provide the control group with the
same information that is available to the participants attending the health
profession led rehabilitation programme. The participants in the control
group were not discouraged from making any lifestyle changes that are
thought to promote recovery and good health.
In many studies the control group consists of usual care. In these studies
participants are aware before they take part that they mayor may not
receive any additional intervention. For the reasons outlined above I did
not want to use usual care as the control in this study. However it was very
important that patients were not misinformed about the nature of the self
managed programme and led to expect more than was actually being
provided. Therefore it was stated in the pre-trial information and reiterated
verbally that the self managed programme consisted of information that
was available to patients generally but that for the purposes of this study it
had been gathered together into one pack.
Ethics and Research Governance
The study was reviewed by the local research ethics committee who gave
approval for the study. Permission to conduct the study at the particular
research site was requested and given by the appropriate research and
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development committee. The progress of the trial was also monitored by
the research and development department.
3.16 Summary
A randomised controlled trial was used to evaluate a health profession led
rehabilitation programme. The control group completed a self managed
programme. The study design is summarised in figure 3.5.
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Figure 3.5: Summary of Study Design
Patient has stem cell
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Chapter 4 - Trial Results
4.1 Introduction
This chapter reports the results of the bone marrow and stem cell
transplant rehabilitation trial. The chapter includes a description of the
study sample and compares the demographic characteristics of those who
took part with those who did not. The reasons participants gave for not
wishing to take part are also reported. Detailed demographic and clinical
details as well as baseline scores for the outcome measures are provided
for participants randomised to the health profession led and self managed
programmes. The results of analysis carried out on the primary and
secondary outcome data is then presented. Exploratory analysis is
presented and finally the SF-36 data from this trial is compared with some
normative data from the UK population.
4.2 Recruitment
Recruitment took place over a 14 month period commencing in August
2005. Recruitment was from the allograft and autologous transplant clinics.
During the recruitment period 158 people underwent treatment with either
an allograft (63) or autologous (95) transplant. All 158 people were
considered for entry into the trial. Of these 158 people, 144 (91%) were
approached with regard to taking part. Of the fourteen potential
participants not approached seven were too ill to meet the inclusion criteria
and two had already taken part in the trial with previous transplants and
they were therefore ineligible, five participants were missed because their
care was transferred to their referring hospital immediately post transplant.
Of the 144 potential participants who were approached about the trial 61
(42%) gave their consent to take part. The most frequently cited reasons
for declining to take part were distance from home to hospital, and that the
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programme did not seem relevant to their needs. Baseline data was
collected from 58 of the 61 people who had consented to take part. Two
people withdrew from the trial before their data was collected and one
person had their care transferred to another hospital and contact was lost.
Everyone who had baseline data collected was randomised to either the
health profession led programme or the self managed programme.
It was calculated that a total of 132 participants needed to be recruited in
order for the study to be adequately powered (shown in chapter three
section 3.9). Despite this the decision was taken to stop recruiting after 14
months when only 58 participants had been recruited. A combination of
factors including the poor rate of recruitment, changes to the clinical
environment and a lack of stability of the health profession led
rehabilitation programme all contributed to the decision to stop recruiting
participants. These factors are explored in greater detail in the discussion
of the methodology (chapter six section 6.2).
The flow of potential participants from transplant to randomisation is
summarised by figure 4.1.
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Figure 4.1: The progression of participants from transplantation
through to randomisation
Not approached (n = 14)
• Too ill to meet inclusion criteria (n= 7)
• Took part in the trial with previous
transplants (n = 2)
• Missed (n= 5)
1
Did not give consent (n = 83)
Reasons given were a
• Distance (n= 30)
• Programme not felt to be relevant (n= 17)
• Transport problems (n= 15)
• No reason given (n= 10)
• Personal commitments (n= 7)
• Desire to avoid further time at hospital (n= 6)
• Relapse (n= 3)
• Unable to contact (n= 2)
• Clashes with other hospital appointments (n= 2)
• Missed? cause (n= 2)
r--- '--_--;lsome potential participants gave more than one reason)
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Baseline data not collected (n = 3)
• Withdrew from the trial (n= 2)
• Care transferred and contact lost (n= 1)
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4.3 Comparison of study participants and non-
participants
In order to assess how representative the sample was of the study
population the demographic characteristics of those who agreed to take
part were compared with those who did not take part. The data includes
both potential participants who were approached but declined to take part
and those who were not approached. This is shown in table 4.1.
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Table 4.1: Demographic characteristics of study participants and
non-participants
Participants Non- p
n = 58 participants value
n = 100
Median age in years SS (43-63) 54.5 (43-60.75) 0.93a
(IQR)
Gender n (0/0)
Male 38 (65.5) 52 (52.0) 0.098b
Female 20 (34.5) 48 (48.0)
Transplant Type n (0/0)
Allo MUD 18 (31.0) 25 (25.0) 0.006b
Allo Sibling 13 (22.4) 7 (7.0)
Auto 27 (46.6) 68 (68.0)
Diagnosis n (0/0)
Leukaemia 19 (32.0) 26 (26.0) 0.19b
Lymphoma 16 (27.6) 25 (25.0)
Myeloma 19 (32.8) 47 (47.0)
Other 4 (6.9) 2 (2.0)
aMann Whitney U test
bChi-squared (X2) test
The median age of both groups was similar, SS years for those who
participated and 54.5 years for the non-participants. There was a slight
gender imbalance between the two groups, with proportionally less women
agreeing to participate than men (p = 0.098). It is plausible that this
borderline difference may not have arisen by chance. For example, more
women than men (six women, one man) when asked about the study cited
other commitments as the reason for their non-participation and this was
frequently related to their responsibilities as a mother or grandmother.
A difference was identified between the participants and non-participants in
relation to transplant type (p = 0.006), with participants who had
undergone an autologous transplant being less likely to take part in the
trial. There are a number of possible explanations for this finding. It may
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be that the better post transplant recovery associated with having an
autologous transplant meant that individuals did not feel the need for
rehabilitation. However it must also be considered that the health
profession led programme was run on the same day as the allograft
transplant clinic, therefore potentially providing an incentive for allograft
patients to take part and a disincentive for autologous patients.
There was a good representation of each diagnostic group in the study
population with no substantial differences identified between the
participants and non-participants. The slight imbalance in the two groups in
relation to myeloma patients is to be expected given the previous
discussion on transplant type since the usual treatment for myeloma is
autologous transplant.
4.4 Comparison of the health profession led and self
managed groups at baseline
Participants in the study were randomly allocated to either the health
profession led programme or the self managed programme. Of the 58
participants who took part, 29 participants were allocated to the health
profession led programme and 29 participants were allocated to the self
managed programme. The purpose of randomly allocating participants was
to ensure that patients in different groups were similar in characteristics
such as age, gender and any other factors that may influence trial
outcomes, however randomisation cannot guarantee that imbalances will
not occur especially when sample sizes are small (Wang and Bakhai,
2006). Therefore the health profession led and self managed groups were
compared to check for imbalances that might have an affect on the
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outcome variables. Table 4.2 provides information about the demographic
and clinical characteristics of the two groups at baseline.
The heath profession led group have a marginally higher median age (57
years) than the self managed group (52 years), however the interquartile
ranges for the two groups were very similar (44-63.5 compared to 42.5-
63). There was a modest gender imbalance between the two groups with
more women being allocated to the health profession led programme (n =
13) than the self managed programme (n = 7). Wang and Bakhai (2006)
recommend that adjustment of the baseline covariate is appropriate if it is
known to be correlated to the outcome. They suggest a covariate that
gives a correlation coefficient >0.5 or <-0.5 requires adjustment. Therefore
the correlation coefficient between each baseline characteristic and the
main outcome measure were calculated. These are shown in table 4.3. The
correlation coefficient for gender was found to be -0.14 and therefore the
imbalance in gender between the two groups in this sample was not
considered to be important.
It was predicted that transplant type might have a major influence on the
outcomes of this trial and therefore the randomisation process included
stratification according to transplant type. The two groups were therefore
well balanced with regard to transplant type. The health profession led
programme included 15 people who had undergone an allograft transplant
and 14 people who had undergone an autologous transplant. The self
managed programme included 16 people who had undergone an allograft
transplant and 13 people who had undergone an autologous transplant.
There was a good representation of each diagnostic group in each arm of
the study with no particular imbalances between the two groups. Only six
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people in the study had transplants using cells harvested from bone
marrow and five of these were allocated to the health profession led
programme. However the source of a participant's cells had a correlation
coefficient of -0.004 with the main outcome measure and therefore this
imbalance was not considered to be problematic. The median time between
diagnosis and transplant was similar in both groups, seven months in those
allocated to the health profession led programme and six months in those
allocated to the self managed programme. A crude measure of social
support, Le. does the participant's next of kin live with them indicated that
individuals in both groups had a similar level of social support. In the
health profession led group 22 people lived with their next of kin compared
to 25 people in the self managed group.
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Table 4.2: Demographic and clinical characteristics of the health
profession led and self managed groups at baseline
Median age in years (IQR)
Gender n (0/0)
Male
Female
Transplant type n (0/0)
Allo MUD
Allo Sibling
Auto
Diagnosis n (0/0)
Leukaemia
Lymphoma
Myeloma
Other
Source of cells n (0/0)
Peripheral Blood
Bone Marrow
Median time between diagnosis
and transplant in months (IQR)
Does participant live with NOK n
(0/0)
Yes
No
HPL Group SM Group
(n = 29) (n = 29)
57 (44-63.5) 52 (42.5-63)
16 (55.2) 22 (75.9)
13 (44.8) 7 (24.1)
8(27.6) 10 (34.5)
7 (24.1) 6 (20.7)
14 (48.3) 13 (44.8)
9 (31.0) 10 (34.5)
10 (34.5) 6 (20.7)
9 (31.0) 10 (34.5)
1 (3.4) 3 (10.3)
24 (82.8) 28 (96.6)
5 (17.2) 1 (3.4)
7 (4-22) 6 (4-14)
22 (75.9 )
7 (24.1)
25 (86.2)
4 (13.8)
IQR = Interquartile Range
NOK = Next of Kin
Table 4.3: The correlation between characteristics measured at
baseline and the primary outcome measure (SF-36 Physical
Functioning score at six months).
Age
Gender
Transplant type
Diagnosis
Source of cells
Time between diagnosis and
transplant
Does participant live with NOK
Correlation co-efficient
-0.13
-0.14
0.08
0.03
-0.004
-0.008
NOK = Next of Kin
-0.01
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Table 4.4 provides a comparison of the summary scores from the
psychometric questionnaires at baseline. The baseline scores in both the
health profession led and self managed groups are similar across the range
of outcome measures.
Table 4.4: SF-36, a general health questionnaire, b quality of lifec and
the shuttle walk test" scores for the health profession led and self
managed groups at baseline
SF-36 Mean, (SO) & Median
Summary Scores
Physical Functioning
Role-Physical
Bodily Pain
General Health
Vitality
Social Functioning
Role-Emotional
Mental Health
GHQ Mean Score (SO)
QoL Mean, (SO) & Median
Summary Scores
QoL Rating
QoL Satisfaction
SWT Mean, (SO) & Median
Summary Scores (Metres)
HPL Group
(n = 29)
SM Group
(n = 29)
41.7 (23.6) 45.0
20.9 (19.6) lS.S
63.1 (29.1) 64.0
49.0 (19.S) 45.0
30.S (20.9) 31.3
37.0 (30.1) 25.0
54.0 (36.S) 66.7
66.6 (17.9) 70.0
17.4 (6.5)
5.6 (1.7) 5.0
4.7 (2.6) 4.5
235.9 (150.4) 260.0
44.0 (25.3) 40.0
23.2 (17.2) 25.0
60.6 (2S.6) 62.0
44.5 (lS.S) 42.0
31.3 (19.1) 31.3
3S.S (27.9) 25.0
44.5 (2S.S) 50.0
62.2 (22.3) 65.0
16.3 (S.O)
5.5 (2.2) 5.5
4.7 (2.6) 4.5
233.1 (133.9) 220.0
• Possible scores range from 0-100. Higher score indicates better functioning.
b POSSiblescores range from 0-36. Higher score indicates worse mental health.
C Possible scores range from 0-10. Higher score indicates better quality of life.
d Possible scores range from 0-1020metres. Higher score indicates better physical
functioning.
GHQ = General Health Questionnaire, QoL = Quality of Life, SWT = Shuttle Walk Test
SD = Standard Deviation
4.5 Participation in the health profession led
programme
Table 4.5 shows the attendance levels for participants allocated to the
health profession led programme. There was considerable variability in the
attendance level of participants with some participants attending for the
entire programme whilst others never attended. No measure of
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participation is reported for those allocated to the self managed
programme.
Table 4.5: Distribution of number of health profession led
rehabilitation sessions attended out of a total of ten by participants
allocated to the HPL programme (n = 29).
0/0 of rehab sessions attended Number of participants
0-3
4-6
7-10
10
6
13
4.6 Attrition
Data was collected from 50 participants at the 12 week data collection
point. 23 of these participants were in the health profession led group and
27 were in the self managed group. Of the eight participants from whom
12 week data was not collected three participants had chosen to withdraw
from the trial and five participants were either undergoing active treatment
again because their disease had relapsed or they had died. By the six
month data collection point a further two participants had either relapsed
or died, one participant was missed and it was not possible to contact one
further participant. Data was collected on the remaining 46 participants.
This information is summarised by figure 4.2.
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Figure 4.2: The progression of participants from randomisation
through to trial conclusion
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4.7 Primary outcome of the trial
The primary outcome measure was the physical functioning score of the
SF-36 at six months which was analyzed using linear regression with
baseline physical functioning and intervention group as covariates. This
analysis and the mean physical functioning scores at baseline and after six
months are shown in table 4.6.
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Table 4.6: Change in the primary outcome measure, SF-36 physical
functioning score/ between the study groups at 6 months
HPL SM Mean
difference
(95% Cl)
p
value
Mean PF 41.7 (23.6) 44.0 (30.1)
score at
baseline (SO)
Mean PF 64.9 (25.3) 65.6 (23.5)
score after 6
month (SO)
Mean Change 21.9 (14.2) 21.4 (22.5) 0.19b 0.97
(SO) (-10.77 to 11.16)
a Possible scores range from 0-100. Higher score indicates better functioning.
b Mean difference calculated from linear regression model with baseline values as covariates to
avoid bias due to regression to the mean.
SO = Standard Deviation, Cl = Confidence Interval
The mean change in physical functioning from baseline to six months was
very similar in both groups, 21.9 for the health profession led and 21.4 for
the self managed programmes. The mean difference in the physical
functioning scores of both groups, calculated from the linear regression
model, was 0.19 and the 95% confidence interval included zero indicating
that no evidence of a difference between the two modes of rehabilitation
could be observed. However, the confidence interval around the estimated
difference in physical functioning could not exclude differences of up to 10
points in either direction.
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4.8 Secondary outcomes of the trial
The secondary outcomes of the trial were change in the SF-36 scores, the
general health questionnaire, quality of life ratings and the shuttle walk
test scores between baseline and six months and also between baseline
and three months. Table 4.7 presents the mean change from baseline to
six months for all outcome measures broken down by treatment group.
The mean changes in the SF-36, general health questionnaire, quality of
life and the shuttle walk test scores from baseline to six months were very
similar in both groups. The smallest mean difference calculated from the
linear regression model was 0.02 (for the quality of life rating data) and
the largest mean difference was -15.06 (for the shuttle walk test data).
The 95% confidence intervals for all outcomes included zero indicating that
the health profession led rehabilitation programme did not have an impact
on recovery that could be detected in this size sample six months after
randomisation.
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Table 4.7: Change between baseline and six months for the HPL
and SM scores of the SF-36,a GHQ/ quality of life scale" and the
shuttle walk test"
HPL SM Mean p
group group Differencee value
(950/0 Cl)
Physical Function
Mean Change 21.85 21.38 0.19 0.97
(SO) (14.22) (22.54) (-10.77 to 11.16)
Role-Physica I
Mean Change 33.44 34.25 -1.17 0.89
(SO) (28.41) (27.43) (-18.05 to 15.70)
Bodily Pain
Mean Change 8.86 11.96 -1.37 0.83
(SO) (24.93) (26.65) (-14.19 to 11.46)
General Health
Mean Change 7.24 10.40 -1.21 0.83
(SO) (23.08) (15.71) (-12.76 to 10.34)
Vitality
Mean Change 21.73 22.50 -0.15 0.98
(SO) (17.07) (23.87) (-11.62 to 11.32)
Social Function
Mean Change 32.14 35.00 -2.64 0.75
(SO) (38.64) (31.25) (-19.21 to 13.93)
Role-Emotiona I
Mean Change 17.91 27.00 2.28 0.77
(SO) (27.61) (33.70) (-13. 17 to 17.73)
Mental Health
Mean Change 5.95 6.40 1.57 0.75
(SO) (16.48) (21.14) (-8.36 to 11.50)
GHQ
Mean Change -5.95 -4.96 -0.36 0.87
(SO) (7.63) (9.39) (-4.60 to 3.88)
QoL Rating
Mean Change 1.60 1.69 0.02 0.97
(SO) (1.99) (2.53) (-1.16 to 1.20)
QoL Satisfaction
Mean Change 2.14 2.44 -0.06 0.94
(SO) (2.50) (3.64) (-1.53 to 1.42)
SWT
Mean Change 126.11 140. 91 -15.06 0.65
(SO) (107.71) (99.85) (-82.45 to 52.33)
a Possible scores range from 0-100. Higher score indicates better functioning.
b Possible scores range from 0-36. Higher score indicates worse mental health.
C Possible scores range from 0-10. Higher score indicates better quality of life.
d Possible scores range from 0-1020 metres.
• Mean difference calculated from linear regression model with baseline values as covariates to
avoid bias due to regression to the mean.
GHQ = General Health Questionnaire, QoL = Quality of Life, SWT = Shuttle Walk Test
SD = Standard Deviation, Cl = Confidence Interval
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The trial design included testing for differences between the health
profession led programme and the self managed programmes immediately
after the end of the intervention period (three months after
randomisation). Table 4.8 presents the mean change from baseline to
three months for all outcome measures broken down by treatment group.
As with the six month data, the mean changes at three months for the SF-
36, general health questionnaire, quality of life and the shuttle walk test
scores were very similar in both groups. The smallest mean difference
calculated from the linear regression model was 0.09 paints, for the quality
of life rating data, and the largest mean difference was 34.7 metres, for
the shuttle walk test data. The 95% confidence intervals for all outcomes
included zero indicating that no evidence of any difference in recovery
between the health profession led and self managed rehabilitation groups
could be observed.
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Table 4.8: Change between baseline and three months for the
health profession led and self managed group scores of the SF-36, a
GHQ, b quality of life scale? and the shuttle walk test"
HPL SM Mean Differencee p
Grou~ grou~ (950/o Cl) value
Physical Function
Mean Change 15.96 11.91 3.94 0.48
(SO) (16.38) (21.62) (-7.13 to 15.00)
Role-Physical
Mean Change 16.85 21.76 -4.89 0.50
(SO) (20.94 ) (27.59) (-19.17 to 9.40)
Bodily Pain
Mean Change 7.48 10.74 -1.27 0.84
(SO) (29.49) (19.05) (-13.81 to 11.26)
General Health
Mean Change 4.13 9.30 -3.93 0.43
(SO) (16.57) (17.92) (-13.75 to 5.89)
Vitality
Mean Change 16. 39 14.74 2.17 0.68
(SO) (13.71) (21.11) (-8.16 to 12.49)
Social Function
Mean Change 20.11 25.46 -3.96 0.60
(SO) (30.32) (31.29) (-18.93 to 11.00)
Role-Emotional
Mean Change 5.43 25.30 -12.76 0.16
(SO) (29.15) (38.01) (-30.82 to 5.30)
Mental Health
Mean Change 5.54 6.67 0.99 0.83
(SO) (13.44) (20.94) (-7.99 to 9.97)
GHQ
Mean Change -4.27 -4.84 1.15 0.58
(SO) (7.49) (8.29) (-3.04 to 5.35)
QoL Rating
Mean Change 0.89 0.98 -0.09 0.85
(SO) (1.60) (1.92) (-1. 01 to 0.84)
QoL Satisfaction
Mean Change 1.32 1.78 -0.38 0.49
(SO) ( 1.49) (2.73) (-1.50 to 0.73)
SWT
Mean Change 145.00 106.54 34.67 0.37
(SO) (170.51) (110.85) (-43.01 to 112.34)
• Possible scores range from 0-100. Higher score indicates better functioning.
b Possible scores range from 0-36. Higher score indicates worse mental health.
C Possible scores range from 0-10. Higher score indicates better quality of life.
d Possible scores range from 0-1020 metres.
e Mean difference calculated from linear regression model with baseline values as covariates to
avoid bias due to regression to the mean.
GHQ = General Health Questionnaire, QoL = Quality of Life, SWT = Shuttle Walk Test
SO = Standard Deviation, Cl = Confidence Interval
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4.9 Confirmatory Analysis
In the data analysis plan it was stated that the data would be checked to
ensure it met the assumptions required for linear regression analysis.
Furthermore, if results that were indicative of a difference between the two
arms of trial occurred for data where there was any evidence to suggest
the assumptions of linear regression had been violated, then non-
parametric tests would be used to see how robust the results were.
The distribution of residuals was checked for all data. No confirmatory
analysis was carried out as no results indicated a difference between the
health profession led and the self managed arms of the study and there
was therefore no risk of a type I error.
4.10 Exploratory Analysis
Prior to randomisation, participants were asked if they had a preference as
to which programme they received. Table 4.9 illustrates the preferences
expressed by participants.
Table 4.9: Programme preference expressed by participants
No Preference Preference for Preference for
HPL SM
All 17 (29.3%) 28 (48.2%) 13 (22.4%)
participants
11 (19.0%)Participants 9 (15.5%) 9 (15.5%)
allocated HPL
Participants 8 (13.8%) 17 (29.3%) 4 (6.9%)
allocated SM
It is clear from these numbers that in each group there were a
considerable number of people who stated a preference for the programme
which they were not allocated to. Given the potentially important
contribution of personal motivation to the impact of the programmes in the
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trial it was considered important to explore this concept of programme
preference and its impact on outcome. Specifically, it was of interest to
explore if a participant being allocated the programme for which they had a
preference had an impact on outcome. Therefore the interaction effect for
preference and allocation on the mean physical functioning scores of
participants at six months was explored. This analysis is shown in table
4.10.
Table 4.10: The interaction effect for preference and allocation on
the mean physical functioning scores of participants at six months
Preference Allocation Mean
Physical
Functioning
score, (SE)
Mean differencea
(Cl)
p
value
None
None
HPL
HPL
SM
SM
SM
HPL
SM
HPL
SM
HPL
2S.2 (S.S)
-2.4 (-23.9 to lS.S)
6.7 (-10.S to 24.1)
5.5 (-13.5 to 24.4)
-2.3 (-29.2 to 24.7)
S.4 (-13.9 to 30.7)
0.73
a Mean difference in PF score according to allocation & group compared to participants with no
preterence who were allocated the SM programme, CClicul(1lt>dfrom linear regression model
with baseline values as covariates to avoid bias due to regression to the mean.
This exploratory analysis provided no evidence to support the theory that
preference was an effect modifier of the relationship between an
individual's allocated treatment and their physical functioning score at six
months.
4.11 Comparison to population norms
The SF-36 data collected at six months post randomisation from both arms
of the trial was combined and compared to UK age group and gender
specific population norms for the SF-36 health survey (Jenkinson et al.
1993). The results of this analysis are presented in figure 4.3.
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Figure 4.3: Norm-based scoring of the SF-36 for stem cell
transplant raclplents"
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'Using SF-36 data collected at 6 months post transplant adjusted for age and gender.
The comparison of the SF-36 scores collected from stem cell transplant
patients six months after their transplants with data from the wider UK
population indicates that in all dimensions of the SF-36 scale stem cell
transplant patients have poorer mean scores than found in the general
population. Predictably, given the nature of the stem cell transplant
procedure, the greatest variation between the two sets of data was seen in
the physical functioning dimension of the SF-36. Encouragingly, there was
least variation in the scores for the mental health dimension of the scale.
This comparison used the SF-36 data collected from stem cell transplant
patients six months after their transplants indicating that recovery after
transplantation can be protracted and therefore endorsing the concept of
rehabilitation for this patient group.
114
4.12 Summary
There was no evidence of any difference in recovery between the health
profession led and self managed rehabilitation groups. The SF-36 scores of
individuals recovering after stem cell transplantation when compared to
data from the wider UK population indicate that in all dimensions of the SF-
36 scale stem cell transplant patients have poorer mean scores than found
in the general population.
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Chapter 5 - Results from the qualitative
interviews
5.1 Introduction
This chapter reports the findings of the qualitative data analysis. Semi
structured interviews were carried out with 15 trial partlclpants and five
members of staff. The interviews ranged from approximately 15 to 60
minutes in length. The participant interviews were designed to explore
each pertlctpant's experience of taking part in the trial. Therefore these
interviews focused on two key issues; the acceptability of each programme
to participants and the burden of participation in the trial. The staff
interviews were an opportunity to explore issues around both providing the
intervention and also of being involved in a randomised controlled trial. The
findings from each group of interviews are presented separately. Firstly,
the views of participant interviewees on the experience of partiCipating in a
randomised controlled trial are presented. Secondly, the acceptability of
each programme to participants is discussed. Finally, the experiences of
the staff interviewees are explored. Before these findings are presented a
summary is given of the characteristics of those who took part in the
interviews.
5.2 Interviewee characteristics
Table 5.1 shows the characteristics of those who agreed to be interviewed.
Of the 15 participant interviewees seven were male and eight were female.
A range of age groups were represented. The youngest participant
interviewee was 20 years old and the oldest was 73 years old. Eight
participant interviewees were aged over SO years and seven were SO years
old or younger. Five of the participant interviewees had been treated with
an allograft transplant and ten had been treated with an autologous
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transplant. Eight participant interviewees had been allocated the self
managed programme and seven had been allocated the health profession
led programme. Of the seven who had been allocated the health profession
led programme their attendance at the programme had varied
considerably. The least attendance was none and the most was all ten
sessions. Three participant interviewees had attended between four and
seven sessions and three had attended three or fewer sessions. All patients
and every member of staff who was approached with regard to being
interviewed, agreed to be interviewed. Five members of staff were
interviewed. Of these one was a physiotherapist, two were nurses and two
were doctors. The nurses and physiotherapist were directly involved in
providing rehabilitation following stem cell transplantation. The two doctors
were not directly involved in running the provision of rehabilitation
although they were highly experienced in the field of haematology and
were very influential in the clinical environment where the trial took place.
It was therefore useful to explore their perceptions of the rehabilitation
needs of patients recovering after stem cell transplantation and of the
programmes on trial in this study.
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Table 5.1: The characteristics of the interviewees
HPL
(n = 7)
SM Total
(n - 8)
5 7
3 8
4 7
4 8
2 5
6 10
n/a n/a
n/a n/a
n/a n/a
Participant Interviewees (n = 15)
Gender
Male 2
Female 5
Age
<=50 3
>50 4
Transplant type
Allograft 3
Autologous 4
Attendance at programme
0-3 sessions 3
4-7 sessions 3
8-10 sessions 1
Staff Interviewees (n = 5)
occupation
Physiotherapist 1
Nu~e 2
Doctor 2
Direct Involvement in the
intervention
Yes 3
No 2
5.3 Participant interviewees' experiences of taking part
in a randomised controlled trial
Participants expressed two key motivations for agreeing to take part in the
trial; that their own health might benefit and that future patients might
benefit. Participant interviewees expressed that they did not find the trial
overly burdensome. Some participants had clearly understood that the trial
was randomised and the reasons behind using this approach. Others were
less clear in their understanding of the randomisation process. One
participant suggested that the investigators must have had some control
over the allocation because they lived a long way from the hospital and
received the self managed programme. Another suggested that they
wished that they had agreed to take part on the condition that they were
allocated the home programme. There also appeared to be confusion over
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why everyone could not receive the hospital programme, two participants
indicated that they believed the study had two arms because limited
resources within the NHS meant that not everyone could have the health
profession led programme. These comments raise questions about how
much participants understood the information that had been given to them
in relation to the randomisation process. This is a widely acknowledged
problem in randomised trials (Stead et al. 2005). In this study considerable
effort was spent on producing understandable patient information leaflets.
However, Featherstone and Donovan (1998) suggest that since the
provision of clear and accurate patient information alone does not ensure
consistent interpretation of difficult concepts such as randomisation,
patients may need to discuss the purposes of randomisation in order to
understand them fully enough to give truly informed consent (Featherstone
and Donovan, 1998). In this study there was a passive approach to such
conversations with potential participants. Staff did not actively promote
discussion on topics such as randomisation but they were available to
answer questions if patients initiated the discussion.
Participant interviewees indicated that completing the questionnaires whilst
waiting for clinic appointments was no inconvenience and that on the whole
the questionnaires were easy to understand and complete. One person
commented that the questionnaires were not sufficiently plain spoken and
that they had found it difficult to understand what was meant by the
questions. Throughout the trial participants occasionally postponed or
refused to complete the shuttle walk test. Sometimes this was due to ill
health, sometimes it was perceived by the researcher that the burden of
taking the test was too considerable due to the physical effort required.
The participant interviewees tended to be enthusiastic about the test
because when viewed in retrospect the test provided a very clear measure
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of physical improvement. However, patients did report finding the test
daunting as is highlighted by the following extract.
P117 (SM) commenting on the SWT
At first I thought, 'oh my god, ' but it proves to you what you can and
cannot do. You know what I mean, like that last time when I was running
up and down here. But, like I say, it proves to me that I can do these
things, you know.
Most participant interviewees when asked if you could step back in time
would you change any of the decisions you made in relation to the trial
stated that there was nothing they would change. This indicated that the
trial itself had a high level of acceptability with participants and that the
burden of participation was not too great.
5.4 Participant interviewees' experiences of the health
profession led programme
Since the health profession led programme contained three distinct
elements the participant interviewees' comments on the programme are
considered in three sections. Firstly I the participants' experiences of the
exercise component are discussed. Secondly, their comments on the
relaxation element of the programme are considered, and finally, their
views and attitudes with regard to the information component are
examined.
The exercise component of the health profession led programme
The majority (four out of six) of those interviewed who had taken part in
the HPL programme were positive about the exercise component of the
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programme. Participants commented that at times taking part had been
enjoyable and that whilst the programme had been tough it had been
rewarding. Participants stated that the exercises were simple, manageable,
and did not require a lot of specialist equipment which made them easily
transferable to home. Participants expressed some surprise at the nature
of the exercises as illustrated by the following quote.
P326 (HPL) Well I mean the first week I obviously didn't know what to
expect, I knew it was certain exercises, and some of them were so hard,
you know I never thought you could actually do something so difficult just
by getting up off a chair and lifting a book up and some of them were really
hard, so no I didn't really expect, I thought for it to be hard you had to be
sort of running or, you know what I mean, it was like something that
seemed more physical but actually it was really very hard, but you didn't
need a lot of equipment in order to do it, that was what was really amazing
for me. 50 it was sort of things that you can do. I'm always telling my
friends you know if you do this or do that, so it's been pretty useful.
Participant interviewees frequently expressed a dual reaction to having
completed the exercises, both exhaustion and satisfaction. Satisfaction was
frequently related to a sense of achievement, in particular participants
appreciated being able to see an improvement in their performance from
week to week.
P315 (HPL) I was umm, I think the word is delighted, at the way 1
improved from one to the other. I was amazed how some of the, well I
think it was about 10 exercises, erm, how some of them I was able to
double week by week which was an amazing step up. Press ups for one,
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cycling things like that. Some of them just edged up a little bit but I don't
think any of them went back at all.
Participant interviewees also expressed some degree of tiredness or
exhaustion after exercising. For most people this was a temporary feeling
that was relieved by resting. However this was not a universal experience
and two participants found the exercises too exhausting. One participant
was particularly concerned about the exercise and suggested that rather
than being beneficial for their health, they felt that, it may in fact have
been detrimental.
P123 (HPL) I was a little bit concerned that I personally felt that it had
perhaps done me more harm than good. And I perhaps thought it was a
bit early because I wasn't coping with it very well .... I was comfortable
with the exercise part of the thing but having done it once I was sort of
knackered for 3 days and that feeling never sort of went away, it sort of
hung about when I was expecting to feel better.
Both of the individuals who did not find the programme helpful commented
that they believed it had been offered too early in their recovery. This may
have been a consequence of the trial protocol which had an entry criterion
of six to eight weeks post transplant.
Pl14 (HPL) I wish I'd done it a few months later when I was a month or so
down the line I was feeling a lot better and had slightly more energy. When
I did it I just couldn't handle it. Couldn't cope with it. My muscles were
shaking and I just had to sit down. I didn't get a lot out of actually going to
the gym, but still built it up slowly doing bits at home.
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One participant could not comment on the exercise programme because
they did not attend any of the sessions. When interviewed this participant
suggested that a combination of ill health and the thought of having to
make another trip to hospital were key factors that affected their decision
not to attend the health profession led programme. With specific reference
to the exercise component of the programme the individual indicated that
the programme was not very appealing and that they were particularly put
off because they knew it involved using exercise bikes.
P317 (HPL) The one other factor, because you mentioned a bicycle, right
and because of my last infection which was three big balls between my legs
including a cyst that burst open. There's no way I could have done it. I
mean its still sore now .... So there's no way back then I could have even
done that, so what was left of the program I don't know. Just to walk
round cones.
Researchers and the clinical team were unaware during the trial that this
individual was reluctant to attend the programme because of the exercise
bikes. If this had been known it would have been easy to reassure the
individual that the bikes were a small element of the programme and that
they were under no compulsion to use them. In many circumstances it may
be appropriate to find out why someone does not want to attend a
programme and if possible to resolve the issue in order to encourage
attendance. However, caution is required since there is a fine line between
this and nagging or coercing people into attending. Particular caution is
required in a trial situation where it is an ethical requirement that
individuals are able to withdraw from the trial without giving a reason.
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In this study the exercise component of the health profession led
programme was acceptable to most patients. This finding is consistent with
the available literature on this topic which indicates that exercise is safe for
stem cell transplant patients to complete (Dimeo et al., 1997a, Hayes et
al., 2003) and that patients find exercise programmes acceptable (Dimeo
2000, Courneya et al., 2000 and Oldervol et al., 2003).
In this study two participants did not find the exercise programme
beneficial and both of these suggested that the programme was acceptable
but that they attempted to take part in the programme too early in their
recovery. The impression of the exercise component that was conveyed to
one participant was very off putting and since they did not attend it is not
possible to know if the reality of the exercise programme would have been
equally unappealing.
The relaxation component of the health profession led programme
The diagnosis and treatment of a life threatening illness combined with
spending a prolonged time in hospital, often in isolation, is undoubtedly a
distressing experience. It has been argued that bone marrow
transplantation is one of the most stressful treatments in modern cancer
care (Heinonen et al., 2005). In this study several members of staff
commented on the stress associated with stem cell transplantation and
suggested that patients lose the ability to relax during treatment. However
this assertion was not matched by the experiences described by all
participants.
Pl17 (SM) I think I am quite a strong willed person anyway so I tend to
just take everyday as it comes and just sort of like if it happens it happens,
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you know what I mean. I've gone past that stage of worrying about things
if you know what [mean. [know this is probably through the illness as
well but I've just gone past that stage, (name of partner) is the witterer
not me.
P315 (HPL) [don't have a great problem relaxing. [don't get very tense
very often.
Guided imagery was included in the trial to promote relaxation and target
stress. Some participants clearly felt uncomfortable with this guided
imagery and one suggested that taking part was like being "subjected to
sort of seances". However, a proportion of the participants did report
experiencing trouble relaxing. These participants who identified themselves
as finding it difficult to relax were also more likely to find the guided
imagery a useful exercise and a number of participants requested
assistance with repeating the exercises for themselves at home.
An individual's reaction to the relaxation sessions may have been affected
by their perceptions of appropriate behaviour for a group environment. One
participant who had not found the exercises helpful said "l think a couple of
the grannies were nodding off. I thought for God's sake try and keep
awake" (P123) indicating that to them falling asleep would have been both
undesirable and unacceptable. However one of the other partlctpants
commented that "l love doing that kind of thing, I could kind of fall asleep"
(P326) indicating that to them falling asleep was both desirable and
acceptable.
Fife et al. (2000) investigated stress during bone marrow transplantation
and reported that patients experienced the greatest stress after admission
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to hospital prior to their transplant and that least stress was experienced
three months and one year after transplantation. This may explain why
staff felt stress to be a problem in this patient population whilst many of
the participants did not report currently feeling particularly stressed.
Furthermore, it suggests that the timing of the relaxation component may
not have been optimal. A more appropriate approach may be to provide
structured advice to inpatients on relaxation techniques.
At the start of the trial the health profession led programme contained
weekly massage as a form of relaxation and informal feedback from
participants suggested that this had a high level of popularity.
Unfortunately the massage was provided by volunteers and the service was
stopped during the early stages of the trial and guided imagery was
introduced as a replacement. Whilst massage has been shown to be no
more effective than guided imagery using relaxation tapes in helping a
sample of patients from general practice to relax (Hanley et al., 2003) the
benefits of massage may not be in its efficacy but in its appeal to patients.
In the paper by Hanley et al. (2003) the authors comment that whilst
massage was no more effective than relaxation tapes it was more popular
with participants. Likewise in this trial it was observed that massage did
appear to be more popular than guided imagery and functioned as a
reward after the physical discomfort of exercising and appeared to provide
a motivation for individuals to attend the programme.
The information component of the health profession led programme
Participants were given the opportunity to comment on each of the
information sessions provided as part of the HPL programme. It was clear
in the interviews that participants tended to only have vague recollections
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of the different sessions. This is not surprising given the time that had
elapsed since the sessions and the volume of information presented to
patients throughout the transplant and recovery process. It was clear that
unless something had really stood out about a session participants did not
have any comments to make. Many participants were not able to identify if
they had been present at any given session.
Participants' reflections on the sessions were generally positive but did not
convey the same level of enthusiasm that was displayed when talking
about some other aspects of the programme. The criticisms most
frequently given were that the information was either repetitive, common
sense or given too late in the transplant process.
P315 (HPL) But a lot of it was repetition and there was a bit of deja vu. I'd
heard and seen a lot of it before.
A further problem identified was that some of the information presented
was only relevant to those who had undergone allograft transplants. This
problem seemed to have been particularly, but not exclusively, associated
with the medications session. Whilst all participants had undergone stem
cell transplants there are significant differences between the
transplantation of donated stem cells and an individual's own cells.
Consequently, the information needed by patients particularly on topics
such as medications varies considerably for the two groups. Therefore it
may not be appropriate to attempt to meet the detailed informational
needs of all patients in the one programme. Since it is not feasible to run
two separate programmes it may be appropriate to remove the elements
that have information relevant to only some patients. However, it is likely
to be necessary to find an alternative way of providing this information in a
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more targeted manner. Unfortunately, this has cost implications since it is
generally cheaper to provide something general than to target individual
needs.
The argument for not including information on topics such as medications
in the rehabilitation programme is supported by the fact that many
participants reported that the information given in the programme was a
repetition of information that they had already received. This repetition of
information is predictable given the nature of the programme. A participant
may not attend the medications session for up to ten weeks after being
discharged from hospital. It is not satisfactory for them to have been self
medicating at home for ten weeks if they require further information about
the medications they are receiving. Therefore it is highly likely and
desirable that patients receive this information in preparation for discharge
from in-patient care. Repeating the information as part of the programme
appears to have been unnecessary and unwanted by partiCipants.
The session facilitated by a vicar appeared to have stood out particularly
strongly in a number of participants memories. Participants' feelings about
the session varied considerably. Some were very enthusiastic about the
session and some were not so enthusiastic, suggesting that they found it
either boring or even intrusive.
P326 (HPL) The guy who came from the church he was quite interesting,
talking about death and how people feel about dying and how you know,
just how people think, yeh that was interesting and just, I can remember
others but I think he was the most interesting one to be honest.
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P320 (HPL) We had the vicar and, and I felt he was a bit, he was very nice,
erm but for me he was a bit intrusive and that was no fault of his that was
just you know the way that I felt about it, erm.
Pl14 (HPL) I found the vicar quite boring ... I'm not, not religious but I
found it, talking about death and things like that [a bit depressing] ... The
others, the older ones seemed to enjoy it but I really did struggle to stay
awake on that one.
The varied reactions to this session emphasise the difficulties that are
inherent in trying to provide an intervention of this sort to a mixed group of
people. Not only is each person different but their reaction to having had a
life threatening illness will be different. It is unrealistic to expect all stem
cell transplant patients to want to discuss the impact of their transplant
with a vicar, who they are unlikely to have met before, and a group of
fellow patients. However, the acknowledgement that having a life
threatening illness does have an impact on your life and the opportunity to
discuss this in a safe environment was clearly appreciated by a number of
participants. An appropriate solution to this problem may be to remove the
expectation that everyone will stay on for the information session that
follows after the exercise component of the programme. If patients are
given information about what the information session is going to be about
each week they can make an informed decision about whether they want
to attend or not.
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5.5 Participant interviewees' experiences of the self
managed programme
During the interviews participants from the self managed programme were
given the opportunity to reflect on each leaflet provided in the information
pack. As with the health profession led programme participant interviewees
often had only vague recollections of the content of the programme. The
strongest opinions and recollections related to the exercise component of
the programme. Adjectives used about the exercises included, "good",
"enjoveble", "too basic", "monotonous", "unappealing", "boring", "difficult",
and "common sense".
Several participants suggested that they never completed the exercises
and others indicated that they gave the exercises a go but quickly lost
interest. Reasons for this included that they lacked motivation to complete
the exercises and that they found other activities more appealing, such as
gardening or walking the dog. One person suggested that the exercises
were too difficult for them to complete. Every participant who identified
themselves as not having completed the exercise programme stated that
they believed that their motivation would have been higher and their
participation greater if they had been allocated to the health profession led
programme. Participants attributed this to two factors: the support
provided by a group environment and a feeling of greater confidence
exercising where there were professionals available to ensure you did not
injure yourself.
In contrast to this three participants suggested that they found the
programme appropriate and helpful and that they had consistently
completed the programme several times a week for a period of many
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weeks. Two of these individuals had been very physically active before
being ill and were highly motivated to regain their fitness and were also
used to exercising alone.
P311 (SM) I found them very good. At first, well I've come from a
background where I've been very physical all my life and I've done a lot of
exercise regimes through the time. I first looked at them and thought this
looks too easy, but, the situation I was in at the time when I came out of
hospital, nothing was easy so they erm, they were very good overall. The
balance was excellent I think.
One further person also reported consistently completing the exercises. In
contrast, this person was older and had not been very physically active
before being ill. However, she also reported being highly motivated to
regain pre-transplant health. Interestingly, this person reported that her
son had helped her to understand the exercises and had checked she was
completing them correctly.
P324 (SM) Initially my son when he used to come and see me he used to
get me on there you know, 'You do some, you're not doing that right mum
do it properly'. So erm, once I got in to the swing I didn't have to refer to
the paper because I knew what was coming after .... I did them for months
and months and I still do them now, not all the time but I walk a lot so
that's my exercise.
With regard to the rest of the leaflets given in the information pack
participants were generally positive but not overly enthusiastic. Every
participant indicated that they had read the leaflets but most felt that they
could no longer remember any details about them.
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P324 (SM) Well I read through them all but then I didn't refer to them after
that. I only kept the exercise one.
P318 (SM) I read um, but to be honest with you you know I can't
remember anything about um, you know.
Participants that could remember individual leaflets tended to comment
enthusiastically on the nutrition leaflet and on the leaflet about
relationships. Two participants particularly remembered and commented on
the leaflet written by a previous patient. One commented that
P324 (SM) I found that quite informing really, he was quite young, half my
age, poor man. And I thought gosh shall I contact him and I never got
round to it.
The reaction of the other was less enthusiastic highlighting once again that
this patient group contains a wide range of individuals and that meeting
everyone's needs with one intervention is not always possible.
P124 (SM) that bloke who wrote a bit, erm, he were crap because its not
from my perspective, you know what I mean, its not, it's aimed, I find it
more aimed at erm, like 40 plus. It's not from like a young person's
perspective, its erm, more aimed at 40 plus you know what I mean.
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5.6 Conclusions from the participants' experiences of
the health profession led and self managed
rehabilitation programmes.
The participant interviews provide invaluable information on patients'
experiences of undertaking both the health profession led and self
managed rehabilitation programmes. From these interviews it is possible to
draw a number of conclusions and to make suggestions for improvements
to the delivery of rehabilitation services for patients who have received
stem cell transplants.
Factors that facilitate or impede exercise
Exercise was a key component of both rehabilitation programmes. Unlike in
cardiac rehabilitation where the benefits of exercise are well documented
(Williams et al., 2006) the benefits of exercise for this patient population
are less well established. The current evidence supports the hypothesis
that exercise can be of physical and psychosocial benefit for survivors of
cancer, however, a number of questions remain. In particular, the optimal
exercise programme remains unclear (Silver, 2007).
This study has identified a number of factors that either facilitate or impede
stem cell transplant patients from exercising. These factors highlight some
of the issues that require consideration when planning interventions for this
patient population. They are summarised in table 5.2.
Motivation is clearly important in either facilitating or impeding exercise.
Those individuals that were highly motivated exercised regardless of which
programme they were allocated and likewise there were individuals in both
programmes who were not motivated to exercise and who therefore did not
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exercise. Several participants who were allocated the self managed
programme indicated that they believed their motivation to exercise would
have been increased by attending the health profession led programme. It
was not within the scope of this study to ascertain whether this assertion
would in fact have been born out in reality.
In this study there was some evidence to suggest that individuals who had
been very active prior to being ill were more motivated to exercise after
completing treatment. However, one individual who had been very
physically active prior to treatment found the deterioration in their physical
abilities depressing which acted as a deterrent to exercising. Courneya et
al. (1999) investigated motivation to exercise in a sample of colorectal
cancer patients. The study identified that individuals with greater intention
to exercise and with higher levels of pre-diagnosis exercise were more
likely to engage in post-diagnosis exercise (Courneya et al., 1999).
A number of individuals from the self managed programme indicated that
lack of confidence in how to complete the exercises was a factor that
hindered their participation in exercise. Linked to this was a concern that if
they did not complete the exercises correctly then they could have a
detrimental rather than beneficial effect on their health. One participant
from the health profession led programme also expressed concern that the
exercises had not been beneficial to their health and that they had
therefore stopped attending the programme. Similarly, experiencing or the
fear of experiencing pain or discomfort when exercising was a factor that
emerged from the interviews with a number of participants. These findings
are supported by the work of Emslie et al. (2007). Their evaluation of an
exercise programme for breast cancer patients identified that after
diagnosis and treatment women in their study felt vulnerable and were
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wary of injuring themselves whilst exercising. The women reported that
they felt safe and secure an exercise class and that they valued expert
instruction and support (Emslie et al., 2007).
Being able to see an improvement in performance over time was a factor
that individuals from both arms of the study cited as a helpful
encouragement to continue exercising. However, fatigue was mentioned by
a number of participant interviewees as a factor that limited their ability to
exercise. Feeling exhausted after exercising was common, however, the
length of time that the feeling lasted varied and was a factor that affected
participants' willingness to exert themselves.
Finding exercise boring or uninteresting were cited as reasons why people
stopped exercising and finding the exercises interesting and enjoyable was
a factor that individuals in the health profession led programme particularly
identified as helping them to exercise. A sense of sportsmanship and
competition was a factor that one member of staff identified as helping
some individuals to exercise. However, one participant commented on what
a disincentive to exercise it was to feel that one was the least physically
able in the group.
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Table 5.2: Factors identified that facilitate or impede exercise
Factors that facilitate exercise Factors that impede exercise
Good personal motivation
Confidence in how the exercises
should be completed
Visible improvement over time
Confidence that exercise beneficial
to health
Improving energy levels
Comfortable and confident in own
bodies reaction to exercise
Interest
Enjoyment
Sportsmanship / competition
Adequate time set aside for
exercise
Poor personal motivation
Lack of confidence in how the
exercises should be completed
No visible improvement over time
Concern that exercise detrimental
to health
Fatigue
Physical discomfort during or after
exercising
Boredom
Lack of enjoyment
Feeling inferior to others
Lack of time
It was identified that it is not always easy to predict the factors that affect
anyone individual's desire and ability to exercise. Furthermore, several
factors that facilitate exercise appeared to need to be present to be
effective in prompting an individual to exercise, whereas one factor that
impedes exercise appeared to be enough to stop an individual exercising.
Investigating the factors that promote or impede exercise was not the
primary aim of this study, however, analysis of the interviewees' comments
on exercise has provided a helpful insight into this topic. More detailed
research specifically investigating this issue is required.
Appropriate provision of relaxation techniques
The relaxation component was the most contentious aspect of the health
profession led programme. Whilst some people reported finding the
techniques helpful, others reported disliking them. For at least one person
this reaction appeared to be sufficiently strong as to contribute to their
decision to stop attending the programme. Research has indicated that the
stress experienced by patients undergoing a stem cell transplant peaks
prior to the transplant and is least after discharge from in-patient care (Fife
et al., 2000). Therefore assistance with relaxation techniques may be more
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appropriate during hospitalisation. If alternative sources of evidence
support the need for assistance post discharge an alternative approach to
delivering this aspect of the programme might be appropriate. Since there
is evidence to suggest that using a tape to complete guided imagery at
home is as effective as using guided imagery in a formal setting (Hanley et
al., 2003), the appropriate solution may be to provide an introduction to
relaxation techniques and to provide the encouragement and resources for
those who desire it to continue using the relaxation techniques at home.
Apposite information required
During the interviews participants confirmed that apposite information was
a desirable component of a rehabilitation programme. However their
evaluations of the programmes suggest that there were a number of
problems in the delivery of information:
• Too much information was given to participants, for example on
issues that were not relevant to them due to the nature of the
transplant that they had received.
Information was not always provided at the time that it was
required. In particular, participants commented that information
was received after it would have been most useful.
• Information was repetitive.
•
• Information was common sense.
Topics that participants had found helpful included nutrition, life after
transplant, relationships and facing a life threatening illness. Topics that
participants did not appear to have found helpful included medications and
financial support.
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Group dynamics
One of the key aspects of this study was to investigate the impact of being
in a group programme. Participant interviewees who had been allocated to
the health profession led programme were mostly (4 out of 7) enthusiastic
about having been allocated the group programme. Specifically,
interviewees frequently expressed finding that other people where
experiencing the same things as them very helpful.
P315 (HPL) It was also useful to have people, other patients, who were
recovering from various things like bone marrow transplants and such to
hear their problems and also to think that the problems I had everybody
else had as well. You know shortness of breath, and the short stamina and
so on.... As I said before the sharing experiences and things with the
people who are there. I thought I was the only one who felt tired and
breathless and so on but of course they all do. And they ache and the rest
of it. So yes it's nice to share it.
One participant who had expressed this idea also suggested that the fact
that he felt himself to be less ill than some of the other participants gave
him a positive feeling. As illustrated by the following quote.
P315 (HPL) In fact because they seemed to be a little more poorly than me
it made me feel a little bit better which is an awful thing to say but its true.
This was not a concept that other participants also expressed but this may
be because as the participant indicates the idea of being cheered by
another's misfortune is not particularly socially acceptable. The logical
138
extension of this view i.e. how terrible it feels to be the least well in the
group was discussed by one participant.
The three participant interviewees who were less enthusiastic about being
part of a group expressed a variety of reasons for not enjoying being part
of the group. Participant 123, highlighted a gender difference that had
occurred when he had been part of the group, referring to the group as a
"sewing circle" and commenting that the "grannies were busy talking about
children and things". Participant 114 commented that she had found the
group intimidating since the other participants had been much older and
were recovering faster than her having been treated with a different type
of transplant. One participant who was allocated the health profession led
programme but who never attended stated that
P317 (HPL) They [would] probably [have] thought I was an absolute
nutcase if I had gone along and told them, what I've told you so far, plus a
lot of other stuff.
Participant 317's belief that people would think she was a 'nutcase'
suggests that she did not believe that her own reaction to treatment was
similar to other peoples. Similarly, participant 317 and 114 did not find it
easy to gain support from the group since they perceived themselves to be
very different to the rest of the group. These experiences highlight the
importance of people feeling a connection with the other people they are in
a group with. It is easy to assume that since the individuals in the group
had all been treated for a haematological malignancy with a bone marrow
or stem cell transplant that they would feel some degree of shared
experience. The reactions of these individuals highlight that In order to feel
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part of a group, individuals themselves must believe that they have
something in common with the other members of that group.
These findings are consistent with social comparison theory, first developed
by Festinger (1954) which suggests that individuals can benefit from
drawing social comparisons with others who are similar to themselves.
Individuals may also draw upwards comparisons with those perceived to be
in some way better off and downwards comparisons with those perceived
to be in some way worse off (Festinger, 1954).
The self managed programme did not involve meeting with other
participants and therefore for opportunities to gain support from others
were more limited. Despite this two participants allocated to the self
managed programme suggested that they had benefited from being able to
compare their experience with other people through the information
provided in the booklets.
P324 (SM) It was because I knew that I wasn't the only one I thought I
was imagining it but I thought I can't, nobody can feel so fatigued,
especially when I was, all my life I've been up and going a very active
person and I just thought it must be normal because reading those books
I'm not the only person that's experiencing such horrible feelings, yes.
One participant in particular commented that this was very helpful with
regard to the information on relationships, commenting that;
P311 (SM) I found, especially the ones about how you're feeling
emotionally were, both me and my wife found the information quite useful.
Because were not ones to go hunting for information over, of that
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particular subject anyway on the net and things like that. So that
information was great to us because we'd not received anything else on
them, on the information, so it was good really.
Whilst for two people the information in the leaflets provided some sense of
shared experience the majority of participants (n=6), including the two
people who had commented positively on the leaflets expressed that being
able to share experiences directly with others was something they really
felt was missing from the self managed programme.
P324 (SM) I felt I'd missed out a wee bit, I would have loved to have
spoken to other people that had been through the same as me and find out
how they were getting on. That bit I missed and would have loved to have
been. As I say just curiosity I suppose. Be able to chat to somebody and
see how they're feeling. I felt a little bit alone.
However, this was not a universal feeling and two participants commented
specifically that they did not desire or need the support of others who had
also had a bone marrow or stem cell transplant.
P310 (SM) I haven't had any inclination to do is to join any groups or
anything. You know to share your experiences.
One participant interviewee, who was generally positive about wanting to
share experiences, did raise an important consideration. They commented
specifically with regard to the written leaflets that
P323 (SM) I think its nice to read other people's experiences but I think
they could be quite frightening because you know, whilst I was in hospital
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you know they kept saying it will kick in next week, and you know it never
did, I mean I was not sick even and it was all sort of tomorrow and you
think oh, and then it never actually happened. So I think sometimes it can
be a bit frightening because you think that's the norm and perhaps I was
the exception to the rule I don't know.
5.7 Summary
The exercise component of the health profession led programme was
generally well received. The evaluation of the self managed exercise
programme was less positive and the programme appears to have only
assisted those who were already highly motivated to exercise. A home
exercise programme may be more appropriate as an add-on to the health
profession led programme, encouraging participants to exercise between
sessions, or as an alternative for those who cannot attend a hospital based
programme.
When considering participants' reactions to the relaxation and information
elements of the programmes it is clear that reactions were mixed. What
one person liked another disliked. This was most clearly demonstrated with
regard to the information session led by a hospital chaplain. Reactions to
the session varied considerably with one individual suggesting that it had
been the best of the ten sessions whilst others indicated that they had not
found the session helpful. Patients are individuals and therefore they have
individual desires, needs and expectations.
The conclusions drawn from the experiences of participants suggest that
from the patient's perspective the ideal programme would provide an
exercise component which was led by experienced health professionals. In
addition to this there would be an additional home element for between
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sessions and for those who do not wish to or cannot attend the hospital
sessions. Relaxation techniques are not a crucial component of such a
programme and should therefore be optional. Potentially, the programme
could contain one session where relaxation techniques are explained and
the necessary advice and/or equipment is provided in order to enable
individuals to continue at home if desired. An information element is
appropriate since some patients do desire the opportunity to gain further
information and support. However, detailed and accurate information as to
the session content should be available prior to the session enabling
patients to make an informed decision about whether to attend or not.
5.8 Staff interviewees' experiences of being involved in
a randomised controlled trial
Perceived value of the intervention
The ethos of the large and busy haematology unit where this research took
place is very technical with an understandable focus on curing people from
a variety of very aggressive cancers. Research has highlighted that
alongside the physical issues there are many psychosocial issues
associated with haematological cancers and their treatment. The unit's
focus on physical health may in part be due to the fact that the illnesses
and treatments seen on the unit lend themselves to hard measures of
health and illness. For example, it is common for the first indication of a
person's haematological malignancy to come not from symptoms
experienced by the patient but from a blood test indicating unusual cell
counts. Similarly, after a transplant great attention is given to the recovery
of a patient's blood cell counts.
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52 I think that we are a technical team, so we focus very much on what
their blood count is, and when they come to clinic ... what's your blood
count, have you got, and it's all physical symptoms.
Some staff interviewees expressed concern that this focus on the physical
may be at the expense of considering the entire individual. This in turn
may result in individuals being cured of their haematological cancer but
experiencing considerable on-going psychosocial side-effects. Interestingly,
when one senior member of the team was asked during an interview about
the rehabilitation needs of this patient group, they mentioned only physical
aspects of recovery in their reply.
It was within this environment that the health profession led programme
was devised and trialled. It is therefore unsurprising that reactions to the
programme were varied. No individuals were hostile to the concept of
rehabilitation but other reactions ranged from great enthusiasm through to
ambivalence and disinterest. Similarly, there was a lack of consensus about
which patients were likely to benefit from rehabilitation. Some individuals,
those who were very enthusiastic about the health profession led
programme, believed that attending a rehabilitation programme should be
a routine part of care after transplantation since all patients would
potentially benefit from this type of intervention.
53 I wanted it to be part now of the service that, you know, for the next
ten years anybody walking through the doors with a diagnosis of leukaemia
or myeloma or lymphoma, after transplant, after treatment they all have a
rehab programme.
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Other members of staff suggested that not all patients needed or were
likely to benefit from a rehabilitation programme. One individual suggested
that transplant type was likely to be a strong indicator of whether or not
rehabilitation was likely to be of benefit to an individual.
54 My own view was that it [the health profession led programme]
probably wasn't going to have a great deal of value for the autografts. It
may have a lot more value for the allografts.
Another member of staff rejected the idea that transplant type was a key
factor in an individual's needs for rehabilitation, suggesting instead that it
is possible to identify those individuals from a range of treatment and
disease types who would benefit from such an intervention. Interestingly,
this staff interviewee also suggested that a rehabilitation programme need
not be confined to individuals that have had a bone marrow or stem cell
transplant, but the scope of the intervention could be broadened to include
other haematological malignancy patients treated with chemotherapy
without a transplant. In contrast to some members of staff this individual
was not advocating a routine attendance at the programme but a targeted,
needs based approach.
Since there were a range of opinions over the probable value of a
biopsychosocial intervention it is unsurprising that individuals also held
strong and varied opinions on evaluating the intervention with a
randomised controlled trial. Those individuals that did not place a high
value on psychosocial care were slightly ambivalent about the rehabilitation
needs of patients and therefore they were not particularly enthusiastic
about the trial. One staff interviewee summarised the argument for
needing a trial by stating;
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54 It [the trial] was the right thing to try to do, yes, I think that's right
because clearly it [the health profession led programme] involves expense,
and the question is how much value it had.
In this individual's opinion it was clear that the health profession led
programme required testing to see if it had any or sufficient benefit to
patients to justify the expense of running it. In contrast to this it was
apparent that some staff members had already formed an opinion about
the efficacy of the health profession led programme. These individuals were
involved in the trial not because they wanted to find out if the programme
worked but because they wanted to prove that it worked.
53 What I signed up to this trial to do was to get it [the health profession
led programme] part of the service.
One member of staff acknowledged that they felt resentful that the health
profession led programme required testing and that they would rather it
was simply implemented as usual care. Staff members that were
particularly committed to the programme also reported finding it very
difficult when participants that they perceived would particularly benefit
from the health profession led programme were allocated to the self
managed programme.
51 There were certain patients that we saw that, you know, you were
desperate for them to get the hospital led programme, and, you know,
quite often they didn't get the one that they wanted.
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These occasions when individuals who really wanted the health profession
led programme or those that staff perceived to really need the health
profession led programme were allocated the self managed programme
resulted in staff members feeling further disillusioned with the trial.
Staff interviewees' experiences of recruiting patients to the trial
Recruitment to the trial was problematic and this was one of the key
frustrations that staff reported in the qualitative interviews. A minor
annoyance was the difficulty that was encountered in seeing patients to
discuss recruitment to the trial at the appropriate point in their transplant
process. This was highlighted to be a particular problem when recruiting
the autologous transplant patients who had a shorter stay in hospital and
less frequent visits to clinic resulting in a shorter window of opportunity to
approach these individuals.
The poor rate of recruitment was a considerable cause of frustration for
staff. During the interviews staff expressed this frustration towards
patients, fellow professionals and towards the trial itself. Staff were
discouraged by the fact that not as many patients as expected agreed to
take part in the trial. Whilst staff were aware of the reasons why patients
might not want to take part they found it very frustrating when individuals
declined to take part.
52 Frustrating because they had no insight into how they were, or how
they might be, and how they might benefit. And you could try and tell
them, but actually to them it was all a bit, oh well it's another trip to
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hospital and this, that and the other, when actually all they're going to do
is sit in their chair at home anyway, you know.
Staff interviewees also expressed disappointment that the wider clinic
environment was not more supportive of the trial. Several staff
interviewees commented that patients were not being encouraged to take
part by the entire clinical team. This frustration was intensified by the
perception that potential participants responded differently according to
who spoke to them about the trial.
51 I know one registrar spoke to a patient last week and the following
week, the patient, you know, had turned up, whereas nurses had been
trying to get them to go for about three weeks, this registrar had said it,
and he was there the next week (Speaking about a patient attending the
rehabilitation programme that has been implemented now that the trial has
finished).
It was suggested in the staff interviews that recruitment would have been
easier if doctors had been more willing to suggest taking part in the trial to
potential participants. The two doctors who were interviewed were both
asked if they had discussed the trial with potential participants. One doctor
indicated that they had never discussed the trial with a patient. Conversely,
another reported a number of conversations about the trial with patients.
Interestingly, this doctor stated that they discouraged some potential
participants from taking part because the doctor perceived that the
patients were too well and would not benefit from a rehabilitation
intervention.
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Staff interviewees also attributed some of the poor rates of recruitment to
the trial itself. It was felt that the inclusion criteria were too strict and that
sometimes people who wanted to take part were denied the opportunity.
The majority of the inclusion criteria were included to ensure the safety of
participants, however one criterion was that participants should be
between six and eight weeks post transplant. This criterion was included as
a means of ensuring a degree of standardisation in the participants at the
start of the trial since it was perceived that the response to the
programmes of those who were recently post transplant would be very
different to those who were months or even years post transplant.
However, in the course of the trial it became apparent that this criterion of
six to eight weeks was unhelpful and that it was a factor in limiting the
number of people who agreed to take part.
At the start of the trial individuals whose inpatient phase of care had lasted
more than eight weeks were automatically excluded. However, it was
perceived that these individuals may be the ones who most needed
rehabilitation and therefore the criterion were altered to allow individuals
whose inpatient care had prevented them being recruited on time to take
part in the trial. A further proportion of individuals were also restricted
from taking part in the trial by the six to eight week criterion. These were
people who initially recovered well from their transplants and who turned
down the trial when offered it but that later developed complications that
made them feel more inclined to take part. However by that point they had
passed the six to eight week window and were ineligible for the trial.
This issue was explored in the staff interviews. There was a consensus that
any reference to time post transplant was unhelpful. It was the opinion of a
number of members of staff that individuals may benefit from this type of
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intervention even years after their transplant. One suggestion was that a
needs based criterion may have been more appropriate. Alternatively,
some staff wanted the programme to be available to everyone without any
particular entry criterion. It should be noted that if the intervention was
redesigned in either of these ways it would remain highly likely that
individuals are likely to respond differently to the intervention according to
how long after their transplant they participate. This would be a potential
problem in any quantitative evaluation of the programme however a more
appropriate solution to this problem may be to adjust for time from
transplant in the analysis of the data.
Staff interviewees' experiences of providing the health profession
led rehabilitation programme
It was clear from the interviews that keeping the health profession led
programme running was hard work, more so than staff expected. Some of
the difficulties lay in providing a consistent service. It was necessary to
liaise with a considerable number of different health professionals in order
to provide the information component of the health profession led
programme and this was time consuming. There were difficulties with
working with the volunteer service. This was a particular problem when
massage was still a component of the health professton led programme.
Even after the massage component was removed the relaxation element
was still identified as difficult to deliver and one staff member in particular
commented that they felt self conscious leading the relaxation exercises.
The issue of the repetitive nature of the programme which was highlighted
in the participant interviews was also raised in the staff interviews.
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52 It seems quite repetitive sometimes when we're doing it, mind, and
with the ten sessions, that's one of the things I would say, well it did seem
quite repetitive at times, but sometimes people needed to hear information
more than once. And whilst, it was repetitive to me, but then I was doing
a day every week, so for them it was a new session.
'The trial killed the intervention'
The small numbers of participants attending the programme at anyone
time was a particular problem identified by the staff. The numbers
attending the programme were low for two reasons: firstly, the trial failed
to recruit participants at the rate that had been anticipated, and secondly,
the attendance rates at the programme were considerably lower than
expected. Staff highlighted that the effect of a small group size were
twofold. Staff found the small group size dernorallslnq. It was clearly
important to ensure that sufficient staff were present should all participants
turn up but frequently staff were taken away from other activities
unnecessarily because only a few or even no participants arrived. Not only
did the small group size have a demoralising impact on the staff but it
appeared to affect the very nature of the health profession led programme.
It was felt that there was a critical size at which the group started to
function well and when fewer participants were present the group was
laboured and dysfunctional. In conversation one member of staff told me
that they felt "the trial had killed the intervention" suggesting that the
conditions required for a randomised controlled trial had fundamentally
changed the atmosphere and potentially the efficacy of the rehabilitation
programme.
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52 I thought that the trial struggled, and I think the outcomes may be
effected, because from the discussions that we had, in terms of the
number of people, if there were only two or three people there, then the
discussion groups are altered, you know, the, the, um, interactions, you
know. So, as a result, I don't think they get the best benefit. If there's a
bigger group, then you, certainly with the pilot group, we had, there was
eight or ten people there, so you got some camaraderie, you got some,
you know, and actually those people still see each other in clinic now, and
still link up and ask how each other are and sit together and, you know, so.
Whereas, I think with the trial, we didn't get that because there weren't
the numbers.
This staff interviewee referred to the differences between the health
profession led programme during the pilot study and the full trial. Since
poor attendance rates were not an issue during the pilot study it is
necessary to consider if the poor attendance rates that occurred during the
trial were, as suggested by this member of staff, a result of the trial itself
and the impact that it had on the intervention. Potentially, the trial had an
impact on the numbers attending in a variety of ways. The fact that the
programme was part of an experiment and involved randomisation may
have made some potential participants reluctant to take part reducing the
number of available participants. The tight entry criteria chosen for the trial
may further have restricted the pool of available participants. Furthermore,
by design 50% of those who had agreed to take part were allocated to the
self managed programme.
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Summary
The experience of being a member of staff involved in the rehabilitation
after stem cell transplantation trial can probably best be summarised by
the word frustrating. The research did not have the active support of the
wider clinical team. Recruitment was slow and difficult and 50% of those
recruited were allocated the control element of the trial. Even within those
allocated to the health profession led programme attendance at the
programme was poor. Running the health profession led programme was
hard work and required preparation and commitment. Many members of
staff became involved in the trial because they believed in the health
profession led programme. The trial did not provide the evidence they
desired to justify the long-term implementation of the programme. To their
credit staff remain committed to the concept of rehabilitation for patients
recovering after stem cell transplantation, despite these problems.
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Chapter 6 - Discussion
This chapter presents a discussion on the findings of the stem cell
transplant trial and the associated qualitative investigation. This is followed
by an examination of the methodology employed in this study. The
rationale for using a randomised controlled trial is reconsidered and the
potential merits and limitations of alternative designs that could have been
employed are debated. Finally, consideration is given to the implications of
this research for practice.
6.1 Discussion of the findings
The trial outcomes
The aim of this study was to assess the efficacy of a rehabilitation
programme for patients who have had a stem cell transplant, using a
randomised controlled trial. The primary outcome measure was change in
the physical functioning dimension of the SF-36 scale at six months post
transplant. The mean change in physical functioning from baseline to six
months was similar in both arms of the trial (21.9 for the health profession
led programme and 21.4 for the self managed programme). The mean
difference calculated from the linear regression model was 0.193 and the
confidence interval included zero. Therefore it is possible to conclude that
no evidence of a difference in the physical functioning of participants as
measured by the SF-36 scale was observed between the two modes of
rehabilitation.
The secondary outcome measures in this trial included a range of blo-
psychosocial outcomes measured at both three and six months after
randomisation. There was no evidence of a difference in any aspect of
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recovery between the health profession led and self managed rehabilitation
groups.
The sample size achieved was 58 participants, only 44% of that calculated
to be required for an adequately powered study. Whilst no differences
between the health profession led and the self managed programmes were
apparent in the findings, it is possible that clinically significant differences
between the programmes were missed by a study of this size. The
confidence interval around the estimated difference in the primary outcome
measure of physical functioning could not exclude differences of up to 10
points in either direction.
The SF-36 data gathered at six months post transplant was compared to
UK population norms. In all dimensions of the SF-36 scale the patients
from this trial had poorer mean scores than found in the general
population. This supports previous research indicating that recovery after
transplantation can be protracted and endorses the concept of
rehabilitation for this patient group.
The qualitative findings
The study contained a qualitative component that provided valuable
insights into the perspectives of participants and staff on rehabilitation
after stem cell transplantation. The interview data highlighted that the
health profession led rehabilitation programme had only a moderate level
of acceptability and that there were various ways in which patients and
staff believed it could have been improved. Furthermore, the interview
data indicated that the self managed programme had a poor level of
acceptability with the majority of patients who were allocated to it. To
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better understand the qualitative findings from this study it is important to
consider them within the framework of existing research. Therefore the
main themes from the qualitative findings are considered below within the
context of the relevant academic literature in relation to exercise,
relaxation, information and social support.
Findings related to exercise
In relation to the exercise component of the programme it was found that
amongst the participants allocated to the health profession led programme
the majority of people found exercising in a group environment helpful.
This is consistent with previous research and a number of other studies
have shown that exercise programmes are acceptable to patients who have
been treated with a stem cell transplant (Oldervoll et al., 2003, Courneya
et al., 2000, Dimeo, 2000).
Individuals with a strong preference for the self managed programme, but
who were allocated the health profession led programme, found exercising
in a group environment unhelpful. Those participants allocated to the self
managed programme, who did not desire to attend the health profession
led programme, found exercising at home acceptable. In contrast
individuals that expressed a preference for the health profession led
programme did not find exercising alone an acceptable alternative. These
findings suggest that if patients do not engage with the format in which the
exercise is being provided they are less likely to complete the exercise
programme.
A study by Segal et al. (2001) compared three exercise programmes - a
home based walking programme, a hospital and home based programme,
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and usual care amongst women treated for breast cancer. Interestingly,
participants allocated to the solely home based programme in Segal's
(2001) study showed a significant improvement in physical functioning
compared to the usual care group, whilst the participants allocated to the
hospital and home based programme showed only a borderline significant
improvement in physical functioning compared to the usual care group
(Segal et al., 2001). The authors were surprised by this finding and were
unable to adequately account for it since there were no differences in
reported adherence to exercise prescription between the two treatment
groups. However, they do note that self-directed exercise is more
convenient for participants and that the research population demonstrated
a high level of motivation to engage in structured exercise (Segal, Evans et
al. 2001).
The questions raised by both the Segal et al. (2001) study and by the
qualitative findings in this study suggest that further research into the
mode of delivery for exercise interventions is warranted. Whilst a
consistent picture is beg inning to emerge from the literature as to the
benefits of exercise for cancer patients there is no such clarity in the
evidence as to the best format for such exercise.
Findings related to stress and relaxation
It has been reported that a minority of patients suffer with clinical levels of
anxiety and depression following stem cell transplantation (Molassiotis and
Morris, 1999a). Other authors suggests that persistent and life affecting
but sub-clinical levels of psychological distress are more common in
patients who have been treated with stem cell transplantation (Lesko et al.,
1992). In the present study the mean general health questionnaire
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(Goldberg, 1978) scores collected throughout the study were not indicative
of high levels of psychiatric distress (see chapter four section four for the
GHQ scores at baseline). Furthermore, the qualitative data supports this
finding with a number of participants reporting that they were not currently
experiencing high levels of stress or anxiety. If patients are not
experiencing levels of stress, anxiety or depression post discharge that are
affecting their ability to relax it raises questions as to the necessity of
providing a relaxation component as part of a rehabilitation programme
following stem cell transplantation.
Exploring patients' experiences of stress across different stages of the
transplant process was not within the scope of the present study. However,
several participants made reference in the qualitative interviews to
diagnosis and active treatment being more stressful times than the period
after their discharge from in-patient care. This is supported by other
research which indicates that patients' stress levels are highest whilst they
are in hospital (Fife et al., 2000) and therefore it may be more appropriate
to target relaxation techniques for this period of a patient's treatment.
Furthermore, a study by Kim and Kim (2005) found that completing
relaxation techniques whilst hospitalised for stem cell transplantation was
associated with a greater reduction in fatigue than usual care. This
provides further evidence that teaching relaxation techniques during acute
treatment rather than post discharge may be appropriate.
Findings related to information
The provision of appropriate information has been shown to increase
patients' control and involvement in their care, to reduce psychological
distress, to increase adherence to treatment regimes and to encourage
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realistic expectations in studies conducted with patients who are being
treated for cancer (Mills and Sullivan, 1999). The provision of information
was therefore a logical and appropriate component of the rehabilitation
programmes in the present study. However, the qualitative findings of the
present study indicate that the provision of information was not as well
received by patients as might have been expected.
Patients found it frustrating when information was repetitive or common
sense. A further problem was that since the same information was given to
patients regardless of their transplant type all of the information was not
relevant to all of the people who received it. It was also noted that
different patients expressed different thoughts as to the quantity and depth
of information required. This finding is consistent with the findings of a
study conducted by Tarzian et al. (1999) which specifically investigated the
information requirements of stem cell transplant patients. The study
highlighted that providing appropriate information is difficult because
different patients desire different amounts of information. Flexibility in the
provision of information may assist patients to receive the information that
they need and want (Tarzian et al., 1999).
Findings related to social support
Previous research has reported the potential psychosocial benefits to
cancer patients of attending a support group (Feigin, Greenberg et al.,
2000). The present study identified that the relationships developed with
fellow patients and staff through a group programme were perceived by
some patients to provide beneficial additional support. Helgeson, Cohen et
al. (2000) investigated which patients are likely to benefit from social
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support interventions and concluded that additional support was only likely
to benefit those individuals who lack other sources of social support.
In the present study social support was provided through attendance at a
group programme that included an exercise component. The provision of
support through a group exercise programme was been found to appeal to
people who would not consider attending a conventional support group
(Adamsen et al., 2001, Emslie et al., 2007). However, in contrast to this
there was some evidence in the present study that patients who were
uncomfortable with the group element of the programme discontinued
attending, thereby receiving neither the exercise nor the support elements
of the programme.
Discussion of the findings in relation to the biopsychosocial
framework
This research was situated within a biopsychosocial framework emphasising
that psychological and social, as well as biomedical, factors have an impact
on health. Previous research has established that the effects of
haematological malignancy and its treatment with a stem cell transplant
are complex and affect not only the physical but also the psychological and
social functioning of individuals. The development of the health profession
led programme that was trialled in this study was influenced by the
commitment of the health professionals involved to the provision of care
that focused on the psychological and social, as well as the biolog ical
deficits caused by haematological disease and its treatment. Therefore the
health profession led programme was made up of a number of component
parts in an attempt to address more than the physical needs of patients.
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Due to the nature of randomised controlled trials it was not possible to
unravel these components and to establish if any of the separate elements
were effective. However, the qualitative component of the study did
highlight that the health profession led programme did not meet the
biopsychosocial needs of participants in the way that had been anticipated.
The exercise component of the intervention was designed to provide
physical rehabilitation through improving muscle strength and stamina but
it was also envisaged that further benefits might be seen in psychosocial
health. For example it was anticipated that as patients grew in confidence
in their physical ability it would enable them to socialise more and
potentially help to reduce negative psychosocial factors such as anxiety or
boredom. For some individuals it seems that the exercise component did
provide a boost to morale as people saw an improvement in their ability
week on week. However other people reported feeling discouraged and
exhausted by attending the programme which arguably hindered their
psychosocial recovery.
The information component of the health profession led programme was
designed to provide additional information about recovery after stem cell
transplantation. It was hoped that this would reduce anxiety and stress by
ensuring that patients were adequately informed about the recovery
process and by allowing additional contact with health professionals
thereby providing an opportunity to discuss concerns not addressed at
clinic. Similarly it was envisaged that the relaxation techniques included in
the health profession led programme would enable partiCipants to release
any tension and anxiety associated with having been treated with a stem
cell transplant. Reactions to these components were varied. It was
suggested that additional information had the potential to increase anxiety
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rather than reduce it and many individuals disliked the relaxation
techniques.
A further key aspect of the health profession led programme was the group
nature of the programme. It was anticipated that this would provide the
opportunity for social support through comradeship, shared mutual
experiences and friendship. The group dynamic of the programme did not
function as was hoped. In part this was related to the small group size,
however the qualitative findings indicate that whilst some participants
enjoyed being part of a group others disliked the group environment
because they did not feel any connection with the other people present.
These issues highlight the complexity of trying to meet the psychosocial
needs of individuals. Whilst the biological consequences of stem cell
transplantation respond to treatment in a relatively predictable fashion, the
psychological and social issues associated with stem cell transplantation
are unique to each individual. In recognition of this a more flexible patient
centred approach to rehabilitation following stem cell transplantation is
required.
Whilst the success of the health profession led programme as a
biopsychosocial intervention can be questioned the findings from this study
do provide a number of insights into the biopsychosocial factors that
influence participation in rehabilitation. Figure 6.1 has been developed to
highlight the biopsychosocial elements affecting rehabilitation following
stem cell transplantation and complements figure 2.4 which is shown in
chapter two section six.
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Figure 6.1: The biopsychosocial factors affecting rehabilitation following
stem cell transplantation.
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It was observed in this study that a number of different biopsychosocial
factors affecting rehabilitation following stem cell transplantation. The
predominant biological factors are an individual's disease status, the extent
and intensity of any side-effects that they are experiencing, their blood cell
counts and their energy levels. All of these factors will impact an
individual's willingness and ability to engage in rehabilitation. The findings
also highlight a number of psychological factors that may have an impact
on rehabilitation. An individuals level of motivation, their confidence (both
in their own abilities and in the expertise of other such as physiotherapists)
their health beliefs, previous experience particularly with regard to exercise
and their anxiety levels will all potentially effect how they engage with
rehabilitation. The study also identified a number of social factors affecting
rehabilitation. These were competing commitments, such as role as a
mother or an employee, desire or otherwise for social contact and meeting
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people who had been through a similar experience. Finally this study
identified the importance of personal preference and individual taste or
desires in the process of rehabilitation. Consideration of these
biopsychosocial factors that affect engagement with rehabilitation is crucial
if rehabilitation programmes are going to appeal to and meet the needs of
individual patients.
6.2 Discussion of the methodology
There are several aspects of the methodology used in this study that merit
further discussion. The trial was stopped before the full sample size had
been achieved resulting in an underpowered study. Therefore it is
important to consider the reasons behind the decision to stop the trial. It is
also essential to reconsider the methods employed in order to explore
whether or not a randomised controlled trial was an appropriate design. It
is also of interest to assess what steps could have been taken to avoid
some of the difficulties that were encountered.
Rationale for early trial termination
After a data collection period of approximately one year it was clear that
the trial was not progressing as intended. The greatest area of concern was
the rate at which participants were being recruited to the study. It had
been anticipated that approximately 65% of the transplant population
would agree to take part. In the event, only 37% actually took part.
164
Factors affecting recruitment
It was noticed that fluctuations in recruitment were related to the
enthusiasm and availability of members of staff. During the pilot study and
at the start of the trial when staff were very enthusiastic and committed to
the trial recruitment was more successful. In contrast, as the trial
progressed and competing time pressures emerged, it was hard for staff to
maintain the same level of dedication and rates of recruitment fell. This is
not an unusual occurrence in trials. The work load and competing time
pressures of staff were two of the many barriers to recruitment identified
by Fayter et al. (2006) in their review of the barriers, modifiers and
benefits involved in participation in cancer clinical trials.
Donovan et al. (2002) explored the recruitment of patients to a
randomised controlled trial. The study identified that the language used by
practitioners and researchers had an impact on whether or not participants
agreed to take part. By giving feedback to researchers and practitioners
they were able to increase the recruitment from 40% to 70% over the
course of the trial (Donovan et al., 2002). The study by Donovan et al.
(2002) highlights the need for clinicians to be engaged in the process of
recruiting patients. In the stem cell transplant rehabilitation trial it became
clear that whilst some doctors were keen to talk to patients about the trial
others were not. Unfortunately, it was observed that potential participants
responded differently to information from different members of staff. In
particular, it was observed that if a doctor spoke to a patient about the trial
then the patient was more likely to agree to take part. Since not all doctors
were willing to discuss the trial with their patients it was questioned
whether a substantial change in rates of recruitment could be achieved.
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It was also clear that the entry criteria for the trial had an impact on
recruitment. In particular the criterion that participants should be six to
eight weeks post transplant when recruited negatively affected the rate of
recruitment. The effect of the six to eight week recruitment window was
that some participants turned down the trial when they were offered it
because they felt their recovery was progressing well. Subsequently, their
recovery did not progress as they had hoped. By the point that they then
felt a rehabilitation programme would be of benefit this six to eight week
window had passed and it was not possible for them to take part.
A small number of potential participants were restricted from taking part
because they were too ill to be recruited during the six to eight week
window. However, this problem was identified early in the trial and the
protocol was adjusted so that individuals could take part in the trial if they
had missed the six to eight week window because they had not been
discharged from in-patient care by week eight.
A number of factors that were potentially affecting recruitment were
identified, relating not to the trial but to the health profession led
programme. During the early stages of the trial a lack of independent
transport to attend the health profession led programme was consistently
cited by participants as a reason for non-participation. In order to reduce
the impact of this problem on rates of recruitment, taxis were provided for
travel to and from the hospital. Interestingly, the rate of recruitment did
not increase after this measure had been introduced.
Two other practical barriers to recruitment identified were participants'
desire not to spend more time at the hospital, and journey time to the
hospital. It would have been interesting to relocate the programme away
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from the hospital and to assess the impact that this had on attendance
rates. Situating the health profession led programme in the community
might have helped to remove these barriers to participation, but since the
transplant population was from a wide geographical area there was no
obvious location for the group to meet that would be convenient for a
majority of patients.
Lower than expected rates of recruitment are common in research studies.
Research investigating rehabilitation with cancer patients is no exception to
this. Previous studies have also indentified the practical barriers to
recruitment that were found in this present study (Campbell et al., 2005,
Stevinson and Fox, 2006, Fayter et al., 2006). Since recruitment problems
are a recurring theme in the literature on rehabilitation for cancer patients
future research specifically investigating this issue may be of benefit to the
research community.
Implications of the slow recruitment rate
The rate of recruitment was considered to be crucial to the success or
failure of the trial since it had an undeniable impact on the health
profession led programme itself in that if people were only recruited a few
at a time, and 50% were allocated the self managed programme, only one
or two participants filtered through to the health profession led programme
at a time. It is highly questionable whether a group intervention with an
average weekly attendance of just three people is actually a group
intervention at all. It had been anticipated that up to ten participants would
take part in the health profession led programme at anyone time,
providing a potentially lively group with a good sense of camaraderie and
companionship. However, the group size never exceeded six participants
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during the trial with an average weekly attendance of three. This small
group size was perceived by the staff to affect the nature of the group,
which the staff argued in turn affected participants' enjoyment, motivation
and commitment to the group. In effect, the small group size, it was
argued, had a downwards spiral effect whereby newly recruited individuals
turned up to the health profession led programme, they did not encounter
a lively dynamic group, and they were less motivated to continue
attending, contributing further to the small group size for future recruits.
This argument was supported by the fact that attendance rates at the
programme were very poor with 34.5% of those allocated the health
profession led programme attending for three or fewer of the ten sessions.
Without a dynamic and lively group there was genuine concern that the
efficacy of the intervention was being affected.
Given these concerns simply extending the time allowed for the trial to be
completed in order to recruit more patients was not an appropriate
response. With some reluctance, consideration was given as to whether
stopping the trial early was the most appropriate response to these
problems. This was not an easy judgement to make and a number of
further factors were taken into account when considering the decision.
The poor attendance rate at the health profession led programme has
already been mentioned as a problem. However, an additional problem
caused by the fact that less than half of the individuals allocated to the
programme attended for seven or more of the sessions was the resulting
dilution effect that was caused whereby individuals allocated to the health
profession led programme were effectively receiving the self managed
programme. This increased the likelihood that any benefit of the health
profession led programme would not be detected. It is possible to account
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for a dilution effect when calculating the sample size required for a study
(Wang and Bakhai, 2006). This precaution was not taken with this study
since the pilot data did not indicate that this was likely to be a problem. If
such a calculation had been performed it would have further increased the
sample size required. Achieving a larger sample size was unfeasible given
the problems that were encountered with recruitment. It therefore became
increasingly clear that even if the trial continued until the sample originally
calculated had been recruited the study would still have been
underpowered.
One further factor that compounded this problem was that it was proving
difficult to ensure a consistent study environment for the duration of the
trial. The framework for the development and evaluation of RCT's for
complex interventions to improve health published by the Medical Research
Council states that once a randomised control trial begins the intervention
must not evolve (Medical Research Council, 2000). Whilst the logic behind
this requirement is clear, achieving such a condition can be difficult if not
impossible. In the present trial the intervention underwent some minor
changes. However, the environment within which the trial was run
underwent some significant changes, which undoubtedly affected the self
managed programme in particular. In part these were due to the merger of
two acute hospital trusts. The merger resulted in the increased provision of
some services. Most significantly, the level of physiotherapy support
increased and a physiotherapist became available to see patients whilst
they were attending clinic. Likewise, the level of dietetic support also
increased and many patients started to see the dietician at clinic
appointments. Prior to the trial, out-patients could not be referred to
hospital based social workers. But during the trial, the service provided by
the social work department evolved and it became possible for out-patients
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to see a hospital social worker. These changes reflect important steps
forward in the provision of care for people who have undergone stem cell
transplantation. However, these changes caused the health profession led
and the self managed programmes to become less distinct, since elements
that were previously only available to the health profession led group
became available to both groups. The issues raised by the changes in usual
care were not sufficiently serious when considered alone to cause the
continuation of the trial to be questioned. However, they further increased
the likelihood that the study would be underpowered and unable to reach
genuine conclusions as to the efficacy of the health profession led
programme.
When all of these factors were taken into account it was clear that the
most appropriate course of action was to stop recruiting to the trial. All
individuals who had already been recruited continued through the trial as
previously planned. Relevant stakeholders, the ethics committee and the
research and development department were all informed of the decision
and the reasons for it.
Suitability of a randomised controlled trial
Given the problems that were encountered in this study it is reasonable to
ask if a randomised controlled trial was the most appropriate method for
evaluating the health profession led programme. Traditionally, randomised
controlled trials have been seen as the 'gold standard' of evidenced based
medicine (Barton, 2000) and the importance of the randomised controlled
trial in developing new drugs and technologies is undeniable.
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On rare occasions, the effects of a new treatment are so dramatic that
there can be little doubt as to their importance. For example, the
effectiveness of penicillin to treat bacterial infections is unquestionable.
However, many potentially worthwhile interventions will never hope to
have such an unquestionable impact and therefore it is important to have a
method of evaluating more subtle health benefits. The advantage of using
a randomised controlled trial design is that it allows greater confidence in
attributing any observed effect to the intervention being tested (Barton,
2000). If assignment to treatment group is not random then it is
impossible to be certain that known or unknown confounding variables are
not the cause of any difference observed between the two groups (Watson
et al., 2004). Proponents of the randomised controlled trial, for example
Pocock (2006), argue that this method is the only way to establish the
efficacy of a treatment.
The primary aim in this study was to investigate the efficacy of a new
intervention and therefore a randomised controlled trial was an obvious
approach to take. However, the intervention was undeniably complex
making the use of a randomised controlled trial more contentious. During
the planning of this study and it was perceived that by creating information
leaflets to support the different elements of the programme a consistent
structure could be provided without inhibiting the complex nature of the
health profession led programme. However, as the trial progressed it
became apparent that it was not the individual sessions that needed
flexibility but that the actual programme needed to be able to adapt and
change according to the needs of different patients. It had been envisaged
that all patients allocated to the health profession led programme would
complete the entire programme. Potentially, the most effective way to
utilise the health profession led programme would have been for staff using
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their skills, experience and expertise to work with patients to identify which
elements of the programme would be of benefit to them and in so doing
provide care that was tailored to meet the needs of individuals. This
approach would not have precluded the use of a randomised controlled
trial.
Black (1996), in his defence of the use of observational studies highlights
four limitations on the use of randomised controlled trials suggesting that
there are occasions when experimentation is unnecessary, inappropriate,
impossible or inadequate. He argues that randomised controlled trials are
inappropriate in a number of circumstances such as when evaluating
interventions deigned to prevent rare events, when the outcomes of
interest are far in the future and when the use of a trial is self-defeating.
Black (1996) uses the term self-defeating to refer to trials in which the act
of randomisation may reduce the effectiveness of the intervention being
tested, suggesting that this occurs "when the effectiveness of the
intervention depends on the subject's active participation, which, in turn,
depends on the subject's beliefs and preferences" (Black 1996 pg 1217).
Many complex interventions, including the one in this study, fall into this
category and therefore Black (1996) would question the appropriateness of
using a randomised controlled trial in its evaluation. Black (1996) argues
that "it is at least as plausible to assume that experimentation reduces the
effectiveness of such interventions as to assume, as most researchers have
done, that the results of observational studies are wrong" (Black 1996 pg
1217).
The qualitative finding that individuals who expressed a preference for the
group programme did not find exercising alone acceptable and stopped
exercising, but that partrclpants allocated to the self managed programme
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who did not desire to attend the group programme found exercising at
home acceptable, is an example of precisely the problem addressed in
Black's (1996) argument. The extent to which participants engaged with
the programme they were allocated inevitably affected their commitment
to exercise. The extent to which this problem affects the validity of the
randomised controlled trial is a contentious issue. There are a number of
potential solutions to this problem and these are discussed in the following
section.
Alternative research designs
Since there are a number of problems associated with using randomised
controlled trials it is important to consider the alternative approaches that
could have been employed in the evaluation of the stem cell transplant
rehabilitation programme.
One alternative to conducting a single centre randomised controlled trial is
to conduct a multicentre trial. This is a trial that is conducted
simultaneously at many centres following the same protocol synchronised
from a single command centre (Wang and Bakhai 2006). All data gathered
is analysed collectively. The advantages of this type of trial are that it
allows for a larger number of participants to be recruited in a shorter
period of time and it has been argued that the results are more
generalisable. However, the resource implications of a multicentre trial are
considerable and therefore the majority of these trials have commercial
funding and are driven by pharmaceutical sponsors (Wang and Bakhai
2006).
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Since the rate of recruitment was a key difficulty in this study a multicentre
approach is an attractive alternative to the single centre design that was
employed. Unfortunately, the resource implications of such a decision were
too prohibitive. Even if funding for a large scale study had been available it
is likely that a number of difficulties would have been encountered with this
approach. In particular, providing comparable complex interventions at
different sites is a potential problem in the use of multicentre trials to
evaluate complex interventions. In this study ensuring consistent provision
of the health profession led programme in one setting was challenging, and
a number of unavoidable changes to the programme occurred in the course
of the trial. Therefore keeping an intervention stable across a number of
centres may have proved impossible.
Furthermore, whilst a multicentre trial would have increased overall
recruitment, it is likely that the recruitment at each individual centre would
have been on a par with that achieved in this study. Presuming, as is the
norm in multicentre trials, that the intervention was provided at each site,
then numbers attending each intervention would not be increased in this
approach. Since it has been argued that failure to achieve a sufficient
group size for the health profession led programme impacted the nature
and potentially the efficacy of the programme, to pursue a conventional
multicentre trial design would have been irrational. A potential solution to
this problem would be to use a multicentre approach with cluster
random isation.
Cluster randomisation uses a group of individuals, a hospital, or a
community as the unit of randomisation and therefore provides a useful
alternative in situations where it is not feasible or desirable to randomise
each individual participant in a trial (Wang & Bakhai 2006). Cluster
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randomisation is a particularly useful tool in the evaluation of complex
interventions and successful studies have been reported that have utilised
this design (Moore et al., 2002, Graham et al., 2002). A cluster randomised
trial is an attractive option for studies of interventions that require group
participation, such as the stem cell rehabilitation trial. In a traditional
multicentre trial where four centres are involved, if 240 partiCipants are
recruited, 120 will be allocated the intervention and these will be
distributed randomly between the four centres with approximately 30
participants from each receiving the intervention. Since in cluster
randomisation it is the centre rather than the individual that is randomised
the participants receiving the intervention in this example would only be at
two sites and therefore the group size at each would be greater.
A further advantage of cluster designs is that they reduce the likelihood of
contamination between treatment arms occurring since individual
participants are only likely to have contact with other participants and
medical staff who are part of the same arm of the trial. In conventional
randomised trials, particularly of non-pharmacological treatments, the
effect of an intervention can be diluted when there is contamination across
arms of the study. For example, in the study by Courneya (2003) of an
exercise intervention for colorectal cancer patients the control group
initiated exercise due to a contamination effect from the intervention
group.
One disadvantage of this approach is that it is crucial to account for cluster
randomisation in the calculation of sample size since much larger samples
are required than for conventional randomised controlled trials (Kerry and
Bland, 1998). This and other factors mean that cluster randomised trials
are expensive to run and require conslderabte resources in terms of
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research expertise. There were not the financial resources available to
conduct a multicentre cluster randomised trial for the evaluation of the
stem cell transplant rehabilitation programme. However, it should also be
noted that even if resources had been available this would have been a
very problematic approach to employ. The reason for this is that the
research was conducted at the request of the unit which had designed the
health profession led programme. It would have been unpalatable to many
staff on the unit to agree to a study design whereby the unit risked being
randomly allocated to the control arm of a trial.
It has been argued that randomised controlled trials can be self defeating if
the intervention being tested requires participants to engage with their
allocated treatment (Black 1996). The concept of resentful demoralisation,
whereby patients who do not receive their preferred treatment have a
poorer outcome, is an important concern (Torgerson and Sibbald, 1998).
This was an area of concern in this study since the extent to which
participants engaged with the programmes was likely to have impacted on
the benefit gained from taking part.
A potential solution to the problems associated with trials of this kind is to
use a patient preference trial (Torgerson and Sibbald, 1998). In patient
preference trials all patients are asked about both their preference for
treatment and their willingness to be randomised. Patients who have no
preference and who are therefore happy to be randomised form one group.
Patients who have a preference but are still willing to be randomised form
a second group. Patients who have a strong preference and are not willing
to be randomised form a third group and receive their treatment of choice.
It can be argued that the results of this type of trial are more generalisable
since many participants who would normally not consent to taking part in a
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trial are included. The disadvantages of this approach are that the analysis
of such trials is uncertain and the design increases the size and cost of
trials (Torgerson and Sibbald, 1998).
The most appropriate way to assess the impact of patient preference on an
intervention is to assess patient preference prior to randomisation, to
randomise all participants, and then to test for an interaction effect
between preference and outcome in the analysis of findings (Torgerson &
Sibbald 1998). This was the approach taken in the present study. However,
this approach is not unproblematic ethically or methodologically. Ethically,
it can be argued that asking about a patients' preferences and then
ignoring them may be more distressing for the patient than not asking.
Methodologically, interaction tests often lack sufficient power to detect an
interaction effect.
Given the difficulties involved in using an experimental approach, the
greater use of well designed observational studies has been advocated
(Black 1998). A prospective observational design charting the recovery of
stem cell transplant patients before and after the introduction of the
rehabilitation programme would have been an alternative design for this
study. Possible benefits to this approach might have been a higher level of
participation, since patients would not have been required to consent to
randomisation. Furthermore, it can be argued that the results would be
more generalisable since strict inclusion and exclusion criterion would not
have been necessary. An observational approach might not have impacted
on the health profession led programme in the way that the trial was
argued to have done. Therefore it may have enabled the observation of a
fully working intervention. However, the clear disadvantage of this
approach would have been that since it is not possible to know the impact
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of unknown confounding variables, any findings that indicated the
effectiveness of the health profession led programme could be artifactual.
Strengths and limitations of the qualitative data
The qualitative interviews conducted as part of this study provided an
insight into the experiences of staff and participants. As with the other
aspects of the study it is important to consider the strengths and
limitations of the approach employed.
Due to the limited size of the research team the same researcher
conducted the qualitative interviews as had managed the quantitative trial.
Through the process of recruiting participants to the main trial and of
collecting the quantitative outcome measures I had developed a rapport
with participants. The advantage of this was that participants felt
comfortable in my company and were at ease in the interviews. The
disadvantage of this was that the participants clearly associated me with
both the rehabilitation programmes and with the trial which may have
moderated the opinions that they were willing to express when discussing
their participation. It can be argued that in an ideal world a new researcher
with no prior contact with the trial would have conducted the interviews.
This would help to allay any fears that participants felt obliged to present a
particular viewpoint in the interviews. However, the fact that participants
did not provide a very favourable account of the programmes suggests that
in this study participants were comfortable to express their opinions even if
they were critical of the trial.
Given the useful information that was generated from the interviews with
participants and staff it is important to consider if a solely qualitative
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approach would have been an appropriate way to evaluate the health
profession led programme. The qualitative data that was gathered as part
of this study was very important in exploring the perspectives of
participants and staff. This information aided the understanding of what
went wrong in this trial, and even if the trial had been successful, having a
qualitative view on the health profession led programme would still have
been invaluable. Could the health profession led programme have been
evaluated just using a qualitative approach? It is possible to argue that it
could; providing answers to such questions as, was the programme
acceptable to patients? Did patients engage with the programme? Did the
programme improve patients' perceptions of their recovery after
transplant? All these questions are very important but unfortunately a
purely qualitative approach is unable to answer the question: did the
health profession led programme actually improve patients' recovery after
stem cell transplantation? If this is a key question then a purely qualitative
approach is not able to provide a sufficient answer.
Conclusions from the discussion of methodology
Whilst there are undoubtedly practical difficulties with using randomised
controlled trials to evaluate complex interventions it remains the gold
standard by which evidence of effectiveness is judged. Therefore the use of
randomised controlled trials in the evaluation of complex interventions
should be encouraged. However, randomised controlled trials are
expensive, and, by definition, the more complex the intervention being
evaluated the more considerable the resource implications.
With regard to the complex intervention in this study, the most appropriate
approach to assessing its efficacy might be to conduct a multicentre cluster
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randomised controlled trial accompanied by a qualitative evaluation of the
programme. Multiple centres would provide access to a greater number of
potential participants. Randomising the centre rather than the individuals
taking part would reduce the problems of contamination and resentful
demoralisation. As with the present study a qualitative component would
enable the evaluation of different individuals experiences of the programme
and provide depth and context to the quantitative data. Furthermore,
future research on this topic might benefit from investigating, not the
impact of a set rehabilitation programme, at a set point in patients'
recovery, but the impact of having a rehabilitation service available to
patients when they require it. Unfortunately, the cost of such an
investigation would be considerable and may prove prohibitive.
6.3 Implications for practice
This research was initiated in the clinical environment in response to the
staff's recognition of the fact that there was insufficient evidence as to the
efficacy of rehabilitation interventions for patients recovering after stem
cell transplantation. The research was designed to provide guidance to staff
involved in clinical practice in how they should proceed in providing
rehabilitation following stem cell transplantation. If the research had
demonstrated that the health profession led programme was more effective
than the self managed programme then this would have provided evidence
with which to pursue clinical support and long term financing for that
programme to be provided routinely. However, no difference in any
outcome measure was observed between the modes of rehabilitation
precluding this eventuality.
Due to the problems with recruitment the study was underpowered.
Underpowered studies are liable to type II errors since it is possible for a
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true difference to exist that cannot be observed in the small volume of
data. Therefore, despite no differences being observed between the two
modes of rehabilitation it is not possible to conclude that the two
programmes are equal. Evidence for equivalence can only be generated
from equivalence trials that require much larger samples (Jones et al.,
1996). Therefore there was no evidence to support the self managed
programme being implemented as routine care for patients recovering after
stem cell transplantation.
The literature review conducted for this thesis, the experiences of staff and
patients expressed in the interviews and the comparison of the SF-36 data
from this study with UK population norms all underline the importance of
rehabilitation for individuals recovering after stem cell transplantation.
Clinical colleagues are keen to continue to provide a rehabilitation
intervention for patients recovering after stem cell transplantation.
However, it is difficult to know exactly how to proceed from this potnt.
It was clear from the interview data from staff and patients that continuing
with the health profession led programme in the format tria lied in this
study was not appropriate. This was supported by the poor attendance
rates at the programme. Furthermore, the self managed programme was
not well received by the majority of patients with the exception of those
who were unable or unwilling to attend a programme based at the hospital.
Having stated that neither programme was ideal in the format in which it
was tria lied in this study it is important to recognise that there were
elements from the programmes that were well evaluated by staff and
patients. Furthermore, the comments and reflections of patients and staff
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enabled a number of suggestions to be developed as to how a
rehabilitation intervention for this patient group could be improved.
With regard to the potential content of a rehabilitation programme to be
implemented in clinical practice the following findings are relevant.
Rehabilitation with an exercise component is appropriate and acceptable to
patients following stem cell transplantation. This is consistent with previous
research (Oldervoll et al., 2003, Courneya et al., 2000, Dimeo, 2000).
Patients value apposite information (Tarzian et al., 1999, Mills and Sullivan,
1999) and an information component is of merit in a rehabilitation
intervention. Group support and the chance to engage with fellow patients
and members of staff can be perceived as very beneficial in promoting
psychosocial recovery after cancer treatment (Feigin et al., 2000),
particularly within the context of an activity based programme (Adamsen et
al., 2001, Emslie et al., 2007). The value of including relaxation exercises
in a rehabilitation programme can be questioned and may be more
appropriate for in-patient care (Fife et al., 2000).
With regard to the potential format for a rehabilitation intervention this
study highlighted that any intervention for this patient group needs to be
flexible allowing for the different needs of different patients. No evaluations
of other rehabilitation programmes providing exercise, information and
social support have been identified for patients recovering after stem cell
transplantation. However, other studies with this patient group have
emphasised the need for flexibility in order to meet the needs of individuals
(Tarzian et al., 1999).
Patient choice and flexibility are central to the success of programmes
which rely on patient engagement. However, this can be problematic within
182
the constraints of the National Health Service. Choice and flexibility must
be balanced with cost-effectiveness and meeting the needs of as many
patients as possible. One potential approach for providing a flexible, patient
centred rehabilitation service may be for staff and individual patients to
work together, selecting from a series of specified options a programme
with the appropriate content and duration to meet that individual's
requirements. This would allow someone who is confident of their ability to
exercise and who does not feel the need for any additional support and
information to exercise unsupervised at home. Alternatively, a person with
more complex needs could attend a supervised programme weekly to build
their confidence in exercising. Similarly, the provision of information and
support could be directed towards those individuals who require it.
Furthermore it may be appropriate to offer this service to anyone who has
had a stem cell transplant regardless of the time since their transplant. To
assume that all transplant related complications will be apparent shortly
after transplantation is simplistic. The needs of patients could be more fully
served with an open service available when it is required.
It is envisaged that the findings of this study in relation to the components
and structure of potential rehabilitation programmes will assist clinical
colleagues with the ongoing development of appropriate interventions
aimed at addressing the known biopsychosocial side effects of stem cell
transplantation. However it must be reiterated that, whilst these findings
are based on the experiences of patients and staff and should therefore
lead to the development of programmes with a greater degree of patient
satisfaction than was identified in this study, the efficacy of providing a
rehabilitation intervention following stem cell transplantation remains
unproven.
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At the centre where the research was carried out a new rehabilitation
programme has been developed which is now being provided as part of
routine care after stem cell transplantation. Early attendance and attrition
rates for the new programme suggest that it now has a greater degree of
acceptability with patients. However, no formal qualitative or quantitative
evaluation of the new programme has yet been initiated.
6.4 Conclusions
Stem cell transplantation is an aggressive treatment associated with
numerous negative biopsychosocial sequelae (Edman et al., 2001, Frick et
al., 2004, Hacker and Ferrans, 2003). The impact of stem cell
transplantation can be prolonged supporting the need for rehabilitation to
promote optimum physical and psychological recovery after treatment
(Bush et al., 1995, Whedon and Ferrell, 1994).
This study aimed to assess the efficacy of a health profession led
rehabilitation programme for patients who have had a stem cell transplant.
The outcome measures in this trial included a range of biopsychosocial
outcomes measured at both three and six months after randomisation.
The 95% confidence intervals for all outcomes included zero indicating that
there was no evidence of any difference in any aspect of recovery between
the health profession led and self managed rehabilitation groups. However
the confidence interval around the estimated difference in the primary
outcome measure of physical functioning could not exclude differences of
up to 10 points in either direction. In all dimensions of the SF-36 scale the
patients from this trial had poorer mean scores than found in the general
population indicating that recovery after transplantation can be protracted
and endorslnq the concept of rehabilitation for this patient group.
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Qualitative evaluation of the programmes highlighted that important
elements of a rehabilitation programme are exercise, information and
social support. However, individual patients have differing needs and
preferences and therefore flexibility is required in the provision of
rehabilitation. Evidence as to the efficacy of rehabilitation for this patient
group remains scant.
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Appendix A - Rehabilitation Leaflets
(The actual leaflets given to patients were AS in size, with the exception of booklet 8
which was A4 with the medications table in the centre across two pages.)
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Exercising after your Bone Marrow Transplant
This information leaflet is to help you as you recover from your
bone marrow transplant. Exercise can help you regain the strength
and mobility that you will have lost during your time in hospital.
At the moment your joints may feel stiff and you may feel tired
very easily. This is normal and is due to your muscles not being
worked whilst you have been in bed.
You have probably lost weight whilst in hospital. You will have lost
a combination of fat and muscle. It is easier to regain the fat you
have lost than it is to regain the muscle. So even if you put weight
back on, you will not regain your muscle bulk and strength unless
you are exercising.
This booklet will give you information about how, why and when to
exercise and a programme of exercises that you can try at home.
There is also a section for you to write down how you get on when
you exercise. This should help you monitor your progress.
Please read all of this booklet before you do any exercise.
Why should I exercise?
• Exercise helps you regain strength in your muscles
• Exercise gives you more energy to do the things you enjoy
• Exercise can help reduce the feeling of fatigue
• Exercise helps you feel fit and healthy
• Exercise can improve your confidence
• Exercise reduces the risk of other diseases such as, heart
disease, stroke and osteoporosis (brittle bones)
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How much exercise should I be doing?
Everyone is an individual. The right level of exercise will be
different for each person. How much exercise you are able to do
will depend on:
• how long you were in hospital for
• what condition you were diagnosed with
• the type of transplant you received
• your strength and mobility prior to diagnosis
Pushing yourself too hard, too quickly will not mean that you get
better faster. It will tire you out and may discourage you.
You should very gradually increase the amount that you do.
You should be aiming to do some form of exercise 3-5 times a
week. .
At first you may get tired very easily, as your muscles are not used
to having to work hard.
You should be able to talk whilst exercising. If you are too short of
breath to talk, you are exercising too hard and need to reduce the
intensity.
Doing too much or too little exercise may make any fatigue you
might be experiencing worse. The leaflet 'managing fatigue after a
bone marrow transplant' gives more details about how to find the
rig ht level of activity.
What sort of exercise should I be dOing?
You should choose a form of exercise that:
• you can do
• you enjoy doing
• you will want to keep doing
• will exercise your whole body.
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Types of exercise you could try are:
• walking
• cycling
• gentle jogging
• circuit exercises
Included in this leaflet are some suitable exercises that you can
complete at home.
Important guidelines
It is important to increase your fitness very gradually. This can be
achieved by:
• increasing the number of times a week you exercise.
• increasing how long you exercise for in each session.
• increasing how hard you work for in each session.
For example:
walking faster
increasing the number of exercise repetitions
adding a weight to the exercise
When you can easily do your current exercises, increase the
amount you are doing by a small amount. Never make large
changes.
Take care when you exercise
• Always start and finish slowly. This will give muscles time to
warm up and cool down reducing the risk of injury.
• Ifthe weather is cold or wet, either make sure you have suitable
clothing on, or do some exercise inside.
• Allow 2 hours after eating before you exercise, to ensure that
food is fully digested.
• If you feel unwell reduce your usual level of exercise until you
feel well again.
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• It is normal to feel some slight muscle soreness after exercising.
Sharp pain or pains lasting more than 24hours suggest that you
need to reduce the amount of exercise you are doing.
• Ifany of the following occur whilst exercising, stop immediately.
Chest pains or increased chest tightness
Severe joint or muscle pain
Dizziness or feeling faint
Excessive shortness of breath. You should be able to breathe
normally within 3-4 minutes after stopping exercise.
Do not restart until you have seen a doctor at clinic.
The Borg scale of perceived exertion
The Borg scale can be used as a guide to make sure you are
exercising at the right intensity. The scale is graded from 6-20 as
shown below. You should use the scale to rate how hard you feel
you are exerting yourself when doing your exercises.
When exercising, you should be working at a level which gives you
a Borg rating of between 12 and 15.
The Borg scale of perceived exertion
6 very very light
7
8 very light
9
10
light11
{ 12 somewhat hardAim to exercise at a 13level which gives 14 hardyou a Borg rating of 15
between 12 and 15. 16
17 very hard
18
19 very very hard
20
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Exercising
We have included an exercise programme, consisting of ten
exercises that are suitable for you to complete at home. We
suggest that you try to do the exercises three to five times a week.
You should get ready to exercise by:
• making sure that you are wearing comfy loose fitting clothes and
flat shoes
• reading the exercise programme through from start to finish
• gathering together the equipment you will need - this should
include
• a drink and biscuit for when you finish
• music to listen to whilst you exercise (optional)
• a pen to write down how you get on
• two weights or tins of beans (optional)
• a short pole or stick (for exercise 5)
Before you start the exercises on the sheet you should walk on the
spot for about a minute to warm up your muscles and get you
ready for exercise.
After warming up you should do each exercise on the sheet in turn.
Repeat each exercise several times before moving on to the next
one. Count how many times you repeat the exercise and write it
down on the exercise sheets.
Gradually increase the number of repetitions that you do. Another
way to make the exercises harder is to add a weight. You don't
need to buy gym weights, a tin of beans will work equally well. If
you find the exercises very hard you should reduce the number of
repetitions that you do.
When you first start these exercises you may need to stop and rest
between exercises. Don't worry if you need to sit and have a rest or
walk slowly on the spot until you feel ready to start again.
If you get any feeling of discomfort make sure you take some time
to recover before continuing.
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When you have finished the exercises on the sheet walk on the
spot, slowly reducing your pace for about a minute. Make sure you
have your drink and biscuit, then take a well-deserved rest.
If you keep exercising you will soon start to see an improvement in
what you can achieve.
Use the exercise diary sheets to record both how you get on with
the exercises and how much other activity such as walking you are
doing each day. By recordlnq how veu are getting on you can look
back and see how much you have improved.
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Exercise Programme
Exercise 1
Stand straight holding onto a chair.
Bring your leg backwards keeping your knee
straight. Do not lean forwards.
Repeat with your other leg.
Exercise 2
Stand with arms hanging down, either with or
without weights, i.e. tin of beans or water in a
bottle.
Bend alternate elbows briskly.
Repeat.
Exercise 3
Sit or stand holding your hands on your chest.
Start with no weights, but progress if required to
a small weight in each hand, i.e. tin of beans.
Alternating arms lift your hands with or without
the weights from your chest straight up and
down.
Repeat.
Exercise 4
Sit on a chair with a cushion under your knee.
Pull your toes up, tighten the front of your thigh
muscle and straighten your knee slowly. Hold for
approximately five seconds.
Change legs and repeat.
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Exercise 5
Stand or sit holding a pole or stick with your arms
down and in front of you.
Lift arms straight up and then lower the stick
behind your neck. Lift arms up and return to
starting position.
Repeat.
Exercise 6
Stand in front of a table or chair holding on to the
support with both hands.
Slowly crouch down as far as you can reasonably
go. Keeping your back straight and heels on the
floor. Stay down for approximately five seconds.
Use arms to pull yourself up a little and then push
up through your legs.
Repeat.
Exercise 7
Stand straight holding onto a support.
Lift your leg sideways, keeping your trunk
straight throughout the exercise.
Repeat.
Exercise 8
Standing with hands clasped in front of you.
Lift both arms straight forward over your head.
Separate your arms sideways and take them back
to the starting position.
Repeat.
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Exercise 9
Stand in front of a step/bottom step on a flight of
stairs.
Step up ten times with one leg leading and then
repeat with the other leg leading.
Ensure your knee stays in line with your toes.
Exercise 10
Stand facing a wall with your arms straight and
hands on the wall.
Do push-ups against the wall keeping your body
in a straight line.
Repeat.
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Walking is an excellent form of exercise. Try to
get out of the house and go for a walk most days.
But remember you may be very weak and you
should start with just a short walk. You can then
gradually increase how far you go.
Climbing stairs is also good exercise.
Images built on Tools@,© Copyright Physio Tools Ltd.
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Exercise Diary: how many times can you repeat each exercise?
Put today's date in the first row, and then underneath record how
many times you completed each exercise.
Date"
Exercise.
1
2
3
4
5
6
7
8
9
10
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Exercise Diary: how many times can you repeat each exercise?
Put today's date in the first row, and then underneath record how
many times you completed each exercise.
Date...
Exercise.
1
2
3
4
5
6
7
8
9
10
213
Exercise Diarv: how many times can you repeat each exercise?
Put today's date in the first row, and then underneath record how
many times you completed each exercise.
Date ...
Exercise.
1
2
3
4
5
6
7
8
9
10
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Eating after your Bone Marrow Transplant
After you have had a bone marrow transplant it is common to
experience some difficulty with eating. This leaflet suggests ways to
help overcome some common food related problems associated
with having had a bone marrow transplant.
Clean diets
On discharge from hospital you will have been told that you need to
follow a clean or neutropenic diet. This is because you are immuno-
compromised. Therefore you are at risk of picking up a stomach
bug from foods that you would normally be able to eat. It is most
important that you follow this advice whilst your white cell count is
below 1.0.
To reduce the risk of getting a stomach bug you should:
• store your food according to the instructions.
• ensure that the food is within the best before or use by date.
• cook your food according to the instructions.
• only eat dairy products that have been pasteurised.
• avoid re-heating food.
• avoid soft or blue veined cheeses, raw meat, raw fish, raw eggs,
and live or bio yoghurts.
Take care when eating food you have not prepared yourself. Avoid
buying take-aways if the company cannot guarantee that your
order will be cooked fresh. Kebabs and other foods that are kept
warm should be avoided. It is also very important that rice has
been freshly cooked as reheated rice is a major cause of food
poisoning. If you want to eat out in a restaurant the same
principles apply. Always ensure you are eating somewhere with a
good reputation for freshly prepared food.
If you microwave food, make sure that all the food is piping hot and
stir the food well as microwaves don't always cook foods evenly.
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Taste changes
Taste changes can last for a while after your treatment but your
taste should return to normal with time. Taste changes affect
different people in different ways. You will need to experiment and
find out what works for you.
Many people find that tea and coffee taste unpleasant. If you stop
drinking tea and coffee it is important that you replace them with
other fluids. You should aim to drink about 2 litres per day. Many
people find that pineapple juice tastes good and it can help to
restore your normal taste palate.
Food may taste bland, sweet or sour. You may find that marinating
meat with wine or sherry may help. Or you could try serving it with
a sweet and sour or BBQ sauce. It may also be helpful to add extra
spices or herbs to your foods. If things taste sour, try eating more
sweet foods.
Some people add extra salt to their food to improve the flavour. If
this helps you then in the short term it won't do any harm. But
remember that salt is not good for your health. Once your taste
improves it is very important to reduce your salt again.
Keep trying different food as you may find you enjoy food that you
don't normally like and you will find that your taste changes over
time.
Poor appetite
If you have a poor appetite it is important that you try to eat well
even if you don't feel like it. Don't try and eat too much at once.
Instead of having three normal size meals a day you may find it
helpful to eat more often but to eat less on each occasion.
A small glass of alcohol before meals can help your appetite. Try to
get some fresh air before eating and avoid the smell of food while it
is cooking. The smell of certain foods, often steamed vegetables,
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may affect you strongly as you may associate them with times
during the treatment when you were feeling nauseous. This should
reduce with time.
Dry mouth
Having a dry mouth is a side effect of the treatment you have had.
This along with so many other things will gradually return to
normal. Whilst you are recovering you may find the following things
help you to cope with the problem.
• Try tart foods such as lemon or pineapple.
• Try drinking pineapple juice or chewing pineapple chunks.
• Eat moist soft foods.
• Have a drink with meals
Some people say that bread and potato feel like cotton wool in their
mouth and are too difficult to eat. If this is true for you try
replacing them with cereal, rice and pasta. Alternatively you could
try serving them with a sq_y.c;e.g. beans on toast, or adding
butter/cream to moisten potatoes.
Weight loss
It is very likely that you have lost weight during or after your
treatment. If you continue to lose weight this will have an impact
on your recovery by affecting your energy levels. There are several
things you could try in order to maximise your food intake.
• Don't push yourself to eat more than you want but eat more
often.
• Have snacks between meals. This could be crisps or biscuits, eat
whatever appeals to you.
• Add butter, cream and cheese to meals, for example mash
potatoes with cream and butter rather than milk.
• Don't buy low fat foods and change your milk and other diary
products to full fat.
• You could try supplementary drinks such as build-up or complan,
which are available in most supermarkets or chemists.
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Nausea (feeling sick)
It is often helpful to eat a little food more often if you are suffering
with nausea because if you go too long between meals the feeling
gets worse.
Try flat fizzy drinks and plain dry foods such as biscuits and toast if
you are having trouble tolerating normal food.
Some people find that foods flavoured with ginger and arrowroot
help.
If nausea is an ongoing problem talk to your doctor. They will
review your medication as there are lots of different anti sickness
drugs you can try.
Diarrhoea
Diarrhoea can be a problem at times. If you have had diarrhoea,
you should always mention it to the doctor when you go to clinic.
It is very important to take extra fluids if you have diarrhoea to
make sure that you don't get dehydrated.
You may also need to temporarily reduce the fibre content of your
diet. To do this you could cut down on white bread, plain cereals,
fruit (especially dried), vegetables and nuts.
Healthyeating
Once you are eating as normal, with a healthy weight, it is
important that you ensure your diet is healthy.
This means watching your intake of sugar, salt and fatty foods.
It is also important to have a good intake of fibre in your diet and
to aim to eat at least five portions of fruit and vegetables a day.
A portion is an apple, banana, orange, two plums or kiwis, dessert
bowl of salad, glass of fruit juice or two tablespoons of cooked
vegetables.
If you have any concerns about any of the things discussed in this
leaflet please remember to ask for some advice at clinic.
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Coping with stress after your Bone Marrow
Transplant
Stress is very difficult to define. It is how we react when
we are in situations that stretch our ability to cope. The
effects of stress may be physical and/or emotional.
There are numerous emotional effects of stress. Stress
may make you feel that you are:
• always rushing
• impatient with others
• keyed up
• often tired
• experiencing strange pains
• often worried
• frustrated
The physical effects of stress are caused when your body
produces adrenaline which makes you feel that your:
• heart is pounding
• muscles are tense
• breathing is fast/shallow
• mouth is dry
• hands are clammy
• head aches.
Coping with stress
It can be very difficult to cope with stress and no one
solution will suit everyone as people cope in different
ways. Below are some suggestions that may help you to
cope with stress.
Exercise
When we exercise chemicals are released called
endorphins. These act on the brain and are associated
with feeling positive and energetic. Exercising regularly
will help you to feel positive and to cope with the stresses
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that you are facing. Use the advice in the leaflet
'Exercising after your BMT' to plan an exercise routine that
will help improve both your physical and mental health.
Leisure pursuits and socialising
Talking to friends can reduce your stress and help you feel
more positive, but seeing people can also be stressful.
Don't let socialising add to your stress. Decide who you
feel comfortable seeing and how long you think you can
cope with seeing them for.
You may find that you are spending more time at home
than you have ever done before and you may get bored
very easily. Being bored will increase your stress levels so
try to find activities to keep your mind busy. You could try
reading, puzzles or listening to music.
Relaxation can be seen as 'doing nothing' but when we
are stressed our bodies and minds find it difficult to
unwind. Just because we are sitting 'doing nothing' our
minds may be racing preventing us from getting the rest
that we need. Specific relaxation techniques can help to
relieve tension and reduce stress. Below are some brief
explanations of some common relaxation techniques.
Have a go at finding out what works for you. If you want
more information there are many books available, most
local libraries have a selection, or you could ask for some
advice when you come to clinic.
Tensing and relaxing each part of your body in turn - Start
with one part of your body, for example your left hand
and try to tense the muscles, pause and then relax the
muscles. Then move on and think about another part such
as your left arm. Work your way systematically round
your body slowly and deliberately tensing and relaxing
your muscles.
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Breathing exercises - When we are stressed our pattern of
breathing can become very fast and shallow. It can be
very effective to focus on deliberately changing your
breathing pattern to control your stress. By breathing
slowly and deeply you will feel calmer and better able to
cope. You should breathe in through your nose a long
slow breath, pause and then slowly release the breath out
through your mouth.
Imagery exercises - There are lots of different imagery
exercises. One exercise involves shutting your eyes and
thinking of a special place where you feel safe and happy.
It might be an actual memory of a place you have visited
or it might be an imaginary place. Spend time imagining
you are there, try to feel what it would be like. Think
about what you might be able to hear, see, smell and
touch.
Relaxation tapes - most local libraries have relaxation
tapes and they are available in shops and on the internet.
There are a variety of different types of tapes available.
Some provide exercises to follow, usually to music, others
are simply a recording of natural sounds such as rippling
streams or whale song. You can put these on, shut your
eyes and drift away to a relaxing place.
Sleep
Getting enough sleep will help you cope with stress. Below
are some tips that will help you get a good nights rest.
• Try to go to bed and get up at the same time each day.
This will help your body to establish a regular sleep
pattern.
• Have a light snack and a drink such as warm milk
before going to bed. If you are hungry in the night it
will disturb your sleep.
• Avoid stimulants such as cola drinks, coffee, tea and
chocolate especially in the evening.
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• Limit your intake of alcohol. Alcohol might help you fall
asleep quickly but your sleep is likely to be disturbed.
• Try to do some exercise each day but avoid exercising
just before going to bed.
A more detailed booklet on sleeping well can be obtained
from the Royal College of Psychiatrists by phoning
020 7235 2351 or from their website - www.repsych.ac.uk
Talking
Some people find it helps to talk about their feelings and
emotions to a good friend. If you want to talk to someone
try to find a friend who you trust and who is good at
listening.
You may want to talk about things that you don't feel
comfortable speaking to a friend about. A variety of
organisation offer telephone support services where you
can ring and talk to someone about how you are feeling.
You could ring the Macmillan Cancer Relief telephone line
or the Cancer Bacup telephone service. They will be happy
to talk with you and can recommend other cancer support
services in your area. The Cancer Counselling Trust offers
a confidential telephone counselling service to individuals,
couples or families affected by cancer.
If you are stressed and you feel that you are not coping,
please ask for some advice next time you visit clinic.
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Macmillan Cancer Relief
89 Albert Embankment
London
SE17UQ
Freephone:
0808 808 2020
E-mail:
cancerline@macmillan.org.uk
Website:
www.macmillan.org.uk
Cancer Bacup Information Centre
Nottingham City Hospital
Hucknall Road
Nottingham
0115 840 2650
Freephone: 0808 800 1234
Website:www.cancerbacup.org.uk
Cancer Counselling Trust
1Noel Road
London
N18HQ
Tel: 020 7704 1137
Fax: 020 7704 1783
Email: support@cctrust.org.uk
Website: www.cctrust.org.uk
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Managing fatigue after your Bone Marrow
Transplant
What is fatigue?
• Fatigue is a feeling of excessive tiredness or exhaustion
that may occur some or all of the time.
• Fatigue is when the feeling of tiredness does not go
away even if you have lots of sleep and get plenty of
rest.
• Fatigue can affect you physically, psychologically and
emotionally.
What causes fatigue?
• There are many causes of fatigue
• We do not always know why one person becomes
fatigued and another does not.
• Chemotherapy and radiotherapy can cause fatigue.
• Fatigue can also be caused by anaemia, which is when
you have reduced levels of red blood cells.
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What can be done to help reduce fatigue?
After your bone marrow transplant you will have regular
blood tests and if your red cell count is very low you may
be given a blood transfusion. Alternatively you may be
given a regular subcutaneous (under the skin) injection of
a red cell growth factor that should increase your red cell
count.
If anaemia is not the cause of your fatigue a blood
transfusion or injections of growth factors will not help
and you need to find other ways to manage your fatigue
until it resolves.
There is lots of advice about how to manage fatigue but
no plan suits everyone. You will need to find out what
works for you. In this leaflet we explain two common
problems, how you can avoid them and what positive
steps you can take to cope with your fatigue.
Under-activity fatigue cycle.
Many people try and deal with fatigue by resting and
sleeping. If you avoid activity and rest continuously you
can become more fatigued rather than less. It might help
you to think of this as an under-activity fatigue cycle.
A lack of activity will cause further physical weakness. You
may feel unable to do the things you want to do, and this
can leave you feeling demoralised. You may lose
confidence or you may feel you are losing control. All of
these things can then make you feel worried, depressed
or anxious which in turn reduces your energy levels, your
fatigue increases and the cycle begins again.
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Under-activity
Fatigue Cycle
t
Loss of control
Loss of confidence
Demoralisation
Unable to carry
out activities
In order to reduce fatigue it is important to break this
cycle. The best place to do that is at the inactivity point.
Increasing your activity a small amount will help you to
increase your muscle strength enabling you to complete
an activity that you want to achieve. This increases your
confidence, reduces the risk of depression and should
prevent increased fatigue. The negative cycle is broken
and a new positive cycle of improving health begins.
There is more information later in this leaflet about how
you can gradually increase your activity levels when you
have fatigue.
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Over-activity fatigue cycle.
Rather than doing nothing, some people experiencing
fatigue try to deal with the problem by doing too much.
Trying to do too much when you are fatigued will result in
increased not decreased levels of fatigue. You may find it
helpful to think of this as an over-activity fatigue cycle.
Unrealistic choice
of activity
Over-Activity
Fatigue Cycle
Loss of control
Loss of confidence
Demoralisation
Unable to
complete activity
In order to reduce fatigue it is important to break this
cycle. The place to do this is at the over-activity point.
Choosing an activity that you can realistically complete is
very important. By gradually increasing your activity
levels and choosing realistic tasks you can rebuild your
strength, increase your confidence, reduce the risk of
depression and your levels of fatigue will slowly reduce.
It is completely normal when faced with fatigue to fall into
one or other of these cycles. It is not uncommon for
people to yo-yo between the two, not able to find the right
level of activity. The rest of this leaflet suggests some
guidelines for finding the right level of activity for you.
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Finding the right level of activity.
When coping with fatigue you need to look for a balance
in the amount you try and achieve. The following tips may
help you to avoid getting stuck in a cycle of increasing
fatigue.
• Pace your activities. Doing activities throughout the day
interspersed with periods of rest will help you to
conserve energy.
• Take a break before you need it so you are able to
maintain a certain level of activity day after day and
avoid over tiredness.
• Be aware that your limits will fluctuate from day to day.
• Do not take on more than you can manage.
• Stop when you feel tired. 'Listen to your body'.
• Take frequent rests both before and after completing a
task. Many short rest periods are better than a few long
ones.
• Set actual time limits and stick to them, especially on
good days when you may feel you can do more.
Learn when in the day you have the most energy and plan
activities accordingly.
On bad days make sure you do a little activity.
• Learn relaxation techniques to ensure proper rest is
achieved. Some basic relaxation techniques are outlined
in the leaflet 'Coping with stress after your BMT'.
• Have a routine sleep pattern by going to bed and
waking at the same time every day.
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• Consider the tasks you do during each day. Usually
there are ways of making each task easier to do:
Can the task be broken down into smaller tasks?
Can any part of a task be eliminated?
Can someone else help with the task?
Coping with fatigue is not easy.
There are no quick fix solutions and your improvement will
be gradual. This leaflet is just an introduction to the issue
of fatigue. If you want more information and support you
could:
• Speak to you doctor at clinic. This is especially
important if you feel that you are becoming depressed.
It is very common to feel this way after treatment for
cancer and it is important that you are honest with your
doctor. If you don't tell them how you are feeling they
can't help you.
• Contact Cancer Bacup and ask for a free copy of their
'coping with fatigue' leaflet.
Cancer Bacup Information Centre
Nottingham City Hospital
Hucknall Road
Nottingham
0115 840 2650
Freephone: 0808 800 1234
Website: www.cancerbacup.org.uk
• Phone Social Services on 0115 969 1169 ext. 46573. If
your fatigue means that you need help with personal
care and assistance at home a social worker may be
able to arrange for you to have some short term
assistance. Many social workers are also trained
counsellors, if your fatigue is getting you down you may
want to talk to them about how you are feeling.
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Financial Support after your
Bone Marrow Transplant
Are you receiving the benefits you are entitled to?
The Benefits Agency publish booklets which outline the
benefits that are available and who is entitled to them. You
can ask for the relevant booklets to be sent to you by
phoning the Benefit Enquiry Line.
Alternatively you can contact Social Services. You can
arrange to speak to a social worker who will check that you
are getting the correct benefits. This is especially important
if you did not see a social worker before you were
discharged from hospital. There may well be benefits that
you are unaware of, that you are entitled to.
Do you need some help with personal care at home?
Do you need help with managing your house and
shopping?
Are you struggling with food preparation?
Help is available for these problems. If you would like to
find out more then you need to speak to a social worker.
You can contact Social Services on the number listed on
page 5.
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Would you like to apply for a one off grant to help
with a particular expense such as a holiday?
Macmillan Cancer Relief provide grants to help people
living with cancer. You can find out more by phoning their
advice line; the number is listed below.
Social Services can also provide you with information about
applying for grants.
Would you like to talk to a trained counsellor?
Many social workers are also trained counsellors. If you
feel that you would benefit from seeing a counsellor
contact social services on the number below.
Several charities also provide advice and counselling for
people affected by cancer. Macmillan Cancer Relief or
Cancer Bacup can give you more information.
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If you think you need any further information about
the services mentioned in this booklet, then contact
any of the organisations shown below:
• Benefit Enquiry Line
• Macmillan Cancer Relief
• Social Services
• Cancer Bacup
0800 882200
0808 808 2020
0115 969 1169 ext. 46573
0115 840 2650
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"My life after a Bone Marrow Transplant"
by someone who has been through it
Welcome to my true-life story. I am 39 years old and I
feel very fit and healthy. My children are growing up fast
around me and I have a fulfilling and happy relationship
with my partner. I am employed and I also volunteer for a
cancer charity. I am proud to be where I am today.
For me the last few years have been a journey and the
ride has not always been a comfortable one. I have
written about my experiences and emotions. You mayor
may not be experiencing similar feelings. The aim of
writing this is to reassure you that you too can get your
life back on track and to let you know that you are not
alone.
At the age of 31, I was diagnosed with Chronic Myeloid
Leukaemia (CML). At this stage in my life I was a healthy,
fit, football playing man with everything to live for. My
symptoms started with feeling really tired so I went to
visit my local doctors. After 3 months of investigations I
was diagnosed and was admitted the next day.
From March to May I was cared for at the Derbyshire
Royal Infirmary, but then my Leukaemia went into a
myloblastic form and then the battle really began. I
remember this day very well - it was my sa= birthday. I
was then admitted to Nottingham City Hospital, where I
received all my treatment prior to, and all the care after,
my transplant. It wasn't until December that I was finally
able to go home and try to get back to a normal life.
After my discharge, appointments had been set up for me
on a weekly basis but still I felt isolated and frightened, as
I really didn't know what to expect. If I got an ache or
pain did this mean my leukaemia was back? If life in the
outside world was too much who would I turn to? My
family had been through enough; I didn't want to worry
them any more than I had to.
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My transplant had been a success, so medically I was fit
for discharge. What hadn't been addressed was what to
expect physically, mentally, emotionally, when facing the
outside world again. I'd gone into hospital looking
relatively fit, yet here I was now looking and feeling
somewhat different.
After all the different types of treatment I'd received I
came out of hospital bald, thin, blotted in the face. One
person said, "you look like a hamster, who's storing its
food in its mouth". Now I can smile, but then it really
brought it home to me what I looked like and it hurt.
People have no idea the battering your body has
undergone to get you back on the road to recovery.
My complexion was quite dark, grey with a tinge of yellow,
not looking like myoid self from before. Basically the way
you look is the last things on your mind. But to people
who haven't seen you since your treatment started it's
somewhat disturbing and embarrassing. You need to
remember what you body has been through and know
that in time it will correct itself.
On the path to recovery there will be lots of visits to the
day case unit for blood checks, transfusions, platelets, and
other forms of healthy top-ups. There could also be other
barriers to test you. You may find yourself battling
infections. You might find these physically and mentally
tiring. Patience and stamina are required through these
stages of recovery, just keep thinking of where you want
to get to, back in a normal and healthy life style.
My own rehabilitation appeared to go in stages and cycles
depending on my body's strength at the time to deal with
these changes. Patience, time and understanding is
required here and slowly but surely month by month you
will get things under control with the help of the after care
clinics. Battling leukaemia is like running a marathon not a
sprint. Something to bear in mind at all times.
There will be lots of feelings running through your mind
when you return home, some nice and some not so nice.
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You may feel lonely after your stay in hospital surrounded
by other patients and nursing staff. You may feel anxiety,
depression, tiredness and other pressures of coping again
in the outside world. Again feelings of 'how do I cope', and
'will I ever get back my normal life?'
On the opposite side to the negative emotions you may
feel, there will always be positive feelings. Good friends,
family and other acquaintances will send you letters and
get well cards. I also had one or two local churches saying
prayers for me. Friends who could not visit in hospital will
start coming round to see you. Once again this can be an
emotional time but you need to take heart and draw on
the support being offered by others.
Remember you should feel extremely proud and positive,
you have just battled with a life threatening disease and
you are on the road to a fit and healthy life again.
Below are some tips from my experience.
• I really feel that good support is vital whether it be
from family, friends, or carers, especially for the first
few months because believe me you are not at your
best!
• Exercise. This word feels like a swear word in the first
few weeks after returning home but the sooner you
start the better you will start to feel, being careful not
to over exceed your limits. You'll quickly find your
stamina improves and your energy levels increase as
you build up your exercise time.
• Force yourself to eat as much as you can. "Little and
often" was always a good tip as your taste buds will not
hold the pleasure they used to. But they will get better.
• Avoid crowds and anyone with a cold or flu, always
remembering your immune system is back in it's
infancy stage. You must give yourself the space your
body needs after the hammering its taken through
chemotherapy and radiotherapy.
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• Set yourself mini goals, strive for these as it helps with
the time on your hands between appointments and
gives you something to focus on. It is very rewarding
too and gives you a lot of satisfaction, as when you
succeed it helps boost your moral.
• Fear is a very strong emotion in that it can take all your
energy. Communicating is definitely the key to this. You
need to find somebody, it can be a family member,
friend, neighbour, who ever it is don't bottle up your
emotions, talk. You'll find it of great benefit and it helps
eradicate a lot of problems. You'll also receive guidance
so you know when you need to seek expert advice. If
you have a question seek advice and ask it, don't let it
eat you up inside.
• What is essential is to keep warm. I felt the cold like
never before but clothes were ill fitting due to the
amount of weight I'd lost. It's essential to wear
comfortable warm clothes in order to feel comfortable,
what I looked like at this stage wasn't even an issue.
Obviously if you don't feel like going out buying clothes
other people can do this for you, just to keep you
ticking over until you do feel like shopping. If you
haven't access to this, don't worry. You can shop as
easily at home now-a-days with catalogues and over
the Internet, you just have to use the services that are
available to you.
• My only other tip that worked for me was positive
thinking. This includes relaxation and visualising your
body healing, though this will take time and require
plenty of rest.
If you would like to get in touch to ask any questions my
email address is lifeafterbmt@hotmail.co.uk
I would be very happy to hear from you.
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Relationships after your Bone Marrow Transplant
This leaflet contains a collection of opinions expressed by people
who have had a bone marrow transplant and by the family and
friends of someone who has had a bone marrow transplant.
There is no normal or correct way to feel after you have had a bone
marrow transplant. You may find that some of the things expressed
in this leaflet voice exactly how you are feeling at the moment. You
might read others and think 'I can't-imagine ever feeling like that'.
You and the important people in your life might find it helpful to
discuss how the process of a transplant has affected your lives by
looking together at what other people have said.
If you are feeling particularly worried or anxious about the issues
raised in this booklet or any other aspect of your recovery it's a
good idea to talk to someone about how you are feeling. At the
back of this leaflet is a list of some of the places you can go to get
support and advice.
If you have any concerns please speak to a doctor or nurse next
time you come to clinic.
Worries and Anxieties
" I couldn't get it across
to people that this was
as major as having a
heart transplant. .. If I'd
had a heart transplant
they wouldn't be
expecti ng me to be
running around ... back to
normal, but a bone
marrow transplant, a lot
of people really felt. .. it's
not very major, because
you don't get cut open 1
think ..."
Patient
"It was a
relief to see
him back in
his own
home but
we were so
fearful of
visiting and
passing on
colds."
Sibling
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"Whilst my
partner was
going through
the transplant
process all I can
remember is
being so scared
and worried. "
What if it does
not work?"
Partner
"I've watched the effect of it when she was coming in and
being all brave and smiling away and going home and crying
all night."
Patient speaking about the effect on his partner
"We were always
anxious for news."
Sibling
"I was afraid of the phone
ringing, in case it was bad
news."
"Emotions were very
high with a feeling of
hopelessness, nothing
we could do to help but
be there."
Keeping Positive
"I always tried
to keep
positive but it
was very hard
especially
when visiting."
Friend
"It brought all
of our
relationships
closer and
stronger. "
Sibling
Friend
"I thought a lot about
why and how this
happened. "
Friend
Parent
"It was also hard because the
closeness you had as a coupie
takes a long time to come back.
I felt very lonely at times. This
does come back but it just takes
time. "
Partner
"I tried to keep my friend
positive by reflecting on our
happy times and trying to look
forward to the future."
Friend
" I have time with my child and my wife ... 1 mean I
never used to see my wife ... but now I try and spend
more time with her and my son."
Patient
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Ways of Coping.
"When my partner returned home
from hospital it was so hard to
cope with the mood swings and of
course you're the closest person
to them so you get the worst of
it. You've got to remember it's
the medication and that they
don't mean to upset you."
Partner
"We took each day, a
day at a time."
Parents
"Talk to the doctors and
nurses ask them
anything you are
unsure about."
Partner
"Talk to people about how you are feeling. I bottled everything
up trying to cope, trying to be brave. Not really wanting my
partner to know how I was feeling. You need help as we". My
family used to ask me if I was okay and I'd say I'm fine! But I
wasn't! I should have been more honest about how I was
feeling. "
Partner
"1 think life means a lot more to you when you have had a
serious illness ... it puts a different light on life ... we" it does for
me anyway, like you ... don't take things for granted any more."
Patient
"a friend of mine .,. went through a very bad experience where
she had a very bad divorce and then got re married really
quickly and 1was concerned and she said she wasn't going to
live her life in fear ... I've really hung onto it, 1wasn't going to
live my life in fear."
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Patient
Where can I go for more help and advice?
If you would like to talk to someone about any of the issues raised
in this leaflet there are several places you could go for further
advice and support.
• You could speak to the doctor or nurse next time you are at
clinic.
• The hospital has support staff from different faiths and religions
who would be happy to talk with you. You can find out more by
ringing 0115 969 1169 ext 46616.
• Cancer Bacup have a cancer information and support centre at
the City Hospital, Nottingham, where you can get advice and
support from a specialist cancer nurse. For more information ring
0115 8402650 or go to www.cancerbacup.org.uk.
• You could contact the Cancer Counselling Trust on
020 7704 1137. The Cancer Counselling Trust offer a confidential
telephone counselling service to individuals, couples or families
affected by cancer.
• You could ring the Macmillan Cancer Relief telephone line. They
will be happy to talk with you and can recommend other cancer
support services in your area. You can contact Macmillan Cancer
Relief on the following Freephone number 0808 808 2020.
• You could ring Social Services on 0115 969 1169 ext. 46573.
Many social workers are also trained counsellors.
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Medicines after your Bone Marrow Transplant
This leaflet will explain what you need to know about the most common
medicines that your doctor may prescribe for you after your bone
marrow transplant.
You can look up the medicine that you have been prescribed in the
table and find out, why each medicine is used, how long you might
expect to need it for, how to take it and any side effects that can occur
when you take the medication. You will not be prescribed all of the
medications in the table. Which medicines you have been prescribed
will be affected by several factors including the type of transplant you
have had.
It is important to take your medication regularly and to make sure you
don't miss doses - this is especially important with antibiotics and
ciclosporin.
Always read the labels and leaflets that come with your medication.
The doses in this booklet are only a guide. There are many reasons
why your doctor may have prescribed you a different dose. For
example you may be prescribed a lower dose in order to reduce the
side effects or if you have kidney or liver problems.
What to do if you experience the side effects of your medication
With all medicines if you notice side effects report them to a nurse,
doctor or pharmacist. You should mention any minor concerns that you
have when you come to clinic. If you feel that you are experiencing
problematic side effects or you want some advice about your
medications you can phone
Lynn Watson (Bone marrow transplant co-ordinator) 0115 969 1169
ext. 45702
Haematology Day-Case Unit 0115 969 1169
ext. 34263
Fletcher ward 0115 969 1169
ext. 34687
What to do if you think you are allergic to your medication
Some people can have an allergic reaction to a medication that they
have been prescribed however this is very unusual. The following
symptoms can occur if you are allergic to a medication;
• sudden wheezing or difficulty breathing;
• swelling of the eyelids, face or lips;
• skin lumps or hives (raised red or white itchy patches of skin).
It is very important that if you experience any of these symptoms you
seek urgent medical advice.
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Appendix B - HPL Programme Exercise Sheets
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Nottingham City Hospital Trust
MacMillan BoneMarrow Transplant Rehabilitation Programme"" Exercise Sheet A
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Nottingham City Hospital Trust
MacMillan Bone Marrow Transplant Rehabilitation Programme - Exercise Sheet A
Name Number
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Nottingham City Hospital Trust
MacMillan Bone Marrow Transplant Rehabilitation Programme '" Exercise Sheet E
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Nottingham City Hospital Trust
MacMillan Bone Marrow Transplant Rehabilitation Programme'" Exercise Sheet B
Name Number
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Nottingham City Hospital Trust
MacMillan Bone Marrow Transplant Rehabilitation Programme - Exercise Sheet C
Name Number
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Nottingham City Hospital Trust
MacMillan Bone Marrow Transplant Rehabilitation Programme #01 ExercIse Sheet C
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Appendix C - Approach Letters and Information Sheets
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Nottingham City Hospital '.!l:bj
NHS TrlJ5{
Nottingham City Hospital
Hucknall Road
Nottingham
NGS 1PB
Date
Dear
We would like to invite you to take part in a research trial which is investigating the
effects of rehabilitation on recovery after bone marrow or peripheral stem cell
transplantation.
This is a randomised controlled trial, which means that, if you agree to take part,
you will be randomly assigned to one of two groups.
One group will be asked to complete a health profession led rehabilitation
programme. This will involve attending the City Hospital in Nottingham, once a
week for 10 weeks. Each week a physiotherapist will assist you to complete an
exercise and relaxation programme - lasting about 1 hour and 20 minutes. This will
be followed by a support/information session. This session is on a different topic
each week and will be led by a relevant health professional. Topics that will be
covered include fatigue, stress, nutrition and financial support. This discussion time
will last about 40 minutes. The total time that the programme takes each week is 2
hours.
The other group will be asked to complete a self managed rehabilitation
programme. This can be completed at home and therefore does not require
additional visits to hospital. The programme provides advice on exercise and
includes a selection of exercises that can be completed at home without specialist
equipment. This programme also provides information booklets on the same topics
as covered in the health profession-led programme.
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If you agree to take part there is a one in two (i.e. 50%) chance of you being
assigned to each group.
Please feel reassured that if you decide not to take part this will not affect your
future treatment in any way.
If you would like more information about the study please feel free to speak to
With best wishes
Clinical Haematology
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Nottingham City Hospital lrl:bj
NHSTru\t
The Macmillan Bone Marrow Transplant Rehabilitation Programme
A randomised controlled trial investigating the effects of rehabilitation on
recovery after bone marrow or peripheral stem cell transplantation.
You are being invited to take part in a randomised controlled trial. Before you
decide if you would like to take part, it is important for you to understand why we
are undertaking the study and what it will involve. Please take time to read the
following information carefully and discuss it with others if you wish. Ask us if
there is anything that is not clear or if you would like more information. Take
time to decide whether or not you wish to take part.
Thank you for reading this.
The purpose of the study
Bone marrow or stem cell transplants are an increasingly common treatment for
many cancers of the blood. However, recovering after a bone marrow or stem cell
transplant can be difficult and frustrating. This is because treatment with a
transplant has many side effects. The extent and type of side effects that people
experience vary. Common problems include fatigue, reduced ability to carry out
physical tasks, and weight loss.
We are investigating ways of supporting people who have had a bone marrow or
stem cell transplant. Two different rehabilitation programmes have been devised
which provide information on how to cope with the common side effects
experienced after a bone marrow or stem cell transplant. We want to compare
these two programmes, so we are inviting people who have had bone marrow or
stem cell transplants to take part in this study. People who choose to take part
will be asked to complete one or other of the programmes.
What do the two programmes consist of?
One programme is a health profession led rehabilitation programme. Participants
assigned to this programme will be asked to attend the City Hospital in
Nottingham once a week for 10 weeks. Each week participants will take part in a
series of group activities. A physiotherapist will assist participants to complete a
group exercise and relaxation programme. This will be followed by a group
support/information session. This session will be on a different topic each week
and will be led by a relevant health professional. Topics that will be covered
include fatigue, stress, nutrition and financial support. The total time that the
programme takes each week is 2 hours.
The other programme is a self-managed rehabilitation programme. This draws
together the information and advice that is available to patients after a transplant
into an information pack that can be read at home. The programme provides
advice on exercise and includes a selection of exercises that can be completed at
home without specialist equipment.
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How do the two programmes compare with the usual care patients
receive after a bone marrow transplant?
Currently patients recovering after a bone marrow or stem cell transplant are
given advice about coping at home before they are discharged from hospital, they
are then seen regularly, initially once a week, at an outpatient clinic. There are
also a large number of resources that patients can access to find out more
information about coping after a transplant, for example the hospital has a
Cancer Bacup Information Centre where anyone affected by cancer can get
information and advice. Regardless of whether or not someone takes part in this
study they will receive this care and the usual support systems will be available to
them.
Can I choose which programme I would like to complete?
If you agree to take part in the study you will be assigned to one or other of
these two programmes. Participants are randomly assigned to one or other of the
groups by a computer that does not have any information about the individual -
ie. by chance.
The fact that assignment to each group is random means that you cannot choose
which group you would like to be part of. None of the staff involved in this trial or
in your routine care have any control over the group to which you are assigned. If
you decide to take part there is a one in two (i.e. 50%) chance of you being
assigned to each group.
Why have I been chosen?
As you have already undergone a bone marrow/stem cell transplant we would like
to invite you to take part in this study.
Do I have to take part?
It is entirely up to you to decide whether or not to take part. If you do decide to
take part you will be given this information sheet to keep and you will be asked to
sign a consent form. If you decide to take part you are still free to withdraw at
any time and without giving a reason. A decision to withdraw at any time, or a
decision not to take part, will not affect the standard of care you receive.
What would I have to do?
As well as completing the programme assigned to them, participants from both
groups will be asked to complete three questionnaires on three separate
occasions; at the start of the trial, at the end of the rehabilitation programme;
and after six months. Participants will be asked to complete these questionnaires
when attending a routine clinic appointment. The questionnaires should only take
about 25 minutes to complete.
Your exercise capacity will also be assessed at the start of the trial, after the end
of the rehabilitation programme and after six months. This assessment will take
place when you come for a routine clinic appointment and should take about 20
minutes to complete.
Some patients will also be invited to take part in an interview with a researcher at
the end of the trial. This can take place whilst you are visiting for a clinic
appointment or we can arrange for a researcher to visit you at home. The
interview will take approximately 1 hour and if you give permission an audio
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recording of the interview will be made. If you agree to take part in an interview
but find that talking about your experiences is distressing, the interview can be
stopped at any time. This is the same whether you are interviewed at clinic or in
your own home. The person conducting the interviews is a trained nurse and they
will seek to minimise the potential for distress.
this research distressing you can contact either
who can provide further support and advice. The
re at the end of this information sheet.
There will be no other restrictions imposed on you, and you should continue with
your usual activities as normal.
What are the risks and disadvantages of taking part?
We do not believe that by being involved in the programme you will be taking any
personal risk. The exercise components of the programme have been designed to
meet individuals needs and capabilities.
What are the possible benefits of taking part?
We hope that undertaking either programme will be of benefit to you, however
we cannot guarantee this. The information from this study may help us to
improve the care given to future patients recovering following a bone
marrow/stem cell transplant.
What if something goes wrong?
If taking part in this study harms you, there are no special compensation
arrangements. If you are harmed due to someone's' negligence, then you may
have grounds for legal action but you may have to pay for it. If you wish to
complain about any aspects of the way you ha
during the course of this study, you can contact
works for the University of Nottingham but is
research. His contact details are provided at the end of this information sheet.
- .-- • • 11 I. I-I' -.-.
• ,--. 1-'· ,- •
Will my taking part in this study be kept confidential?
All information collected about you during the course of the study will be kept
strictly confidential. Any information about you which leaves the hospital will have
your name and address removed so that you cannot be recognised from it.
If you decide to take part we will be informing your GP of your participation in
this trial.
What will happen to the results of the study?
We do not anticipate producing any results of the research until the two-year
programme has been completed. Your identity will remain anonymous upon
publication of the results.
Once the results have been analysed you will be invited to an informal meeting at
the City Hospital, Nottingham so that you can find out how the study went. A
brief written report will also be sent to you.
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Who is organising and funding the project?
The study is being organised by a team from the School of Nursing at the
University of Nottingham, working with the Haematology team at Nottingham City
Hospital.
The programme has been funded with a grant from Macmillan Cancer Relief.
None of the team will be financially rewarded by your taking part in this study.
Finally we would like to thank you for reading this. If you have any more
questions please contact a member of the team who will be happy to discuss the
study with you.
Contact names and numbers.
For information and support please contact
Details removed to maintain confidentiality
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Participant Information Sheet
The Macmillan Bone Marrow Transplant Rehabilitation Programme Trial.
We would like to invite you to be interviewed about your involvement in the
rehabilitation after bone marrow or peripheral stem cell transplantation research
trial. Before you decide it is important for you to understand why the research is
being done and what it will involve. Please take time to read the following
information carefully. Talk to others about the study if you wish.
Ask if there is anything that is not clear or if you would like more information. Take
time to decide whether or not you wish to take part.
What is the purpose of the study?
We are conducting a number of interviews with doctors, nurses and allied health
professionals as part of a larger study investigating recovery after bone marrow or
stem cell transplantation. It is anticipated that the interviews with these staff will
provide an opportunity to explore the thoughts and opinions of staff about recovery
after bone marrow or stem cell transplantation and the Macmillan Bone Marrow
Transplant Rehabilitation Trial.
Why have I been chosen?
You have been chosen to be invited to take part in an interview because you have
been involved in the rehabilitation trial.
Do I have to take part?
No. It is up to you to decide whether or not to take part. If you do, you will be
given this information sheet to keep and be asked to sign a consent form. You are
still free to withdraw at any time and without giving a reason
What will happen to me if I take part?
If you decide to take part we will arrange a time and location for an interview which
is convenient for you. This will be during work time and the interview will take place
in a quiet room in the clinic or office areas. It is not expected that interviews will
last for longer than 1 hour.
Will my taking part in the study be kept confidential?
Yes. All the information about your participation in this study will be kept
confidential. Your identity will remain anonymous in any publications of the results.
What if I have a complaint about the study?
If you have a concern about any aspect of this study, you should ask to
the primary researcher who will do their best to answer your questions
If you remain unhappy and wish to complain formally,
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this through the NHS Complaints Procedure. Details can be obtained from the
hospital.
What will happen to the results of the research study?
Once the results have been analysed you will be invited to an informal meeting at
the City Hospital, Nottingham so that you can find out how the study went. A brief
written report will also be sent to you.
Who is organising and funding the project?
The study is being organised by a team from the School of Nursing at the University
of Nottingham. The programme has been funded with a grant from Macmillan
Cancer Relief.
For further information about the study please contact
Thank you for taking the time to read this information sheet.
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Appendix 0 - Trial Paperwork
Consent forms, GP information letter, consultant referral form & randomisation letters
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Nottingham City Hospital 'rl;bj
NHSTru~t
CONSENT FORM
A randomised control trial investigating the effects of
rehabilitation on recovery after bone marrow or peripheral stem
cell transplantation.
Nottingham City Hospital
Department of Clinical Haematology and the University of Nottingham
I confirm that I have read & understood the patient information sheet
I confirm that I have had opportunity to ask questions & discuss the
study and my questions have been answered satisfactorily
I understand that my participation is voluntary and I am free to
withdraw at any time, without giving a reason, without my medical
care or legal rights being affected.
I understand that sections of any of my medical notes may be looked
at by the researcher from the University of Nottingham or from
regulatory authorities where it is relevant to my taking part on this
research. I give permission for these individuals to have access to my
records.
I give permission for my GP to be informed that I am taking part on
this research.
I agree to take part in the above study.
Pleaseinitial box
o
o
o
o
o
o
Name of Patient Date Signature
Name of person taking consent
(if different to researcher) Date Signature
Researcher Date Signature
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Nottingham City Hospital ,.'l:bj
NHS TflJ\t
CONSENT FORM for interview participation.
A randomised control trial investigating the effects of
rehabilitation on recovery after bone marrow or peripheral stem
cell transplantation.
Nottingham City Hospital
Department of Clinical Haematology and the University of Nottingham
Please initial box
I agree to being interviewed about my experience of
recovering after a BM/SCT D
DI agree to the interview being recorded with audio equipment
I understand that anonymous quotations from this interview
may be used in publications about this research D
I understand that I am free to stop the interview at any time, without
giving a reason and without my future care or legal rights being
affected. D
Name of Patient Date Signature
Name of person taking consent
(if different to researcher) Date Signature
Researcher Date Signature
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Nottingham City Hospital '~l:bj
NHS Tru~t
CONSENTFORMfor interview participation.
A randomised control trial investigating the effects of
rehabilitation on recovery after bone marrow or peripheral stem
cell transplantation (BM/SeT).
Nottingham City Hospital
Department of Clinical Haematology and the University of Nottingham
Please initial box
I agree to being interviewed about my involvement in the BM/SCT
rehabilitation trial. D
D
I agree to the interview being recorded with audio equipment
I understand that anonymous quotations from this interview
may be used in publications about this research D
I understand that I am free to stop the interview at any time, without
giving a reason and without my employment and legal right being
affected. D
Name of Participant Date Signature
Name of person taking consent
(if different to researcher) Date Signature
Researcher Date Signature
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Nottingham City Hospital [lJ:]
NHS Trll';t
The Macmillan Bone Marrow Transplant Rehabilitation
Programme Trial.
A randomised controlled trial investigating the effects of rehabilitation on
recovery after bone marrow or peripheral stem cell transplantation.
GP Information Letter
Name of Patient
Hospital Number
We are writing to inform you that the above patient has agreed to take part in the
Macmillan Bone Marrow Transplant trial. Some information regarding this study is
included below but if you would like further information please contact Lydia Bird on
9249924 ext 42462.
Signature
The purpose of the study
It is estimated that world-wide approximately 100000 people are 5 year survivors of
bone marrow/peripheral blood stem cell transplant (BM/SeT). This once
experimental procedure is now the treatment of choice for many patients diagnosed
with haematological malignancies. However the enormous impact that diagnosis and
subsequent treatment with BM/SCT has on an individual should not be
underestimated. Whilst this process does now offer the chance of cure from
previously fatal diseases, it is still a high risk treatment which is associated with
significant short and long term side effects that have a considerable impact on
patients' quality of life. Common complications include infection, bleeding, malaise,
nausea, pain, reduced physical functioning and fatigue.
This study aims to investigate physical and psychosocial recovery after BM/SCT. A
randomised controlled study design has been chosen to evaluate different
programmes aimed at providing support and information to patients who have
undergone a BM/SCT. Participants are randomly allocated to one or other of the
rehabilitation programmes.
What do the two programmes consist of?
One programme is a health profession led rehabilitation programme. Participants
assigned to this programme will be asked to attend the City Hospital in Nottingham
once a week for 10 weeks. Each week participants will take part in a series of group
activities. A physiotherapist will assist participants to complete a group exercise and
relaxation programme. This will be followed by a group support/information session.
This session will be on a different topic each week and will be led by a relevant
health professional. Topics that will be covered include fatigue, stress, nutrition and
financial support. The total time that the programme takes each week is 2 hours.
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The other programme is a self-managed rehabilitation programme. This draws
together the information and advice that is usually given to patients after a
transplant into an information pack that can be read at home. The programme
provides advice on exercise and includes a selection of exercises that can be
completed at home without specialist equipment.
How do the two programmes compare with the usual care patients receive
after a bone marrow transplant?
Currently patients recovering after a bone marrow or stem cell transplant are given
advice about coping at home before they are discharged from hospital, they are then
seen regularly, initially once a week, at an outpatient clinic. There are also a large
number of resources that patients can access to find out more information about
coping after a transplant. Regardless of whether or not someone takes part in this
study they will receive this care and the usual support systems will be available to
them.
What are participants asked to do?
As well as completing the programme assigned to them, participants from both
groups will be asked to complete three questionnaires on three separate occasions;
at the start of the trial, at the end of the rehabilitation programme; and after six
months. Participants will be asked to complete these questionnaires when attending
a routine clinic appointment.
Participants exercise capacity will also be assessed at the start of the trial, after the
end of the rehabilitation programme and after six months.
Some patients will also be invited to take part in an interview with a researcher at
the end of the trial.
Who is organising and funding the project?
The study is being organised by a team from the School of Nursing at the University
of Nottingham, working with the Haematology team at Nottingham City Hospital.
The programme has been funded with a grant from Macmillan Cancer Relief.
For further information about the study please contact
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Nottingham City Hospital r.'l:bj
NHS Trw.!
The Macmillan Bone Marrow Transplant Programme Trial.
Consultant Referral
Name of Patient
Hospital Number
Date of Transplant
Type of Transplant
I am in agreement with the above patient taking part in the
Macmillan Bone Marrow Transplant programme trial. I have
assessed the above and their blood counts and confirm that they
are physically able to take part in the programme.
Signature of Doctor
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Nottingham City Hospital h'l:bj
NHSTru\t
Nottingham City Hospital
Hucknall Road
Nottingham
NG5 1PB
Date
Dear
Thank you for agreeing to take part in the Macmillan Bone Marrow Transplant
Rehabilitation Trial. You have been randomly allocated to the Health Profession Led
Rehabilitation Programme.
This will involve attending the City Hospital in Nottingham, once a week for 10 weeks.
Each week a physiotherapist will assist you to complete an exercise programme. The
exercise programme will be tailored to your current level of health. The exercise
session is followed by a relaxation time which will usually consist of a hand, foot or
shoulder massage. This will be followed by a support/information session. This
information session is on a different topic each week and will be led by a relevant
health professional. Topics that will be covered include fatigue, stress, nutrition and
financial support. The total time that the programme takes each week is
approximately 2 hours.
The first rehabilitation session that you should attend will be held on
You need to arrive by 12pm and report to the Physiotherapy Main Department
Gym.
Please wear comfortable loose fitting clothes and flat shoes. You do not need to wear
sports clothing and trainer shoes. You might also like to bring a warm jumper or
jacket as you may feel cold when you finish exercising.
like more information please feel free to speak to
With best wishes
The BMT Rehabilitation Trial Team.
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Nottingham City Hospital 'rl:bj
NHS Truq
Nottingham City Hospital
Hucknall Road
Nottingham
NGS 1PS
Date
Dear
Thank you for agreeing to take part in the Macmillan Bone Marrow Transplant
Rehabilitation Trial. You have been randomly allocated to the Self Managed
Rehabilitation Programme.
With this letter you will be given a information pack that has been written specifically
for people who have just had a bone marrow or stem cell transplant. The pack
contains advice and information on eight different topics. One of these is exercise. As
well as providing guidance on exercising safely the leaflet suggests a programme of
exercises for you to complete at home.
Please take these leaflets home with you and read them carefully. You can ask any
questions, you may have, relating to the information in the leaflets on any visit to
clinic. In approximately 12 weeks time you will be asked to complete the same
questionnaires as you have completed today. We will also ask you to complete them
again in 6 months time.
If you would like more information please feel free to speak to
With best wishes
The BMT Rehabilitation Trial Team.
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Appendix E - Data Collection Questionnaires
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Study Number:
Today's Date:
Date of Birth:
Your Health and Well-Being
This survey asks for your views about your health. This information will help
keep track of how you feel and how well you are able to do you r usual activities.
Thank you for completing this survey!
For each of the following questions, please tick the one box that best describes
your answer.
1. In general, would you say your health is:
Excellent Very good Good Fair Poor
T T T T T .-.
D. - 02 D) D. Os
2. Compared to one year ago, how would you rate your health in general
!!.!n!?
Somewhat Somewhat
Much better better About the worse Much worse
now than one now than one same as now than one now than one
year ago year ago one year ago year ago year ago
T T ... ... T
D. Ol D) D. Os
SF-36v2'" Hwth Survey e 1992-2002 by Health Assessment Lab, Medical Outcomes Trust and Qu,alilyMelric Incorporated. AUrights reserved,
SF-36e is a registered trademark of Medical Outcomes Trust
(IQOLA SF-36v2 Standard, English (United Kingdom) 8102)
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3. The following questions are about activities you might do during a typical
day. Does your health now limit you in these activities? If so, how much?
Yes, Yes, No, not
limited limited limited
a lot a little at all
T T T
Vigorous activities, such as running, lifting
heavy objects, participating in strenuous sports 0 I • .• • • • • • .• • • •0 2 • • ..• .• • • .• • • 0 3
b Moderate activities, such as moving a table, pushing
a vacuum cleaner, bowling, or playing golf 0 1 • • • • • • • • • • • • •0 2 • • • • • • • • .• • .•D]
Lifting or carrying groceries D I ·• · · ·• · · · ·• .•0 2 • ..• ..• • • .• • • D 3
Climbing several flights of stairs D 1 • .• .........• 0 2 .......• ...• . D 3
Climbing one flight of stairs ..· · .· · · · · · · · · · · · · · · ·.. · 0 I D 2 D 3
Bending, kneeling, or stooping 0 I 0 2 D 3
Walking more than a mile 0 I D 2 D 3
h Walking several hundred yards D 1 D 2 03
Walking one hundred yards 0 I 0 2 D 3
Bathing or dressing yourself.. 0 I 0 2 • .• .......... D 3
4. During the past 4 weeks, how much of the time have you had any of the
following problems with your work or other regular daily activities as a
result of your physical health?
All of
the time
Most of
the time
T
Some of A little of None of
the time the time the time
T T T
Cut down on the amount of
time you spent on work or
other activities 0 1. 02 0 3 .• • ....• ...... 0 05
Accomplished less than you
would like O 1. ..• ....• ....• 02 0 3 • • • • • • • • • • • • • •0 4 • • • • • • • • • • • • • •05
c Were limited in the kind of
work or other activities 0 1. .......• ..... 0 2 0 3 • • • • • • • • • • • • • •0 0 5
Had difficulty performing the
the work or other activities (for
example, it took extra effort) O 02 0 3 • • • • • .• • .• ..• •0 4 • • .• • ..• • • ..• . 05
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5. During the past 4 weeks, how much of the time have you had any of the
following problems with your work or other regular daily activities as a
result of any emotional problems (such as feeling depressed or anxious)?
Some of A little of None of
the time the time the time
T T T
All of
the time
T
Most of
the time
T
Cut down on the amount of
time you spent on work or
other activities 0 1 • ..• .• • • • ..• .• 02 0 3 ..• .......• .• • 04 0 S
Accomplished less than you
would like O 1........• ...• • 02 0 3 • • • • • • • • • • • • • •0 4 • • • • • • .• • • • • • •0 S
c Did work or other activities
less carefully than usual O 1. 0 2··· .. • • • · • .• • •0 3 0 4 • ..• • • .• • • • • • •0 S
6. During the past 4 weeks, to what extent has your physical health or
emotional problems interfered with your normal social activities with
family, friends, neighbours, or groups?
Not at all
T
01
Slightly
T
Moderately
T
D3
Quite a bit
T
D4
Extremely
..
Ds
7. How much bodily pain have you had during the past 4 weeks?
None Severe Very severe
T
06
T
01
Very mild
T
02
Mild
T
Moderate
T
04
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8. During the past 4 weeks, how much did pain interfere with your normal
work (including both work outside the home and housework)?
Not at all
...
01
A little bit
...
02
Moderately
...
03
Quite a bit
...
o.
Extremely
...
05
9. These questions are about how you feel and how things have been with you
during the past 4 weeks. For each question, please give the one answer that
comes closest to the way you have been feeling. How much of the time
during the past 4 weeks • .•
All of
the time
Most of
the time
Some of A little of None of
the time the time the time
Did you feel full of life? 0 I. 0 2 ..• • • • ....• • • • 0 3 .• • • .• .......• 04 0 5
Have you been very nervous? 0 1. 02 0 3 • .• • • • • ..• • .• •0 05
Have you felt so down in the
dumps that nothing could .
cheer you up? 0 1 • .• • • • • • • • • • • •02 0 3. 04 05
Have you felt caIrn and
peaceful? O1 • • • • • • • • .• • • • •02 0 3 • • .• • • .• • .• • • .0 0 s
Did you have a lot of energy? 0 1..• • • .• • .• ..• •0 2 • • • • • • • • • • • • • •0 J • • • • • • • • • • • • • •0 4 • • • • • • • • • • • • • •0 5
Have you felt downhearted
and low? 0 1. 02 0 3··· · · · 0 0 s
Did you feel worn out? 01 0 2 ..• ..• .• ...... 03. 04 05
Have you been happy? 0 1. ...• .• ....... 0 2 • • • • • • • • • ...• •0 3 • ..• .• • • • • • • • •0 0 s
Did you feel tired? 0 I 0 2 • • • • • • • • • • • • ..0 3. • • .• .........04 0 s
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10. During the past 4 weeks, how much of the time has your physical health
or emotional problems interfered with your social activities (like visiting
with friends, relatives, etc.)?
All of
the time
T
01
Most of
the time
T
02
Some of
the time
T
03
A little of
the time
T
o
None of
the time
T
Os
11. How TRUE or FALSE is each of the following statements for you?
Definitely Mostly
true true
T T
Don't
know
T
Mostly Definitely
false faIse
T T
I seem to get illmore
easily than other people O 1 • • • • • • • • • • • • • •02 0 3 • • • • • • • • • • • • • •0 0 S
b Iam as healthy as
anybody Iknow O 1. 02 0 3·.· 0 0 S
Iexpect my health to
get worse 0 1. ...• .....• • .. 02 0 3 • • • .• • • • • .• .• •0 0 s
My health is excellent 01. 0 2 .• • • .......• .. 0 3··· · • • • • • • ....0 0 S
Thank you for completing these questions!
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Study Number:
Today's date:
Date of Birth:
General Health Questionnaire
(GHQ-12)
PI............. .......,.
We shoutd like to know if you have had any medical complaints and how your health has
been in general. over the last few weeks. Please answer All the questions simply by under-
lining the answer which you think most nearly applies to you. Remember that we want to
know about present and recent complaints. not those that you had in the past.
It is important that you try to answer ALl the questions.
Thank you very much for your co-operation.
Have you recently . . .
1. been able to COII08i tilate Better Same less Much less
onwhata ... than usual as usual than usuaJ than usual
you're doktg?
2. 10st much sleep Not No more Rather more Much more
over worry? at aM than usual than usual than usual
3. felt that you are playing a More so Same less useful Much less
useful part in things? than usual as usual than usual useful
4. leh capable of making More so Same less so Much less
decisions about things? than usual as usual than usual t';an usual
5. feh constantly Not No more Rather more Much more
under strain? at all than usual than usual than usual
6. felt you couldn't Not No more Rather more Much more
overcome your at all than usual than usual than usual
difficuhies?
7. been able to enjoy More so Same less so Much less
your normal day-to-day than usual as usual than usual than usual
activities ?
8. been able to face up to More so Same Less so Much less
your problems? than usual as usual than usual able
9. been feeling unhappy and Not No more Rather more Much more
depressed? at all than usual than usual than usual
10. been losing confidence in Not No more Rather more Much more
yourself? at all than usual than usual than usual
11 been thinking of yourself Not No more Rather more Much more
as a worthless person? at all than usual than usual than usual
12. been feeling reasonably More so About same Less so Much less
happy, all things than usual as usual than usual than usual
considered?
(c) Goldberg. 1978. Reproduced with the kind permission of tbe author and the publishers. NFER-NELSON
This measure is part of Measures In Health Psychology.' A User's Portfolio, written and compiled by Professor Marie
Johnston, Dr Stephen Wright and Professor John Weinman. Once the invoice has been paid, it may be photocopied for
use within the purchasing institution only. Published by The NFER-NELSON Publishing Company Ltd, Darville
House, 2 Oxford Road East, Windsor, Berkshire ~I .1 1m: IlK Code 4920 03 4
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Study Number:
Today's Date:
Date of Birth:
The Graham and Longman Two Question Quality of Life Scale.
(Graham and Longman 1987).
• How would you rate you current quality of life?
(poor) 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 (excellent)
• How satisfied are you with your with your current quality of life?
(not satisfied at all) 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 (very satisfied)
Thank you for taking the time to answer these questions.
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Name
Date
Which Rehabilitation Programme would you prefer to
complete?
Self Managed I Health Profession Led I No preference
Please be aware that your choice will not affect which group you
are allocated to.
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Nottingham City Hospital rrf:bj
NHS Trmt
The Macmillan Bone Marrow Transplant Programme
Patient Demographic Information
Name of Patient
Hospital Number
Disease Type
Date of Diagnosis
Date of Birth
Gender
Height
Weight
Type of Treatment:
Conditioning protocol
Male/Female
Type of Transplant
Source of Cells
Date of Transplant
Disease status (time of transplant) _
Current Disease Status
Most Recent Blood Count Results:
Haemoglobin _
Platelets
White cells
Neutrophils
CMV status:
Donor
Recipient
GVHD:
Grade
Site
Acute/Chronic
Social Circumstances, patient lives:
Alone
With NOK
With dependants
Yes/No
Yes/No
Yes/No
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285
Interview Guide - HPL
Thank you for agreeing to see me. Please feel free to say exactly what you want. I am interested in your
story and your views. What you tell me will be treated in the strictest confidence.
I have come to talk to you today about the rehabilitation trial that you have taken part in over the last 6
months.
Now that you are at the end of the trial how do you feel about having taken part?
How did you feel about the fact that the allocation of the rehabilitation programmes was done randomly?
Did you receive the programme that you most preferred?
At the time how did that make you feel?
Looking back now do you still feel the same way?
Can you tell me about the rehabilitation programme that you received?
Was the programme what you expected?
How did you find the exercise component of the rehab?
Was it helpful?
Would you change anything about the exercise sessions?
Did you use the structured exercises that were described in the leaflet?
How did you find them?
Do you use the exercise diary?
Are you still doing them?
How did you find the information sessions?
Which ones were you able to attend?
Were you given information that was new / helpful?
What stands out in your memory about the information sessions?
Would you change anything about the information sessions?
What about the other information leaflets?
Were they helpful?
What stands out in your memory about the leaflets?
Would you change anything about the information leaflets?
Did you find the relaxation exercises helpful?
How did you find being in a group with other people who had also had bone marrow or stem cell
transplants?
How important or unimportant was this aspect of the programme for you?
How did you find the questionnaires that you were asked to fill in?
How did you find the walking test?
Where these a bother to complete? Did you find that they caused any problems with your visit to clinic?
Did you have to make an extra trip to hospital to complete them?
If you could step back in time would you change any of the decisions you made in relation to the trial?
Is there anything that you think should be changed about the trial?
Is there anything else you would like to share with me about either the trial or the rehab programme?
GeneralProbes:
Couldyou tell me a bit more about that
Howdid you find that experience
Whatdo you meanby...
Howdid that makeyou feel
Whatcould havebeendone different
Whydo you think that happened
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Interview Guide - SM
Thank you for agreeing to see me. Please feel free to say exactly what you want. I am interested in your
story and your views. What you tell me will be treated in the strictest confidence.
I have come to talk to you today about the rehabilitation trial that you have taken part in over the last 6
months.
Now that you are at the end of the trial how do you feel about having taken part?
How did you feel about the fact that the allocation of the rehabilitation programmes was done randomly?
Did you receive the programme that you most preferred?
At the time how did that make you feel?
Looking back now do you still feel the same way?
Can you tell me about the rehabilitation programme that you received?
Was the programme what you expected?
How did you find the exercise component of the rehab?
Did you use the structured exercises that were described in the leaflet?
How did you find them?
Do you use the exercise diary?
Are you still doing the exercises?
What about the other leaflets?
Were they helpful?
Did they contain information that was new to you?
What stands out in your memory about the leaflets?
Would you change anything about the information leaflets?
How did you feel about not being in a group with other people who had also had bone marrow or stem
cell transplants?
How did you find the questionnaires that you were asked to fill in?
How did you find the walking test?
Where these a bother to complete? Did you find that they caused any problems with your visit to clinic?
Did you have to make an extra trip to hospital to complete them?
If you could step back in time would you change any of the decisions you made in relation to the trial?
Is there anything that you think should be changed about the trial?
Is there anything else you would like to share with me about either the trial or the rehab programme?
GeneralProbes:
Couldyou tell me a bit more about that
Howdid you find that experience
Whatdo you meanby...
Howdid that makeyou feel
Whatcouldhavebeendonedifferen
Whydo you think that happened
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Staff interviews - Nursing and Physio staff
Thanks for agreeing to be interviewed.
Can you start by telling me about the work that you do with BMT patients as part
of your regular clinical role?
Can you tell me about your involvement in the BMT rehab trial?
Design, Set up, Running, Recruiting
And what about the HPLprogramme in particular?
Which elements of the programme did you think were particularly important?
How did you find your involvement in the trial?
What was positive/negative?
How did you feel about the trial being run in the department?
Did you have any concerns about the trial?
As you will be aware the trial did not recruit as many patients as would have been
ideal. Did this surprise you?
Where you involved in speaking to patients about the trial?
How did you find this?
Do you have any ideas about how recruitment and retention could have been
increased?
From your experience of working with patients who have had BMTwhat do you
think are the key barriers to engagement with rehab ~r.rvir:p.~?I\nd what do you
think promotes engagement?
In both this study and others, where patients have been interviewed
retrospectively about their illness many patients suggest that they would have
liked more rehab. Yet engagement with the intervention in this trial was low. Do
you have any ideas why that is?
What do you think should happen to the programmes now that the trial has
finished?
HPL/SM
Is there anything you think should be done differently if the trial was starting
over again?
Can you tell me what you hoped the trial would achieve? Do you think this
happened?
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Staff interviews - Doctors
Thanks for agreeing to be interviewed.
How did you feel about the trial being run in the department?
Did you have any concerns about the trial?
As you will be aware the trial did not recruit as many patients as would have been
ideal. Did this surprise you?
Where you involved in speaking to patients about the trial?
Did patients ever speak to you/seek advice from you in relation to the trial?
Do you have any ideas about how recruitment and retention could have been
increased?
From your experience of working with patients who have had BMTwhat do you
think are the key barriers to engagement with rehab services? And what do you
think promotes engagement?
In both this study and others, where patients have been interviewed
retrospectively about their illness many patients suggest that they would have
liked more rehab. Yet engagement with the intervention in this trial was low. Do
you have any ideas why that is?
What do you think should happen to the programmes now that the trial has
finished?
HPL/SM
Is there anything you think should be done differently if the trial was starting
over again?
Can you tell me what you thought the trial would achieve? Do you think this
happened?
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Appendix G - Power Calculation
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Power Calculation to determine sample size.
The following formula (Pocock, 1983) was used to calculate the
sample size required for the trial.
a = the standard deviation of the mean change obtained from
the pilot data
v2 - VI = expected change in mean response
f(a,p)= Value for power and significance obtained from Pocock
(1983) where alpha=O.05 and beta=O.2.
_ 2 x 18.922 7 9
n - 2 x.
10
n = 56.6
2n = 114
Aim to recruit 132 to allow for 15% attrition.
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